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Synopsis 
 
Eine Grundvoraussetzung für strukturbiologische und biochemische Analysen ist die 
Verfügbarkeit von Proteinen in großen Mengen und ausreichender Qualität. Die 
Identifizierung von exprimierbaren Varianten eines Zielproteins und die Evaluierung des 
am besten geeigneten Expressionswirtes ist jedoch ein zeit- und arbeitsaufwendiger sowie 
kostenintensiver Prozess. Daher stellt die rekombinante Produktion von Zielproteinen in 
eukaryotischen Expressionssystemen einen entscheidenden Flaschenhals in der 
strukturbiologischen Forschung dar.  
In dieser Arbeit wurde der neuartige Expressions- und Donorvektor pFlpBtM konstruiert, 
der für die Produktion von Zielproteinen in den verschiedenen eukaryotischen 
Expressionssystemen der Helmholtz Protein Sample Production Facility (PSPF) eingesetzt 
werden kann. Dies wurde durch die bislang nicht verfügbare Kombination der Elemente 
mehrerer leistungsfähiger Expressionsmethoden in einem einzigen Plasmid ermöglicht. 
Der Vektor eignet sich dadurch sowohl für die parallele Evaluierung von verschiedenen 
Wirtssystemen sowie für ein schnelles Screening von verschiedenen Proteinkonstrukten 
mittels transienter Expression. Die Funktionalität des Vektors konnte über die 
erfolgreiche Expression unterschiedlicher Modellproteinklassen in der humanen Zelllinie 
HEK293-6E, dem Baculovirus Expressionsvektorsystem sowie in stabiler genomischer 
Expression nach Rekombinase-vermitteltem Kassettenaustausch (RMCE) in einer 
dedizierten CHO Lec3.2.8.1 Masterzelllinie gezeigt werden.  
Die Expressionsplattform wurde zudem um speziell entwickelte Insektenzelllinien 
erweitert, die eine stabile genomische Expression von integrierten Proteinen ermöglichen 
und sich daher als optimierte Wirtszelllinie für die baculovirale Expression von besonders 
anspruchsvollen Zielproteinen eignen. Die bislang nicht verfügbare Implementierung des 
flexiblen RMCE für die Integration von auxiliaren Proteinen in Insektenzellen ist 
kompatibel zu dem bereits vorhandenen System in CHO Lec3.2.8.1 Zellen. Durch die 
Kombination des vielseitigen Vektors und optimierten Wirtszellen bietet die PSPF jetzt 
eine integrierte Infrastruktur zur Proteinproduktion in eukaryotischen Systemen, die als 
„multi-host expression system“ (mHost-XS) bezeichnet wird. 
   Synopsis 
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Synopsis 
 
A prerequisite for structural and biochemical analyses of proteins is the availability of 
large amounts of high-quality material. However, the recombinant production of complex 
proteins typically requires a profound screening process to identify expressible constructs. 
Furthermore, the evaluation of an optimal expression host has an important impact on 
protein quality, yield and cost efficiency. As a result, the production of target proteins in 
eukaryotic systems remains a major bottleneck in structural biology. 
In this work, the novel expression/donor vector pFlpBtM has been constructed to be 
utilised for both, the rapid screening for expressible protein variants and the evaluation of 
an optimal expression host. The range of applications of this vector comprises a variety of 
highly efficient eukaryotic hosts for recombinant protein production used at the 
Helmholtz Protein Sample Production Facility (PSPF). It was realised by the unique 
combination of the elements required for different expression methods including 
transient, viral and stable expression strategies. The efficiency of the vector is 
demonstrated in a comparative expression study of model proteins from different protein 
classes. In order to optimise the production strategy for each protein, they have been 
produced employing pFlpBtM as the donor- or expression vector by transient expression 
in HEK293-6E cells as well as in the baculovirus expression vector system and by stable 
expression using a recombinase mediated cassette exchange system in CHO Lec3.2.8.1 
cells. 
Additionally, engineered BEVS host cell lines were generated, which enable the stable 
genomic expression of auxiliary proteins to facilitate the production of particularly 
challenging target proteins. The flexible RMCE system was implemented in insect cell 
lines for the first time to provide optimised coexpression for each target protein and 
deploy compatibility to the RMCE CHO Lec3.2.8.1 cell lines previously developed in our 
group. With the combination of a versatile donor/expression plasmid and optimised 
mammalian and lepidopteran producer cell lines, the PSPF offers an integrated platform 
for protein production in eukaryotic systems. This high performance infrastructure was 
therefore termed “multi-host expression system” (mHost-XS). 
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1 Introduction 
1.1 Recombinant protein expression 
Proteins represent the most versatile class of biological molecules since they are involved 
in virtually every essential process within cells, such as metabolism, regulation, signalling, 
transport or structuring. Thus, knowledge of structure and function of proteins is 
indispensable for the understanding of biological processes and concepts. Moreover, 
information about functional sites and binding partners of proteins that are involved in 
pathogenesis substantially facilitates the development of drugs and treatment strategies 
(Buchanan, 2002).  
The beginnings of protein research date back to the early 19th century. In the paper “On 
the composition of some animal substances” Gerardus J. Mulder described molecules 
much larger than those chemists of the time were used to deal with (Mulder, 1838). His 
hypothesis that there was a fundamental substance from which all proteins were 
composed, led to the identification of the amino acids (Perrett, 2007). About 200 years 
later, proteins are not only the aim of basic research, but also have become a versatile tool 
for biotechnological and pharmaceutical applications. They are used as enzymes in 
biocatalytical processes, vaccines or therapeutics. This fact illustrates how visionary Jöns J. 
Berzelius had been, when he coined the term protein in 1838 from the Greek word 
πρώτείος, meaning “primary” to emphasise its importance. 
However, a prerequisite for the structural and functional analysis of proteins as well as 
for their use in biotechnological or pharmaceutical applications is the availability of 
proteins in large quantities and high quality. These demands usually cannot be met by 
isolating proteins from natural sources. Thus, protein production is performed by 
recombinant expression, which not only allows to comply with the requirements 
mentioned before, but also enables the generation of genetically optimised products or 
isolated protein domains that are not available in vivo. These include fusions with markers 
for identification, purification or improved solubility (Arnau et al., 2006), as well as 
truncated protein variants, single domains, hybrid proteins or novel engineered protein 
species such as alternative antibody formats (Carter, 2006; Kontermann, 2011). 
  INTRODUCTION 
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Heterologous expression of proteins was not possible until the development of 
recombinant DNA technology in the early 1970s (Cohen et al., 1973). Rapid progress in 
that field enabled the recombinant production of human insulin by the end of that decade 
(Goeddel et al., 1979) that finally was available as the first biotechnologically produced 
pharmaceutical by Eli Lilly in 1982. Ongoing advances over the last 30 years allowed an 
extension of the spectrum of expression hosts beyond prokaryotic systems, thus today 
also yeasts as well as invertebrate or vertebrate cell lines are used for the heterologous 
production of proteins. The diverse hosts show major differences regarding the required 
expression strategy as well as in protein quality and yield (Hunt, 2005). Furthermore, 
protein production in eukaryotic cell lines is generally more time-consuming and 
expensive than in bacteria. Thus, a profound screening for the best protein construct as 
well as the most appropriate host regarding both yield and quality of protein is essential. 
Accordingly, the development of new methods and optimised production procedures 
represent a worthwhile challenge for biotechnological research. 
 
1.2 Bacterial and fungal expression hosts 
E. coli is the predominant host for recombinant protein expression due to its well-
characterised genetics and its ability to grow rapidly at high densities on inexpensive 
substrates (Baneyx, 1999). Today, a large variety of optimised dedicated expression strains 
and an increasing number of cloning vectors are available (Sorensen & Mortensen, 2005). 
Furthermore, cultivation techniques have been established that permit labelling of 
recombinant proteins with heavy atom derivatives such as selenomethionine or with 
stable isotopes such as 2H, 13C and 15N facilitating structural studies by X-ray 
crystallography and nuclear magnetic resonance (NMR) spectroscopy (Bernard & Payton, 
2001). Besides E. coli, strains of the gram positive streptomyces and bacillus species are also 
used as bacterial expression hosts. B. megaterium for instance is distinguished by the 
absence of endotoxins and its efficient secretory pathway. Thus, recombinant production 
of secretory proteins such as Penicillin G amylase or antibody fragments has already 
successfully been performed in this host (Yang et al., 2006; Jordan et al., 2007). However, 
many viral and mammalian proteins either require post-translational modifications for 
proper folding and full biological activity or have to be coexpressed with binding partners 
as a multi protein complex for their structural stability (Nettleship et al., 2010). Since 
INTRODUCTION 
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prokaryotes are not capable to impart these modifications, misfolding of heterologous 
proteins may occur upon overexpression leading to the formation of inclusion bodies 
(Gray, 2001). As a result, only 10 - 20 % of eukaryotic proteins can be expressed in E. coli 
in soluble form (Büssow et al., 2005). Therefore, eukaryotic expression hosts are 
indispensable for recombinant production of those proteins and consequently about 10 % 
of all protein structures submitted to the Protein Data Base (PDB) have been solved after 
expression in eukaryotic systems.  
Besides mammalian cell cultures and baculoviral expression in insect cells which are 
described more detailed in chapters 1.3 and 1.4, yeasts are the third major eukaryotic 
system for recombinant protein expression. As single-cell eukaryotic hosts, they combine 
some of the advantages of prokaryotic and eukaryotic based expression systems being 
physically robust and amenable to high-density fermentation and additionally possess the 
necessary cellular machinery to carry out post-translational modiﬁcations (Aricescu et al., 
2006). The methylotrophic yeast Pichia pastoris and the baker’s yeast Saccharomyces 
cerevisiae are the most important fungal expression hosts. In P. pastoris, more than 400 
different heterologous genes have been expressed under the control of the strong and 
tightly regulated P. pastoris alcohol oxidase 1 (AOX1) promoter (Cereghino et al., 2002). 
The combination of strong expression and efficient secretion mediated by the MATα 
prepro secretion signal (Brake, 1990) allows to produce large amounts of recombinant 
proteins, which accumulate in the culture supernatant (Cregg et al., 2000). Additionally, 
minimal media enable the production of 13C-labelled proteins for NMR-based structural 
analyses (Laroche et al., 1994). The major disadvantage in the use of Pichia as expression 
host is that no episomal replication of the expression plasmids is possible. Transfer 
vectors bearing the gene of interest need to be integrated into the host cell genome via 
homologous recombination. The time-consuming screening for a expression clone limits 
the use of this system for a parallel high-throughput screening. In S. cerevisiae genes of 
interest are expressed under the control of the copper inducible metallothionein promoter 
(CUP1). Although episomal replication of genetic elements harbouring the transgene is 
possible in this host, the quality of recombinantly produced target proteins is adversely 
affected by the occurrence of hyperglycosylation. Proteins expressed in S. cerevisiae often 
carry poly-mannose glycans composed of up to 350 mannose residues (Nakamura et al., 
1993) and are thus not suitable for crystallisation as complex and inhomogeneous glycan 
side chains inhibit the formation of protein crystals (Baker et al., 1994). 
  INTRODUCTION 
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1.3 Baculoviral expression in insect cells 
Lepidoptera cell lines are favourable for the production of proteins for crystallization due 
to their simple glycosylation pattern (Tomiya et al., 2004) and the scalability of the virus-
dependent expression in suspension culture. Hence, the Baculovirus Expression Vector 
System (BEVS) is predominantly used for the production of proteins for structural 
analyses with a share of almost 50 % among all eukaryotic systems (Figure 1-1). Since 
Lepidoptera are the natural hosts for baculoviridae, infection, viral replication and 
promoter activity are highly effective. Thus, yields of up to 75 mg recombinant proteins 
per L have been reported (Meghrous et al., 2009).  
 
 
Figure 1-1: Total number of protein chains deposited in the PDB by expression host 
Cumulative total number of protein chains in the PDB whose expression system was identified as mammalian, insect, 
baculovirus, fungi or yeast is plotted by year of deposition. Expression data were parsed by Joachim Reichelt from the 
set of PDB files available as of December 2011. Chains were counted rather than PDB entries as expression information 
is recorded by chains in the PDB. 
 
Three lepidopteran cell lines are of major relevance for recombinant protein production in 
the BEVS. IPLB-SF-21AE (Vaughn et al., 1977) was generated at the USDA Insect 
Pathology Laboratory (IPLB) from pupal ovarian tissue cells of the Fall Armyworm 
Spodoptera frugiperda (Gardiner & Stockdale, 1975). In 1983 the Sf9 cell line was derived as 
a subclone thereof by G. Smith at Texas A&M University (Summers & Smith, 1987). In 
recent years, genetically engineered Sf9 subclones have been described, where stable 
genomic integrations of mammalian glycosyltransferases enable their use for the 
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production of glycoproteins with human like glycosylation (Jarvis et al., 1998; Hollister et 
al., 2002; Legardinier et al., 2005). The third important host cell line is BTI-Tn-5B1-4 
(Wickham & Nemerow, 1993) which had been generated at the Boyce Thomson Institute 
in Ithaca and is commercialised by Invitrogen as High Five™. Its parental line BTI-Tn-
5B1-28 had been isolated from ovaries of the Cabbage Looper Trichoplusia ni (Granados et 
al., 1986). Other less common host cell lines for protein production are MB0507 derived 
from Mamestra brassicae (King et al., 1991) or Bm5 from Bombyx mori (Grace, 1967). 
While the simple and homogenous glycosylation pattern provided by insect cell lines is 
advantageous for producing proteins for structural biology, it is likewise a major 
drawback for the production of pharmaceuticals. The high-mannose and paucimannose 
type glycan chains would compromise in vivo bioactivity of therapeutic proteins and 
potentially induce allergenic reactions (Durocher & Butler, 2009). However, as a viral 
system it is well-suited for producing antigens and virus like particles for the 
development of vaccines. The first licensed vaccine produced in insect cells is Cervarix™ 
by GlaxoSmithKline. It is a truncated form of the human papilloma virus major capsid 
protein L1 types 16 and 18 and is administered to prevent cervical cancer. By now, more 
than 10 BEVS-derived products are now either commercially available or in clinical trials, 
e.g. vaccines against prostate cancer (Provenge™) as well as seasonal and pandemic 
influenza (Flublok™, Chimigen™) and some veterinary vaccines (Cox & Hollister, 2009; 
Durocher & Butler, 2009; Krammer & Grabherr, 2010). Additionally, the production of 
insect cell derived virus like particles of filoviridae like Marburgvirus and Ebolavirus is in 
early stage development (Ye et al., 2006).  
1.3.1 Autographa californica multicapsid nucleopolyhedrovirus 
First descriptions of baculoviruses date back almost 200 years, when silk worm diseases, 
which represent a large economic risk to the silk industry, were investigated by the 
upcoming light microscopy techniques. The presence of highly refractile occlusion bodies 
that were symptomatic of the affected insects could be characterised as a prominent 
feature. These polyhedron shaped particles led by the mid-1800s to the naming of the 
diseases associated with these structures as 'polyhedroses' (Figure 1-2). However, it took 
another hundred years until the availability of high-resolution electron microscopy in the 
late 1940s before the presence of rod-shaped baculoviral virions within the occlusion 
bodies (OB) was demonstrated (Bergold, 1947).  
  INTRODUCTION 
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Figure 1-2: Baculoviral occlusion bodies 
Occlusion bodies are crystalline protein matrices containing numerous virions. They are formed in the nucleus upon hyperexpression 
of the viral proteins polyhedrin and P10 during the late phase of the infection. The left picture shows a cross section of an infected cell 
prior to cell lysis (picture courtesy of Department of Chemical Engineering, The University of Queensland). The right picture is an EM 
scanning of released polyhedral occlusion bodies upon disintegration of the host (source: A: K. Hughes and R. B. Addison taken from 
Rohrmann, 2008). 
 
The family of the baculoviridae belongs to the double-stranded DNA viruses and is divided 
into the genera of Granulovirus and Nucleopolyhedrovirus. The latter can be further divided 
into single-nucleopolyhedroviruses (SNPV) and multiple-nucleoplyhedroviruses (MNPV) 
depending on the number of nucleocapsids per virion. The Autographa californica 
multicapsid nucleopolyhedrovirus (AcMNPV), which is used as a vector in the BEVS is 
infective for more than 30 different Lepidoptera species. As a member of the MNPVs, a 
virion consists of several nucleocapsids, each containing a copy of the 134 kbp large 
circular genome (Ayres et al., 1994). The polyhedral occlusion bodies are formed by 
embedding numerous of these virions in a matrix of the polyhedrin protein  
(Figure 1-3 A). The immobilization of the infective particles within the crystalline protein 
lattice provides an environment where they are protected from extreme temperatures and 
UV light. This allows the virus to remain viable indefinitely outside of the host 
(Rohrmann, 2008).  
Upon ingestion by the host, the alkaline pH in the midgut of the insect causes the 
dissolution of the polyhedrin matrix of the OB. The released occlusion derived viruses 
(ODV) subsequently cause a primary infection of the epithelial cells (Figure 1-3, B). By 
fusion of the virions with the peritrophic membrane the nucleocapsids enter the cells 
(Volkman & Goldsmith, 1985). In the cytosol their trafficking is mediated by actin 
polymerization by which they finally reach the nucleus (Ohkawa et al., 2010). 
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Approximately 6 h post infection (hpi), the first replicated viruses are released by 
budding from the membrane as budded virus (BV). They spread the infection via the 
hemolymph to the deeper tissue; a process called secondary infection, which finally leads 
to a systemic infection of the entire host.  
 
 
Figure 1-3: Schematic view of the AcMNPV and the infection of the host in vivo 
A: In MNPVs a virion contains multiple nucleocapsids. Outside of the host numerous virions are occluded by a 
proteinacious matrix formed by the viral proteins polyhedrin and P10. Secondary infection of deeper tissue in the host 
as well as in cell culture is mediated by budded viruses. The nucleocapsid is enveloped by a membrane during budding 
from the host cell. The viral protein gp64 is presented at the surface and enhances the fusion with cell membranes 
thereby mediating virus entry. B: Primary infection occurs after the uptake of occlusion bodies by the insect larvae and 
dissolution of the protein matrix in the midgut (edited work, original source: A. J. Cann, www.microbiologybytes.com). 
 
However, a significant part of the newly assembled nucleocapsids are not released as BV, 
and remain in the nucleus instead. These particles are occluded in the late phase of the 
infection. This process starts upon expression of very late genes resulting in the 
production of high levels of the matrix proteins polyhedrin and P10 24 -96 hpi. Finally, 
viral proteases and chitinases cause the liquefication of the host and degradation of the 
chitinous exoskeleton, thereby releasing the OB into the environment (Figure 1-4). 
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Figure 1-4: Liquefied insect larvae as a result of baculoviral infection 
In the very late phase of the systemic infection, the expression of the protease cathepsin and the chitinase Ac126 lead 
to a total disintegration of the host. This process is termed melting or liquefaction and permits the release of occluded 
virions to the environment (source: L. King, Oxford). 
 
1.3.2 Baculovirus expression vector system 
The first biotechnological application of baculoviridae aimed at agricultural purposes. 
Intensive studies in the 1970s enabled the success of using a nucleopolyhedrovirus to 
control the Douglas-fir tussock moth (Martignoni, 1984). Subsequent effort was taken to 
understand the molecular biology of baculoviridae. It was shown that BV are up to 1,000-
fold more efficient at infecting cultured cells compared to ODV, which have a 10,000-fold 
higher ability to enter midgut epithelial cells instead (Volkman et al., 1976; Volkman & 
Summers, 1977). Moreover, the matrix proteins polyhedrin and P10, which are 
hyperexpressed in the late phase of infection, are not essential for viral reproduction and 
infectivity in cell culture (Kuzio et al., 1984; Williams et al., 1989; Summers, 2006). These 
findings directly promoted the use of AcMNPV for recombinant protein expression in 
vitro. The BEVS was pioneered at the laboratory of Max D. Summers at the Texas A&M 
University and patented in 1988 (US Patent No. 4,745,051).  
The first version of the BEVS made use of homologous recombination of transgenes into 
the polyhedrin locus. Therefore host cells were cotransfected with viral DNA and a donor 
plasmid on which the gene of interest is flanked by corresponding sequences. Since the 
double crossing over essential for the integration is a very rare event (Glick et al., 2009), 
only 0.1 % of the viruses carry the gene of interest. Therefore, a purification of 
recombinant virus based on a phenotypic evaluation of the cells was necessary: those cells 
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in which the polyhedrin gene is lacking due to the exchange by the gene of interest do not 
exhibit the formation of occlusion bodies. A first improvement was established by the 
integration of a unique Bsu36I restriction site into viral genome. This enabled the 
transfection of linearised viral DNA which is not replicated in the cells unless 
recircularised upon homologous recombination with the donor vector. This improvement 
increased the yield of recombinant viruses from 0.1 % to 30 % (Kitts et al., 1990) and is still 
in use in commercial available systems like BaculoGold™ (BD) or BacPAK™ (Clontech) 
with efficiencies up to 99 %. A similar system relies on the deletion of essential gene 
sequences within open reading frames (ORFs) of the viral genome. Only by restoring the 
gene functions by homologous recombination, recombinant virus retrieves its ability to 
replicate (Kitts & Possee, 1993). It is commercialised by Novagen as BacMagic™ and 
achieves also nearly 100 % effectiveness. 
The most versatile strategy for the generation of recombinant viruses is shown in  
Figure 1-5 A and relies on the integration of genes into a baculovirus shuttle vector in  
E. coli (Luckow et al., 1993). It was developed at Monsanto by the integration of DNA 
elements into the polyhedrin locus that comprise a miniF-replicon, which enables 
autonomous replication in E. coli as a bacterial artificial chromosome (Hosoda et al., 1990; 
Shizuya et al., 1992). Furthermore, the integration contains a kanamycin resistance gene 
for selection and the lacZ sequence encoding β-galactosidase in which attTn7 sites for the 
bacterial transposon Tn7 are located (Grinter, 1983). The integration of genes into the 
bacmid follows a two-step process. Firstly, the gene of interest is cloned into the 
expression cassette of a donor plasmid comprising a baculovirus promoter and flanking 
Tn7 sequences. Upon transformation of the E. coli strain containing the bacmid the 
cassette is transposed into the viral genome by a bacterial transposase coded on a helper 
plasmid (Luckow et al., 1993). The integration disrupts the lacZ ORF, thus allowing to 
identify positive recombinants by blue-white selection. Following isolation of the 
recombinant viral DNA, it can be directly used for the transfection of insect cells without 
the need for subsequent plaque purification steps. This principle was commercialised as 
Bac-to-Bac™ system by Invitrogen in 1994 (US Patent No. 5,348,886) and constituted the 
basis for novel systems emerged thereof such as MultiBac (Berger et al., 2004) or ACEMBL 
(Bieniossek et al., 2009; Trowitzsch et al., 2010), which are described in Figure 1-5 B&C.  
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Figure 1-5: Generation of recombinant viral DNA by Tn7 transposition & multigene integration in MultiBac system 
A: The gene of interest, present on a transfer vector, is integrated via Tn7 transposition into a baculovirus genome 
maintained as a bacmid in DH10B E. coli cells. Screening for composite bacmids can be performed by blue-white 
selection, since the Tn7 attachment sites on the bacmid are embedded within a lacZ gene. B: In the MultiBac system a 
second integration locus was introduced by a deletion of the baculoviral genes coding for a cathepsin protease (v-cath) 
and a chitinase (chiA). They have been replaced by a loxP imperfect inverted repeat together with an ampicillin 
resistance marker. This facilitates the integration of a second donor plasmid via Cre recombination. Due to the special 
design of both donor plasmids, integration of up to 8 genes is possible for coexpression using a single virus. C: A more 
recent bacmid is EMBacY, which has been constructed by the integration of an expression cassette for enhanced YFP 
production under control of the polh promoter. It allows for efficient monitoring of virus performance and expression 
of other heterologous proteins integrated into the Tn7 site from the same bacmid (edited work, original sources: 
Trowitsch, et al. 2010 & Bac-to-Bac manual, Invitrogen). 
 
1.4 Mammalian expression hosts 
Protein production in mammalian expression systems provides authentic folding, 
assembly and post-translational modification of proteins of the same origin. Thus, about 
70 % of all proteins for pharmaceutical or clinical applications are produced in 
mammalian cell culture (Wurm, 2004). In the last 20 years, progress in genetic 
engineering, high-throughput techniques, media composition and process control has led 
to a 100-fold increase in volumetric productivity so that yields in large scale cultivation 
have recently reached the gram per litre range (Andersen & Krummen, 2002; Brondyk et 
al., 2009) . 
INTRODUCTION 
 
 14  
Two different strategies are used for the production of recombinant proteins in 
mammalian cells: transient and stable expression. The selection of an appropriate method 
is dependent on the characteristics and intended applications of the protein (Brondyk et 
al., 2009). Whenever criteria such as growth behaviour of host cells, clonality, stability and 
reproducibility are of major importance, stable expression is favoured. This is the case in 
the production of proteins for crystallization or biochemical assays as well as for 
pharmaceutical applications. Thus, most therapeutic antibodies currently on the market 
are produced in stable CHO cell lines. Conversely, recombinant protein production for 
research purposes (e. g. in HTP screenings, test expressions or construct evaluation) is 
mainly driven by the cost-effectiveness, simplicity, and speed of the process. In this case 
transient gene expression - predominantly performed in HEK293-derived cell lines - is 
superior (Geisse & Fux, 2009). Although recombinant protein expression using the BEVS 
is also transient, the term is only used to refer plasmid based expression in this work. 
1.4.1 Transient expression in HEK293 
The cell line HEK293 originates from a primary culture of human embryonic kidney 
epithelia, which was transformed by a type 5 adenovirus (Graham et al., 1977). Numerous 
improvements in culturing techniques led to its dominant use in the production of 
recombinant proteins by transient gene expression. The development of high-effective as 
well as cost-efficient transfection methods utilizing calcium-phosphate or 
polyethylenimine (Graham & van der Eb, 1973; Boussif et al., 1995) and adaptation to 
serum free culture media (Cote et al., 1998) enabled an upscaling of transient expression in 
HEK293 to bioreactor scale (Pham et al., 2003). Due to these improvements, yields of 
several hundred mg per L can be achieved (Baldi et al., 2007) and various proteins have 
been successfully produced for X-ray structure determinations (Bishop et al., 2009; 
Forneris et al., 2010; McLellan et al., 2011). To further improve recombinant protein 
expression in this cell line, genetically engineered variants have been developed. These 
strains allow for episomal replication of expression plasmids by a genomic integration of 
the simian virus 40 (SV40) large T-antigen (Lebkowski et al., 1985) in HEK293T and the 
Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) in HEK293-6E, respectively (Van 
Craenenbroeck et al., 2000; Durocher et al., 2002). EBNA1 is a multifunctional protein 
consisting of a DNA binding domain, a transcription activating domain and a nuclear 
localisation signal (Langle-Rouault et al., 1998; Dean et al., 1999; Dean et al., 2005). The 
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protein binds specifically to the Epstein-Barr-Virus origin of replication (EBV-oriP) and 
mediates the nuclear transport of cytoplasmic DNA (Ambinder et al., 1991; Fischer et al., 
1997). There plasmids harbouring the EBV-oriP are replicated, allowing the dissemination 
of plasmid copies to the daughter cells upon cell division (Lindner & Sugden, 2007; 
Kishida et al., 2008). The combination of higher copy numbers, increased nuclear 
localization, transcription activation and extended plasmid half-life in the cell culture, 
lead to impressive yields of more than 1 g/L with this system (Backliwal et al., 2008a). 
1.4.2 Stable expression in CHO 
Stable expression of recombinant proteins requires the integration of the gene of interest 
into the host cell genome. Thereby it facilitates the reproducible production over extended 
cultivation periods as well as efficient upscaling in bioreactors with several thousand 
litres (Xing et al., 2009). Thus, this method is commonly used when large quantities of 
recombinant proteins are needed. Under optimised conditions yields of up to 5 g/L have 
been reported (Durocher & Butler, 2009). Likewise, stable expression over a long period of 
time in perfusion mode is also especially beneficial to gain significant amounts of hard-to-
express proteins, which are produced only with extremely low yields. The antihemophilic 
factor VIII, with 2,332 amino acids an extremely large and fragile protein, is reliably being 
manufactured in suspension-cultivated baby hamster kidney cells (BHK) and harvested 
continuously for up to 6 months with yields of 150 g/year (Böedeker et al., 1994).  
Since the Chinese hamster ovary cell line CHO (Tjio & Puck, 1958) integrates exogenous 
DNA with a high efficiency (Hoeijmakers et al., 1987) it has become the predominant 
mammalian host cell line for stable expression. The recently accomplished sequencing of 
the CHO genome (Wurm & Hacker, 2011) will probably pave the way for directed 
metabolic engineering to develop optimised producer strains for various purposes during 
the next decade. A series of glycosylation mutant cell lines such as CHO Lec3.2.8.1 
(Stanley, 1989) are already available for the production of glycoproteins for structural 
analyses. The proteins derived from CHO Lec3.2.8.1 possess only N-linked glycans of the 
high mannose type Man5GlcNAc2 which can be further truncated efficiently to a single N-
acetylglucosamine (GlcNAc) by endoglycosidase H (endo H) making them more 
homogeneous and even more likely to crystallise (Davis et al., 1993). Thus, structures of 
various glycoproteins produced in this cell line have successfully been solved (Butters et 
al., 1999; Niemann et al., 2007).  
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However, the integration of genes into the host cell genome by conventional methods is a 
rare and random event. Moreover, expression characteristics can dramatically differ 
within a population of transfected cells due to gene copy variations and neighbouring 
chromosomal elements that modulate the promoter activity to a high extent in cis (West & 
Fraser, 2005). This position effect is also referred to as mosaicism or variegation (Bestor, 
2000; Kito et al., 2002). An intensive screening and evaluation procedure is necessary to 
isolate a stable, high-producer cell clone. This is typically facilitated by using a vector 
comprising the gene of interest and a selective marker for the integration (Gurtu et al., 
1996). The most common selection methods rely on gaining resistance to an antibiotic 
agent or on the complementation of deficiencies in essential metabolic pathways in the 
host cell. The integration of bacterial neomycin phosphotransferase gene for instance 
mediates resistance to the antibiotic Geneticin (G418) (Southern & Berg, 1982), whereas 
the complementation of the genes of dehydrofolate reductase (DHFR) and glutamine 
synthetase (GS) enable cells with a corresponding defect to grow in glutamine-free or 
hypoxanthin- and thymidine-free media, respectively (Urlaub & Chasin, 1980; Cockett et 
al., 1990). Upon transfection, cells are cultivated for several passages under selective 
pressure, allowing only those cells to propagate, in which the transfer vector is stably 
integrated and the transgenes are expressed constitutively. By increasing the 
concentration of antibiotic or inhibitors, an enrichment of cells with a very high 
expression rate or gene copy number is possible, eventually obtaining clones with up to 
several hundred gene copies and increased product yields (Wurm et al., 1986; Kim et al., 
2001).  
However, identical copies at different loci within the genome exhibit a tendency to 
recombine and thereby causing chromosomal aberration (Derouazi et al., 2004). Likewise, 
tandem-repeat integrations at the same locus might induce so called “repeat-induced 
gene-silencing” (RIGS), what is considered to be a defence-mechanism against 
retroviruses (McBurney et al., 2002). Additionally, prokaryotic sequences on the 
transfection vector (e. g. replication origin, selection markers) flanking the transgene 
might influence its transcriptional activity due to their divergent nucleotide composition 
(Scrable & Stambrook, 1997). Furthermore, removing of antibiotic selection pressure 
during cell propagation frequently results in declining protein yields caused by mosaic 
gene silencing (Liu et al., 2006). These effects underline the need for a clonal isolation of 
cell lines and a subsequent evaluation of their stability and productivity over numerous 
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passages (Gellissen, 2005). Thus, cell line development from gene transfer to larger-scale 
production can still take several months to a year despite the development of robotic 
devices for high-throughput screenings of millions of individual cell clones. 
1.4.3 Cell line development by site specific recombination 
An alternative method for integrating transgenes into the host cell genome is site specific 
recombination. This process utilises heterologous recombinase enzymes to induce the 
deletion, insertion or inversion of DNA fragments at specific sequences within the 
genome. It was originally developed to study gene functions as well as regulation and 
expression characteristics of certain loci (Branda & Dymecki, 2004). The most common 
systems are the Cre system, derived from the E. coli phage P1 (Stark et al., 1992), the 
Streptomyces phage ΦC31 integrase (Groth et al., 2000) and the Flippase Flp from S. 
cerevisiae (Wirth et al., 2007). The corresponding enzymes Cre and Flp are tyrosine 
recombinases, whereas ΦC31 is a serine recombinase. They cleave the DNA backbone via 
a nucleophilic attack on a phosphodiester bond, exchange the strands of the two DNA 
double-helices involved, and religate the DNA backbones. This reaction does not involve 
the hydrolysis or synthesis of DNA (Kolb, 2002).  
However, a prerequisite for the generation of producer cell lines with these systems is the 
preceding integration of specific recombinase target sites (RT) into the host cell genome; a 
process called “tagging”. These short sequences are the 34 bp loxP site (Cre), the 48 bp 
FRT site (Flp) and the heterotypic sites attB (34 bp) and attP (39 bp) for ΦC31. The 
generation of tagged master cell lines is based on random integration and requires effort 
in screening and evaluation. Though, this tagging process has to be performed only once 
for any host cell line. Additionally, alternative screening procedures based on fluorescent 
activated cell sorting (FACS) have been established for this purpose (Qiao et al., 2009). 
Subsequent to the generation of a tagged master cell line, targeted integration of the gene 
of interest into the pre-tagged locus and the clonal isolation and propagation of producer 
cell lines is feasible within less than 3 months. 
The ΦC31 integrase mediates recombination of two different RTs , attP and attB, located 
in the host cell genome and a donor plasmid harbouring the gene of interest, respectively. 
By the recombination process, the plasmid is integrated into the genome and the RT 
sequences are altered resulting in flanking sites attL and attR. Since those are not 
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substrates for the integrase, the recombination is a unidirectional process (Thyagarajan et 
al., 2001). For cell line development a commercial version of this method is offered by 
Invitrogen termed Jump-In™. However, the occurrence of pseudo integration sites in the 
mammalian genome, which may cause unexpected integrations cumulating in genomic 
instability has been proposed (Thyagarajan & Calos, 2005). 
Unlike the RT sites of the ΦC31 integrase, the tyrosine recombinases Cre and Flp mediate 
the recombination between identical sites based on a double-reciprocal crossover. Both, 
FRT and loxP sites contain an 8 bp asymmetric spacer sequence flanked by long inverted 
repeats to which the corresponding enzymes bind to mediate the reaction (Figure 1-6). 
The spacer sequence is responsible for DNA-DNA base pairing and determines the 
orientation of the RT (Andrews et al., 1985).  
 
A Cre recombinase target site (loxP) 
 
                      5’ ATAACTTCGTATAATGTATGCTATACGAAGTTAT 3’ 
                      3’ TATTGAAGCATATTACATACGATATGCTTCAATA 5’ 
 
B Flp recombinase target site (FRT) 
 
      5’ GAAGTTCCTATTC C GAAGTTCCTATTCTCTAGAAAGTATAGGAACTTC 3’ 
      3’ CTTCAAGGATAAG G CTTCAAGGATAAGAGATCTTTCATATCCTTGAAG 5’ 
 
Figure 1-6: Cre target site loxP and Flp recombinase target site FRT 
A: The Cre recombinase target site is termed loxP and consists of two 13 bp inverted repeats (light arrows) flanking an 
8 bp asymmetrical core, or spacer (blue) in which DNA breaking and rejoining occurs. B: The Flp recombinase target 
site is termed FRT. It also consists of an asymmetric 8 bp spacer (blue) which is flanked by three 13 bp inverted repeats 
representing three binding sites for Flp (light arrows). Only the two inverted repeats directly flanking the spacer 
sequence are required for a minimal FRT site. The third upstream repeat, separated by a single base, is present in the 
2 µ plasmid but is dispensable for Flp-mediated recombination. Thus, the minimal FRT has a size of 34 bp. By contrast 
to a loxP site, the inverted repeats of an FRT site contain a single bp difference (underlined). 
 
Cre and Flp can mediate an excision, insertion or a translocation of DNA sequences. The 
relative orientation of a pair of RT sites to each other determines the type of 
recombination (Branda & Dymecki, 2004). When two copies of an RT site are arranged as 
direct repeats, the corresponding enzyme excises the DNA sequence between the copies. 
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The reverse reaction leads to an insertion of circular DNA containing one RT site. Due to 
thermodynamic reasons, the entropy-driven, monomolecular excision is favoured to the 
bimolecular insertion (Baer & Bode, 2001). Flp and Cre mediate an inversion of a DNA 
sequence to a dynamic equilibrium, when flanking RT sites are positioned in inverse 
orientation, whereas a recombination of single RTs on two linear DNA molecules results 
in the translocation of distal sequence (Figure 1-7).  
 
 
Figure 1-7: Types of recombination mediated by Flp and Cre depending on the RT site arrangements 
The relative orientation of target sites with respect to one another determines the outcome of the recombination 
reaction: Cre or Flp will excise a circular molecule from between two directly oriented target sites or integrate a circular 
molecule into a linear molecule each possessing a target site (A). A sequence flanked by a pair of RT sites with opposite 
orientation will be inverted (B). Translocation of DNA sequences occurs when a combination of two identical RT sites is 
present on two linear molecules (C). 
 
If recombinases are used to integrate transgenes into host cells, a stringent selection 
system is required, since the insertion reaction is thermodynamically unfavoured 
compared to the excision. A system that effectively meets this criterion is the so called 
“selection trap” which relies on the complementation of a non-functional, ATG-deficient 
resistance gene. The donor vector harbouring the gene of interest comprises a promoter 
and the missing start codon. Upon integration the resistance gene in the host cell genome 
is complemented and thereby transcriptionally activated. Consequently, resistance is 
exclusively conferred to correct recombinant daughter cells (O'Gorman et al., 1991). This 
method was commercialised by Invitrogen as Flp-In System (Figure 1-8 A). However, this 
approach has some important limitations. Due to the reversibility of the reaction, 
recombinase activity has to be strictly limited. Furthermore prokaryotic sequences and a 
positive selection marker originally used to screen for successfully tagged cell lines are left 
behind in the chromosome after the integration (Wirth et al., 2007). 
A   Excision & Integration B   Inversion C   Translocation
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A significant improvement was the development of non-interacting variants of the RT 
sites with mutated spacer sequences for both Flp and Cre target sites (Schlake & Bode, 
1994; Bouhassira et al., 1997). They can be used to flank the initial tagging cassette, thus 
allowing a precise exchange of the selectable marker with the sequences of an incoming 
donor vector harbouring the gene of interest. This method was termed recombinase 
mediated cassette exchange (RMCE). Its main advantage is the lack of excision and an 
increased frequency of targeting of up to 100 % due to stringent selection strategies 
(Schucht et al., 2006). Additionally, no bacterial vector sequences are integrated which 
potentially limits mammalian gene expression (Figure 1-8 B). 
RMCE has been demonstrated for Cre/loxP and Flp/FRT systems. Due to the 
thermolability of Flp at 37 °C Cre has been considered for a long time to be the most 
efficient system (Buchholz et al., 1996). However, temperature optimised Flp mutants have 
been developed which show a 4-fold higher recombination efficiency (Buchholz et al., 
1998) and an increased activity in in vitro RMCE reactions (Takata et al., 2011). Moreover 
the de novo synthesis of the mouse codon-optimised variant FlpO enabled an increase of 
recombination efficiencies to levels comparable to those of Cre (Raymond & Soriano, 
2007). Thus, Flp mediated recombination is considered as superior compared to Cre/loxP 
system today, since several pseudo-loxP sites are present in the mammalian genome 
(Thyagarajan et al., 2000). This technology has been successfully applied for the 
establishment of viral producer cells (Coroadinha et al., 2006), for the evaluation of vector 
design (Verhoeyen et al., 2001) and for the production of recombinant proteins such as 
EPO (Kim & Lee, 2008), or IgGs in CHO-K1 and HEK293 (Nehlsen et al., 2009). At the 
Helmholtz Protein Sample Production Facility a RMCE master cell line based on the 
glycosylation deficient CHO Lec3.2.8.1 has been established especially for the production 
of glycoproteins for crystallization (Wilke et al., 2011). Various proteins have been 
produced in our facility using this cell line by now, e. g. the lysosome-associated 
membrane glycoprotein 3 (LAMP3), the extracellular domain of the Toll-like receptor 2 
(TLR2) and the γ-interferon-inducible lysosomal thioreductase (GILT) (Wilke, 2011) and 
numerous projects are still in the expression pipeline. 
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Figure 1-8: Schematic overview of the Flp-In™ system and RMCE 
A: In the Flp-In™ system host cells are tagged at an expression hot spot by an expression cassette consisting of a  
simian virus 40 promoter (PSV40), followed by an ATG start codon, one FRT site (F) and a lacZ-Zeocin fusion gene for 
selection. Upon cotransfection of the host cell line with a pFlp-In donor and a helper vector expressing the Flp 
recombinase, the integration of the donor is initiated. Those cells, where the GOI under the control of a pCMV is 
successful integrated can be selected due to the complementation of the ATG-deficient incoming hygromycin 
resistance gene. B: The RMCE master cell lines contain the GFP marker flanked by heterologous FRT mutants. Its 
expression is driven by a promoter located upstream of the leading F3. A neomycin resistance gene missing its ATG 
start codon as well as a promoter (∆neoR) lies downstream of the wild type FRT (F) site. The incoming donor vector 
harbours the gene of interest as well as a promoter followed by the start codon flanked by corresponding FRT sites in 
the same orientation. Upon RMCE, these elements are integrated upstream of the neomycin resistance gene which 
thereby becomes activated and confers resistance against G418. Cones = FRT sites (F3 and F), P = promoter, 
pentagons = secreted protein product encoded by the GOI, ampR = bacterial beta-lactamase gene, 
pUCori = replication of origin, pA = poly adenylation site, GOI = gene of interest (source: Wilke, 2011). 
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1.5 Model proteins 
The evaluation of promoter activities, optimisation of transfection methods or 
comparative analyses of expression systems are typically performed by the expression of 
model proteins. In order to be utilised as a reporter, a protein has to meet the following 
fundamental criteria: expressibility in the particular host, the absence or distinctiveness of 
endogenous homologous and the availability of sensitive as well as easy detection 
methods (Cullen, 2000). Commonly, enzymes such as chloramphenicol transferase (CAT) 
(Corsico & Howard, 1990), the firefly luciferase (Gould & Subramani, 1988) or secreted 
alkaline phosphatase (SEAP) (Berger et al., 1988) are used, since well-established assays 
are available to detect and quantify their activity from cell lysates or culture supernatants, 
respectively. However, to achieve proof-of-concept studies with novel expression vectors 
as well as to perform quantitative and qualitative evaluations of different expression 
strategies and hosts, it is advisable to use proteins from different relevant protein classes 
and host species. In this work, test expressions to demonstrate the applicability of vector 
constructs and to determine expression characteristics in different hosts have therefore 
been performed with model proteins from three different protein classes. GFP variants of 
different size have been expressed as fluorescent reporters to proof intracellular 
accumulation of recombinant proteins. Production of secretory proteins has been 
evaluated using scFv-hFc fusions, since they represent a class of biotechnologically 
relevant proteins, which are usually produced with high yields. Additionally, expression 
characteristics of the extracellular domain of Toll-like receptors have been studied as an 
example of truncated, yet challenging protein fragments. 
1.5.1 Fluorescent proteins 
Expression of fluorescent reporter proteins can be directly detected by fluorescence 
microscopy or flow cytometry. Thus, no cell lysis, purification or assay-development is 
necessary. Additionally, an easy quantification is possible upon cell disruption via 
correlation with an fluorescent standard. The most prominent representative of 
fluorescent proteins is the green fluorescent protein, which originates from the jellyfish 
Aequorea victoria (Shimomura et al., 1962). Because of its invaluable importance as a 
reporter in modern cell biology, its discoverer Osamu Shimomura has been awarded with 
the Nobel prize in 2008.  
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The 27.2 kDa large protein consists of 238 amino acids which form a β-barrel structure 
composed of 11 beta sheets as shown in Figure 1-9 (Ormo et al., 1996). The amino acids 
Ser65, Tyr66 and Glu67 located in a α-helix in the interior of the barrel constitute the 
chromophore by autocatalytic formation of an aromatic system (Heim et al., 1994). The 
excitation maximum of GFP is in the UV range at 488 nm and the emission peak is at 
509 nm. 
 
  
Figure 1-9: Structure of green fluorescent protein (GFP).  
A β-barrel is formed by 11 β-sheets which surround a α-helix comprising the chromophore-forming amino acids S65, 
Y66, und E67. The molecule has a diameter of 2.4 nm and a length of 5 nm (source: PDB ID 1RM9). 
 
Several variants of GFP have been developed by mutations of the amino acids forming the 
chromophore or in the surrounding environment, thereby creating molecules with 
different excitation and emission characteristics. The mutations S65T and F64L generated 
a significantly brighter variant by abetting the deprotonated form of the chromophore. 
Because of its optimised quantum yield and 35-fold higher brightness compared to wtGFP 
it was termed enhanced green fluorescent protein (eGFP) (Cormack et al., 1996). 
Mutations of Y66 caused a shifting of the emission wavelength, thereby creating cyan and 
blue colour variations (CFP, BFP), respectively (Heim et al., 1994; Heim & Tsien, 1996). 
Homologs of GFP from different species have also been identified and characterised. The 
red fluorescent protein drFP583 for instance, was isolated from the mushroom coral 
Discosoma sp. and is now commonly known as DsRed (Matz et al., 1999). Its excitation 
peak is at 558 nm and a maximal emission can be measured in the red light range 583 nm. 
It is an obligate tetramer with the tendency to form oligomers, which can lead to protein 
aggregation. To optimise its expression qualities and fluorescent characteristics, mutations 
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within the chromophore and its vicinity have been performed, thus generating several 
variants with major differences in brightness, colour, stability and folding speed (Shaner 
et al., 2004). Figure 1-10 shows a genealogic tree of available DsRed mutants. 
 
 
Figure 1-10: Genealogy of DsRed-derived variants 
Amino acid mutations critical to the phenotype as well as insertions or exchange of N- and C-termini are annotated. 
GenBank accession numbers are given under the name of each protein. For detailed sequence alignments of the 
variants see original source (Shaner et al., 2004). 
 
Two DsRed variants have been used as fluorescent model proteins in this work. The first, 
tdTomato, is a covalently linked tandem dimer of dTomato which possesses the same 
emission maximum at 581 nm but improved folding characteristics compared to the 
physiological dTomato dimer. Upon expression, it forms a dimer of tandem dimers, 
resulting in a higher brightness. In contrary, mCherry, the second DsRed variant 
expressed as a reporter, is a strict monomeric mutant of DsRed with an emission 
maximum at 610 nm. It matures very rapidly (t0.5 = 15 min) and is particularly stable 
against photobleaching. However, due to its monomeric form, it has only 30 % of the 
brightness of the DsRed tetramer (Shaner et al., 2004). 
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1.5.2 Single-chain antibody fragments 
Recombinant antibodies are the fastest growing class of therapeutic proteins and exhibit 
an impressive track record. It took only one decade from the first generation of a 
monoclonal antibody in 1975 (Köhler & Milstein, 1975) to the approval of the first 
therapeutic antibody Murononab-CD3 which reduces acute rejection of transplanted 
organs (Goldstein et al., 1985; Emmons & Hunsicker, 1987). After no significant increase in 
novel products until the year 2000, genetic engineering methods finally enabled two 
major steps which leveraged their extensive use for pharmaceutical applications: the 
generation of chimeric and humanised antibodies in the late 1980s (Jones et al., 1986; 
Queen et al., 1989) and the development of alternative antibody formats (Figure 1-11). 
Monovalent antibody fragments and engineered variants such as single-domain 
antibodies (also referred to as nanobodies) retain the targeting specificity of whole mAbs 
but can be produced more economically. Moreover, they possess unique properties 
thereby extending and improving the range of diagnostic and therapeutic applications. 
For instance, they show an improved tissue penetration, the ability to transmigrate the 
blood brain barrier, are suitable for in vivo detection or targeting of intracellular proteins 
(as so called intrabodies) and many more (Holliger & Hudson, 2005; Hagemeyer et al., 
2009; de Marco, 2011). Thus, today more than 400 clinical studies with antibody related 
therapeutics are ongoing (Dübel, 2007).  
Besides their tremendous importance for therapeutical and diagnostical applications, 
antibodies are also used as tools for protein aggregation studies and crystallography 
chaperones (Hunte & Michel, 2002). Especially, single domain antibodies are used to 
improve crystal packing and X-ray phasing, as they give an ideal template for molecular 
replacement or can be used for SeMet labelling (Tereshko et al., 2008). Since antibodies 
and antibody fragments are expressed and secreted with a high efficiency, impressive 
yields up to several g/L can be achieved in industrial processes (Durocher & Butler, 2009). 
Therefore, this protein class represents an excellent model for secreted proteins and to 
compare volumetric yields achieved in different expression systems and strategies.  
In this work, scFv-hIgG1Fc-4E3, a CD30-specific single-chain Fv fused to a human Fc 
fragment (Menzel et al., 2008) has been used for expression studies. Its antigen CD30, a 
120 kDa transmembrane type I glycoprotein, belongs to the tumor necrosis factor receptor 
superfamily. The antibody was originally isolated from a semisynthetic human antibody 
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library by phage display and converted into the scFv-format at the TU Braunschweig. 
Likewise, a second variant of the antibody with a carboxy-terminal fusion of a human 
pancreatic RNAse (scFv-hIgG1-Fc4E3-RNase) was provided (Braschoss et al., 2007).  
 
 
Figure 1-11: Immunoglobulins composed of combinations of heavy and light chains 
IgGs are composed of two heavy and two light chains connected by disulphide bonds. Each chain consists of a variable 
(V) and one or more constant regions (C). The canonical antigen-binding fragments (Fab) are composed of variable 
heavy (VH), variable light (VL) and constant regions (Fc) of the light (CL) and heavy chains (CH). The building block that 
is most frequently used to create novel antibody formats is the single-chain variable (V)-domain antibody fragment 
(scFv), which comprises V domains from the heavy and light chain (VH and VL domain) joined by a peptide linker of up 
to ∼15 amino-acid residues. The engineered fragments differ from the full-size IgG molecule in affinity, 
immunogenicity, and circulating half-life. Inter-chain disulphide bonds are depicted as green bars, glycosylation as blue 
boxes, peptide and chemical linkers are shown as orange and red lines, respectively. CH, C = domain of 
immunoglobulin heavy chain; CL, C = domain of immunoglobulin light chain; dsFv = disulphide-stabilised scFv (source: 
Carter et al., 2006). 
 
1.5.3 Toll-like receptors 
Toll-like receptors belong to the family of the pattern recognition receptors (PRR), and are 
thus part of the innate immune system (Janeway & Medzhitov, 2002). The name was 
coined due to the similarity of TLRs to the drosophila protein Toll (Medzhitov et al., 1997). 
These transmembrane receptors recognise molecules from exogenous origin via binding 
of conserved motifs, so called pathogen associated molecular patterns (PAMPs). 
Subsequently, a signal cascade is initiated, that finally results in the activation, 
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modulation and direction of immune responses (Sabroe et al., 2008; Medzhitov, 2009). This 
principle is summarised in Figure 1-12 A. Until today, 13 TLRs have been found from 
which TLR1 - 9 seem to be closely homologous between mice and humans. In contrast, 
TLR10 is only found in the human genome, whereas TLR11, 12 and 13 are solely present 
in the mouse (Moresco et al., 2011). According to the nature of their specific ligands, TLRs 
are located within the outer cell membrane or in intracellular compartments: TLR3, TLR7, 
TLR8, TLR9, and probably TLR13 of mice remain within the endoplasmic reticulum (ER), 
endosomes, multivesicular bodies, and lysosomes, whereas all other TLRs are secreted to 
the outer cell membrane (Blasius & Beutler, 2010). Similar to other immune receptor 
families, TLRs have a clearly deﬁned domain organization, consisting of a ligand 
recognition domain, an effector domain and a transmembrane region which connects both 
domains. The ligand recognition domain comprises a series of leucine rich repeat (LRR) 
modules whereas the effector domain consist of a Toll/Interleukin-1 Receptor (TIR) motif 
which induces the downstream signalling (Figure 1-12 B). 
 
  
Figure 1-12: Simplified schematic of TLR signalling 
TLRs sense ligands via their LRR ectodomains (purple) leading to receptor dimerization. Adaptor proteins (blue) are 
recruited to the dimeric TIR domain scaffold (red), creating a multiprotein complex located at either the plasma (i) or 
endosomal (ii) membrane. Adaptor protein usage varies with TLR. Signal transduction is propagated through the 
action of signal transducers such as the IRAK and tumor necrosis factor receptor-associated factor (TRAF) family 
members, as well as the mitogen-activated protein kinase (MAPK), p38 and c-Jun N-terminal associated kinase (JNK) 
pathways. Subsequently, the signalling leads to a cellular response that includes the production of pro-inflammatory 
cytokines and the upregulation of pro-IL-1β and pro-IL-18. This results in an increase in the levels of active 
transcriptional activators such as NFκB and members of the interferon response family (modified work, original source: 
Monie, et al. 2009). 
Ligand recognition 
Receptor activation 
Signal transduction 
Cellular response 
A B 
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The four adaptor proteins MyD88, TIRAP (also called MAL), TICAM1 (also called TRIF), 
and TICAM2 (also called TRAM) directly bind to the TIR domain of activated TLRs and 
recruit downstream signalling components (Monie et al., 2009). They initiate a signal 
transduction that ultimately induces the expression of numerous genes required for the 
inflammatory response, such as inflammatory cytokines, chemokines antimicrobial 
molecules (e.g. hydrolytic enzymes, peptides, proteases), and major histocompatibility 
complex (MHC) as well as costimulatory molecules important for adaptive immune 
activation (Moresco et al., 2011).  
TLRs and other immune receptors not only play an important role in infection processes, 
but also contribute to chronic diseases or even induce potentially fatal clinical conditions 
such as sepsis upon inappropriate or excessive responses (Ospelt & Gay, 2010). Thus, 
understanding the mechanism of ligand-mediated receptor activation is considered as an 
important requirement for the development of improved therapies for multiple clinical 
conditions, antimicrobial treatments and vaccine adjuvants. Therefore, intense efforts 
were made to investigate crystal structures of the extra cellular domains (ECD) of TLRs in 
complex with their binding partners. In recent years, the structures of the extracellular 
domains of TLR1, 2, 3, 4 and 6 have been solved (Choe et al., 2005; Jin et al., 2007; Kim et 
al., 2007; Kang et al., 2009). Structure models of these TLRs in complex with their 
corresponding ligand are shown in Figure 1-13. 
 
 
Figure 1-13: Structures of TLR dimers and interactions with ligands 
Complex structures of TLR2–TLR6–Pam2CSK4 lipopeptide (3A79), TLR2–TLR1–Pam3CSK4 lipopeptide (2Z7X), TLR3-
dsRNA (3CIY), and TLR4–MD-2–LPS (3FXI) are shown as side view (upper panels) and top view (lower panels). The 
Protein Databank ID numbers are indicated in parentheses (source: Moresco et al., 2011). 
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The TLR-ECDs typically contain 19–25 consecutive LRRs that form a solenoid structure. 
Within each LRR, consensus hydrophobic residues point to the interior to build a stable 
core where three residues in the β-strand configuration align to form a hydrogen-bonded 
parallel β-sheet. Because the β-strands are more closely packed than the non-β portions of 
the LRR loops, the solenoid is forced into a curved horseshoe-like configuration (Kajava, 
1998). As a result, each LRR protein contains a concave and a convex surface. The inner β-
strands and the convex surface are connected via loops on the ascending lateral surface 
whereas a descending lateral surface is located on the opposite side (Bella et al., 2008). In 
most LRR proteins, ligand binding occurs on the concave surface. By contrast, in the 
known TLR-ligand structures, ligand binding occurs most often on the ascending lateral 
surface of the TLR-ECD. The interaction is supported by the absence of N-linked glycans 
on this surface of the protein (Botos et al., 2011).  
Many LRR family proteins are difficult to produce in quantities sufficient for 
crystallization and purified material often could not be crystallised for X-ray diffraction 
studies (Jin & Lee, 2008). This fact underlines that a proper construct design with regard 
to domain boarders and secondary structure elements, is an essential prerequisite for 
soluble and stable protein products. In consequence, recombinant expression of the ECDs 
of human TLR1, 2, 4 and murine TLR2 and 6 for structure determination could only be 
achieved by means of an elaborate expression strategy called hybrid-LRR technology (Jin 
& Lee, 2008; Kang et al., 2009). It relies on the creation of N- or C-terminal fusion 
constructs of TLR ECD truncations with fragments of the hagfish variable lymphocyte 
receptor 6 (VLRB6), an adaptive immune receptor discovered in jawless fishes, lamprey 
and hagfish (Pancer & Cooper, 2006). Since VLRs are also members of LRR protein family, 
it represents a structurally compatible fusion partner. The hybrid constructs have been 
generated by C- or N-terminal fusions of TLR and VLR fragments within the most 
conserved “LxxLxLxxNxL” motif. Since this sequence always forms β-strands upon 
expression, the secondary structure at the fusion position is conserved and a stable N- or 
C-terminus is generated by the corresponding termini of the VLR (Figure 1-14). However, 
despite the use of the hybrid-LRR technology only low volumetric yields of mTLR2 and 6 
of not more than 100 µg purified protein from 1 L insect cell culture have been reported 
(Kang et al., 2009). Recently, the full length ectodomain of hTLR4 fused to a Protein A tag 
could be coexpressed with MD-2, but likewise to the VLR hybrids of hTLR1, 2 and murine 
TLR4, the yields have not been disclosed (Park et al., 2009). 
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Figure 1-14: Hybrid LRR technology  
Structures of the three human TLR4-VLRB.61 N-terminal (VT) and C-terminal (TC) VLR hybrids. The N-terminal fusions 
comprising amino acids 27 - 227 and 27 - 527 of hTLR4, whereas the C-terminal fusion comprises amino acids 383 – 631. 
The full-length ectodomain of human TLR4 was assembled after superimposition of the overlapping regions of the TV8 
and VT3 hybrids. TLR4 fragments are coloured blue and VLRB.61 fragments gray. Disulphide bridges are represented 
in orange (source: Kim et al., 2007). 
 
Since Toll-like receptors are bridging innate and adaptive immunity (Pasare & Medzhitov, 
2005) and thus are attractive targets for structural and biophysical investigations, several 
internal and external collaborative projects concerning TLRs are currently ongoing at the 
Helmholtz-Centre for Infection Research. This underlines the demand of improving 
recombinant expression of these targets. Therefore, the full length ectodomain of mTLR2 
comprising amino acids 1 – 578 served as a model protein for difficult-to-express targets 
in this work. Additionally, the ECD of human TLR5, which structure was not known 
before, has been used for extended expressibility trials in different hosts. It represents an 
especially challenging target protein for recombinant production. Moreover, unlike the 
other TLRs, which structures have been solved, its main ligand is bacterial flagellin and 
thus a proteinaceous PAMP which makes it a particular worthwhile target for structural 
analyses. 
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1.6 Aim of this Work 
Recombinant production of complex eukaryotic proteins for structure determination 
typically requires a profound screening process to identify expressible constructs. 
Furthermore, the evaluation of both the most suitable expression host and the optimal 
expression strategy has an important impact on protein quality, yield and cost efficiency. 
Hence, facilities dedicated to protein expression for structural biology like the Helmholtz 
Protein Sample Production Facility (PSPF) usually provide a broad spectrum of 
eukaryotic expression systems. Although vectors suitable for the use as expression- and 
donor plasmids in different systems have been published (Novy et al., 1999; Berrow et al., 
2007), they suffer some major drawbacks, which limit their usability in multiparallel 
expression studies in state-of-the art systems. For instance, they are not compatible to 
advanced transposition based techniques for the generation of recombinant bacmids and 
lack the EBVoriP for enhanced expression in optimised HEK derived cell lines. 
Additionally, they are not applicable for stable genomic expression in mammalian cells by 
the Flp-recombinase mediated cassette exchange system (RMCE). 
The primary aim of this work was therefore the development of an improved 
expression/donor vector for protein production in the PSPF. Its range of applications 
should comprise different expression methods including transient, viral and stable 
expression strategies to facilitate both a rapid screening for expressible protein variants as 
well as the evaluation of the optimal expression host for any target protein. Thereby, the 
vector should enable the direct shifting to large-scale production with the proper 
construct in the system of choice avoiding time-consuming recloning steps. Subsequent to 
the construction of this vector, a proof-of-concept should be provided by test expression 
of a set of different model proteins to demonstrate its qualification.  
The second part of the project aimed at the implementation of the RMCE system to insect 
cells, allowing the generation of specialised BEVS host cell lines for stable expression of 
auxiliary proteins to aid or enhance baculoviral expression of challenging target proteins. 
By the combination of a new versatile vector for different expression systems and the 
implementation of a compatible RMCE platform for mammalian and insect host cell lines, 
an integrated expression system at the PSPF should be provided, to facilitate an efficient 
multiparallel screening and thereby streamline the expression pipeline. 
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2 Material and Methods 
2.1 Chemicals, kits and reagents 
If not stated otherwise, all chemicals used in this work were of “pro analysis” grade and 
were purchased from the companies Amersham Biosciences, Difco, Fluka, GE Healthcare, 
Gibco, Invitrogen, Macherey-Nagel, Merck, Millipore, QIAGEN, Riedel de Haen, Roche, 
Roth, Sigma and Stratagene.  
2.1.1 Enzymes and molecular weight standards 
Commonly used enzymes and molecular weight standards are listed in Table 2-1 and 
Table 2-2. 
Table 2-1: Enzymes 
Name Supplier 
Restriction Endonucleases New England Biolabs 
T4 Ligase Roche 
Antarctic Phosphatase New England Biolabs 
SAP (Shrimp Alkaline Phosphatase)  Roche 
Platinum Pfx DNA Polymerase  Invitrogen 
Phusion HotStart DNA Polymerase Finnzymes 
DNAse MOSB, HZI 
 
Table 2-2: Molecular weight standards 
Name Usage Supplier 
Smart Ladder agarose gel electrophoresis Eurogentech 
PageRuler Plus prestained SDS-PAGE Fermentas 
PageRuler unstained SDS-PAGE Fermentas 
Precision Plus unstained SDS-PAGE BioRad 
Precision Plus AllBlue SDS-PAGE BioRad 
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2.1.2 Culture media & supplements 
Cultivation of bacterial cultures was performed using LB medium (Bertani, 1951) 
supplemented with appropriate antibiotics or reagents for blue-white selection (Table 
2-3). For resuspension of transformed strains subsequent to electroporation SOC medium 
(super optimal broth for catabolite repression) was used (Table 2-4). Media for bacterial 
cultures were autoclaved 20 min at 121 °C. Heat instable components such as glucose and 
antibiotics were added after filtration (0.2 µm).  
Table 2-3: Antibiotics for bacterial cultures 
Antibiotics Final concentration 
Ampicillin (Amp) 100 µg/mL 
Chloramphenicol (Cm) 25 μg/mL 
Gentamicin (Gm) 7 μg/mL 
Kanamycin (Kan) 50 μg/mL 
Tetracyclin (Tet) 10 μg/mL 
Bluo-Gal  100 μg/mL 
IPTG  40 μg/mL 
Table 2-4: SOC medium 
Composition Final concentration 
Bacto-Tryptone 20 g/L 
Yeast extract 5 g/L 
KCl 0,186 g/L 
MgCl2 10 mM 
NaCl 50 mg/L 
Glucose 10 mM 
in ddH2O 
 
Cell culture media for insect and mammalian cell lines (Table 2-5) were purchased as 
ready-to-use solutions or prepared from powdered formulations. Powder media was 
sterilised after dissolving in purified water (MilliQ) by a filtration line (Pall) combining 
two nylon filter units with decreasing pore size (1 µm, 0.2 µm). Supplements were added 
according to Table 2-6 after filtration (0.2 µm)  
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Table 2-5: Cell culture media 
Cell culture medium  Cell lines Supplier 
EX-CELL™ 405 Hi5 SAFC 
EX-CELL™ 420 Sf21 SAFC 
F17 HEK293-6E Gibco 
ProCHO5 SWI3-26 (CHO Lec3.2.8.1) Lonza 
Table 2-6: Supplements 
Supplements used in F17 Medium Final concentration  
G418 0,025 mg/L 
Pluronic F68 1 g/L 
L-Glutamine 7,5 mM 
Supplements used in ProCho5 Final concentration  
Phenolred 11 g/L  
L-Glutamine 7,5 mM  
Supplements Supplier 
Fetal Calf Serum (FCS)  Gibco 
Fungizon (250 µg/mL) Gibco 
Gentamicin (10 mg/mL) Gibco 
Geneticin G418 (50 µg/mL) Gibco 
Penicillin (5000 U/mL) / Streptomycin (5 mg/ml) Gibco 
Pluronic F68 (100 g/L) Invitrogen 
L-Glutamine (200 mM) Invitrogen 
Phenol red Sigma 
Tryptone N1, cat # 19553 Organotechnie S.A.S. 
Valproic acid (80 mM) Sigma-Aldrich 
 
2.1.3 Transfection reagents 
Delivery of recombinant DNA to cells was performed using cationic lipofection 
techniques. The reagents used for each cell line and DNA construct as listed in Table 2-7. 
Table 2-7: Transfection reagents 
Reagent  Use Supplier 
Cellfectine Transfection of insect cells Invitrogen 
Insect Gene Juice Transfection of insect cells Novagen 
Lipofectine Transfection of insect cells Invitrogen 
Superfect Bacmid Transfection QIAGEN 
Polyethylenimine (linear, MW ~25 kDa) Transfection of HEK293-6E Polysciences 
MetafectenePRO Transfection of CHO Biontex 
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2.2 Oligonucleotides and plasmids 
Oligonucleotides were used for sequencing, site directed mutagenesis and cloning of 
DNA-fragments. They have been ordered at MWG Eurofins Operon in HPLC purified 
quality. A complete list of all used primers is in the appendix. 
All plasmids generated in this work or used as parental vectors for the construction of 
pFlpBtM variants, tagging vectors and donor vectors of model proteins respectively are 
listed below. 
pFlpBtM variants 
pFlpBtM-I 
Vector for transient expression in insect cells and donor for Tn7 transposition based generation of 
recombinant bacmids. It also contains FRT sites compatible for RMCE in the CHO Lec3.2.8.1 master cell 
line SWI3-26. Construction, gene integration and evaluation is presented and discussed in this work. 
 
pFlpBtM-II 
Multi host expression and donor vector for transient expression in mammalian cell lines and Tn7 
transposition based generation of recombinant bacmids. It also contains FRT sites compatible for RMCE in 
the CHO Lec3.2.8.1 master cell line SWI3-26 and an inducible T7 promoter for expression in E. coli. The 
version pFlpBtM-II(beta) has no Shine-Dalgarno sequence and differs in the design of the MCS and 
included tags. Furthermore it lacks restriction sites flanking FRT sites and promoters. Construction of 
pFlpBtM-II variants, gene integration and evaluation is presented and discussed in this work. 
 
Tagging vectors 
pie1-eGFP-dneo 
Tagging vector used for the integration of an RMCE cassette with neomycin selection trap in Sf21 and Hi5. 
It is a derivative of pFS-eGFP-dneo (Wilke, 2011) where the EF-promoter was excised by BglII and HindII 
and replaced by a PCR-fragment containing the ie1 and p10 promoter of pIEX/Bac5. 
 
pie1-tdTomato-dneo 
Derivative of pie1-eGFP-dneo. The eGFP sequence was excised by BstBI and BsaBI and replaced by a PCR-
fragment containing tdTomato. 
 
Vectors used for construction 
pFastBac (Invitrogen) 
Standard donor vector of the Bac-to-Bac™ system. This plasmid was the basis for the construction of 
pFlpBtM vectors. 
 
pIEx/Bac 5 (Novagen) 
Dual purpose vector for transient and viral expression in insect cells. It contains a promoter fragment with 
the baculoviral immediate early 1 and the late viral p10 promoter. This plasmid was used as a template for 
generating a PCR-fragment of the promoter region to construct pFlpBtM-I and pie1-eGFP-dneo. 
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pTriEx (Novagen) 
Expression vector for transient expression in vertebrate cells, in E. coli and donor vector for homologuos 
recombination with triple cut baculoviral DNA to generate recombinant baculoviruses. It was used as a 
template to generate a PCR-fragment of the promoter region containing a CMV ie promoter/enhancer, the 
baculoviral p10 promoter and a T7/lac sequence for the construction of pFlpBtM-II 
 
pTT5 (NRCC) 
Expression vector for transient expression in HEK293 cells. It contains the Epstein-Barr virus oriP sequence 
for episomal replication and enhanced nuclear transport in cells expressing the Epstein-Barr nuclear 
antigen 1 (EBNA1). This vector served as a reference in transient expressions in HEK293-6E. Furthermore, it 
was the template for the generation of a PCR-fragment containing the EBNA1 oriP, the beta-lactamase 
gene and the pMB-ori upon deletion of NcoI and BbsI sites in the backbone by site-directed mutagenesis. 
This fragment was used for the construction of pFlpBtM-II. 
 
pTT5-VLR-recipient 
Derivative of pTT5 with an integration of a hagfish variable lymphocyte receptor sequence followed by a 
TEV protease site and a one-STrEP- and His8 tag. It was used as a template to generate a PCR-fragment 
containing the TEV-STrEPHis8 sequence which was subsequently integrated into pFlpBtM-II 
 
pFS-eGFP-dneo (S. Wilke, HZI) 
Tagging vector used for the integration of an RMCE cassette with neomycin selection trap in  
CHO Lec3.2.8.1 (Wilke et al., 2011). A promoterless neomycin phosphotransferase (Δneo) gene lacking the 
ATG codon is located downstream of GFP. When the reporter is exchanged by a cassette including a 
promoter and start codon, Δneo becomes complemented. Thus, the cell gains resistance against the 
antibiotic G418 allowing for selection of recombinant cells.  
 
pFS-sighis-PGKd (S. Wilke, HZI)  
Targeting vector to integrate genes into the RMCE locus. It is compatible with the FRT sites of pFSeGFP-
dneo and contains a PGK promoter with a ATG codon downstream of its MCS for the selection trap 
system. This vector was used as a PCR-template to amplify a fragment consisting of the FRT sites, the MCS 
and the elements for the selection trap. This fragment was integrated into pFlpBtM-I. 
 
Parental vectors with inserts 
pFBDM-mTLR2 (N. Kuklik, HZI) 
pFBDM-mTLR2 is a donor vector of the MultiBac system to generate recombinant bacmids. It contains 
sequence of the ECD of murine TLR2 (uniprot accession no. Q9QUN7, kindly provided by C. Kirschner, 
Univ. Essen). The plasmid was used as a PCR-template to generate a fragment to be integrated into 
pFlpBtM vectors as a model protein. 
 
pmCherry & ptdTomato (Clontech) 
These vectors contain the sequences of the DsRed mutants mCherry and tdTomato, respectively (Shaner 
et al., 2004). They have been purchased from Clontech and were used as a PCR-template to generate 
fragments of each gene to be integrated into pFlpBtM vectors as model proteins. 
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pCMV-scFv-hIgG1Fc-4E3 (C. Menzel, TU Braunschweig) 
Mammalian expression vector harbouring the sequence of an scFv-hIgG1-Fc fusion construct (Menzel et 
al., 2008). It was used as a reference in transient expressions in HEK293-6E and served as a PCR-template 
to generate a fragment of the scFv-hIgG1Fc gene which was cloned into pFlpBtM-II and pTT5. 
 
pTTo/GFPq (NRCC) 
This vector is a variant of pTT and harbours an GFPq-gene (red shifted green fluorescent protein). It is used 
as a transfection control plasmid in transient expression in HEK293-6E cells. Transfection efficiency can be 
determined by flow cytometric measurements of fluorescent cells upon transfection. 
 
 
2.3 Bacterial strains and cell lines 
2.3.1 Bacterial strains 
Cloning steps to construct new plasmids or integrate coding sequences into expression 
vectors were performed in Xl1 Blue or Top10 E. coli strains. For the generation of 
recombinant baculoviral DNA DH10 strains harbouring the corresponding bacmids were 
used. All strains are listed in Table 2-8. 
Table 2-8: Bacterial strains 
E. coli strain Genotype Source 
Top10 F-, mcrA Δ(mrr-hsdRMS-mcrBC) Φ80(lacZ) Invitrogen 
  ΔM15ΔlacX74 recA1 araD139 Δ(ara, leu) 
  7697 galU galK rpsL (StrR) endA1 nupG 
 
XL1-Blue endA1 gyrA96(nalR) thi-1 recA1 relA1 lac  Stratagene  
  glnV44 F’[ ::Tn10 proAB+ lacIq Δ(lacZ)M15]  
 hsdR17(rK
-
 mK
+
) 
 
DH10MultiBac F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80(lacZ)   EMBL (Berger) 
DH10EMBacY ΔM15ΔlacX74 recA1 endA1 araD139 
  Δ(ara, leu)7697 galU galK l- rpsL nupG  
 /BacloxP/ pBADZ-His6Cre/pMON7124 
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2.3.2 Cell lines 
The following mammalian and lepidopteran cell lines have been used as host cell lines for 
protein expression in this work.  
CHO Lec3.2.8.1  
CHO Lec3.2.8.1 is a glycosylation mutant clone derived from the parental chinese hamster ovary (CHO) 
clone Pro-5 (a proline auxotroph, ATCC no. CRL 1781) by selection for resistance to different lectins 
(Stanley, 1989). This clone was adapted to grow in suspension.  
HEK293-6E  
The human embryonic kidney epithelial cell line HEK293 was established in 1977 by transformation of a 
primary culture with a adenovirus (Graham et al., 1977). The subclone HEK293-6E (NRC Canada) is adapted 
to suspension and carries an integration of a truncated Epstein-Barr nuclear antigen 1 (EBNA1) (Durocher 
et al., 2002). 
IPLB-SF-21AE (Sf21)  
The insect cell line IPLB-SF-21AE (DSMZ no. ACC 119) was originally isolated from ovaries of the fall 
armyworm Spodoptera frugiperda (Vaughn et al., 1977). It is adapted for growth in suspension and used in 
the BEVS for primary infection, virus amplification and protein production. 
BTI-Tn-5B1-4 (Hi5) 
BTI-Tn-5B1-4 (Wickham & Nemerow, 1993) is an ovary cell line which originates from the cabbage looper 
Trichoplusia ni. It is a subclone of the cell line BTI-Tn-5B1-28 (Granados et al., 1986) and is commercialised 
under the brand name High Five™ by Invitrogen. Due to higher expression rates this cell line is an 
alternative host for protein production using recombinant baculoviruses. 
 
 
2.4 Molecular biological methods 
Molecular-biological methods used in this work comprise plasmid preparation, PCR, 
restriction digest, extraction of DNA from agarose gels, ligation of DNA fragments, site 
directed mutagenesis and transformation. The corresponding protocols have been 
adapted from standard collections of methods and protocols (Sambrook & Russel, 2000; 
Asubel et al., 2007) and will not be explained here in detail. Isolation of recombinant 
bacmid DNA was performed according to the MultiBac manual (Berger et al., 2008). 
Subsequent to cloning procedures, plasmid constructs were sequenced at the Genome 
analysis department at the HZI. 
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2.5 Cell culture techniques 
2.5.1 Maintaining cells in culture 
If not stated otherwise cell lines were maintained as suspension cultures in 125 mL 
(culture volume 20 – 50 mL) or 500 mL shake flasks (culture volume 100 – 200 mL) on 
orbital shakers (Infors TR250, Biometra WT12 or Kühner ES X). Media and supplements 
for each cell line were used according to Table 2-5 and Table 2-6 on page 34.  
HEK293-6E and CHO Lec3.2.8.1 were cultivated at 37 °C and 100 rpm in humidified 
atmosphere with 5 % CO2. Adherent cultures were incubated at 8 % CO2. To maintain 
cells in suspension in the exponential growth phase, they were subcultured in fresh 
medium every 3 to 4 days with a seeding cell density of 1.5-3 x 105 cells/mL. Adherent 
cultures were expanded to larger vessels or transferred to suspension culture when 
reaching confluency. 
Sf21 and Hi5 were cultivated at 27 °C and passaged every 2 to 3 days to a cell density of 3-
7 x 105 cells/mL. Suspension cultures have not been humidified or maintained in a gassed 
atmosphere, whereas adherent cultures were stored in a humidified incubator to prevent 
evaporation.  
2.5.2 Determination of cell number and viability 
Cell numbers and viability were assayed by trypan blue dye exclusion method in a 
Neubauer hemocytometer or by flow cytometry after staining with propidium iodide. 
Both dyes cannot permeate intact cell membranes so that only dead cells are stained. 
Trypan blue binds to proteins whereas propidium iodide intercalates with nucleic acids. 
For manual determination of the cell density and viability 25 µL cell culture were diluted 
in 75 µL 0.5 % trypane blue solution. Both stained and unstained cells of 4 big squares of 
the hemocytometer were counted and the cell density and viability were calculated 
according to the following equations:  
   Eq. 1 
 
    Eq. 2 
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The determination of cell density and viability by flow cytometry was performed using a 
Guava EasyCyte™ Mini System (Millipore). Cell suspensions were diluted 10-fold in PBS 
and stained with a final concentration of 50 µg/mL propidium iodide to identify dead 
cells. The principle of flow cytometry is described in detail in 2.5.6 on page 42. 
2.5.3 Cell size determination 
Since an increase in insect cell diameter of 10 % to 20 % can be observed upon baculoviral 
infection, measurements of cell size variations have been performed in this work to 
monitor the progress of the infection. The CASY Cell Counter (Innovatis) facilitates a 
simultaneous measurement of cell number, viability and size due to its high acquisition 
rate of 106 min-1. The device utilises the principle of electric current exclusion for the 
determination of the size of particles diluted in an electrolyte. While flowing through a 
capillary the particles pass an electrical field and induce a resistance which is proportional 
to their size. Since dead cells exhibit membrane permeabilization, the resistance induced 
by those cells is significantly lower. Thus, a determination of the viability of a cell 
suspension is possible following a cell type specific calibration. The measurements were 
performed according to the manufactures guidelines after the samples were diluted in an 
isotonic, particle pure buffer to reach the measurement range of the device. 
2.5.4 Cryopreservation 
Cell banks of cell lines were stored in the vapour phase over liquid nitrogen. To prepare 
the cells for long term storage they were harvested from suspension culture by 
centrifugation at 180 ×g for 4 min. The cell pellet was resuspended in freezing medium 
(45 % (v/v) culture medium, 45 % fresh medium and 10 % DMSO) at a cell density 
2 × 107 cells/mL. Each cryo-tube (Nunc) was filled with 1.8 mL cell suspension. To 
provide a constant cooling rate of -1 °C/min the vials were stored in a special freezing 
container (Nalgene) in isopropanol at -70 °C for 24 h. Subsequently, the cryo-tubes were 
transferred into the liquid nitrogen container for long term storage. 
2.5.5 Chemical based transfection of eukaryotic cells 
Transfection of cell lines with plasmids or recombinant viral DNA (i.e. bacmids) was 
performed by cationic lipofection techniques. This process relies on complex formation of 
negatively charged DNA with lipofection reagents that possess linear or branched 
structures terminating at positively charged amino groups. Since the DNA-reagent 
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complexes show a net positive charge, they bind to negatively charged receptors (e.g., 
sialylated glycoproteins) on the surface of eukaryotic cells. The compact structures 
optimise the entry of DNA into the cell. Upon endocytosis and fusion with the endosome, 
the reagents are capable of pH-buffering the lysosome ensuring inhibition of lysosomal 
nucleases and stability of the DNA complexes.  
Different lipofection reagents are composed of different cationic or neutral polymers (or 
different ratios thereof) such as N-[1-(2,3-dioleyloxy)propyl]-N,N,N-trimethylammonium 
chloride (DOTMA) (Felgner et al., 1987), dioleoyl phosphatidylethanolamine (DOPE) 
(Felgner et al., 1994) or N,NI,NII,NIII-tetramethyl-N,NI,NII,NIII-tetrapalmityl-spermine (TM-
TPS) (Gao & Huang, 1995). Hence, for the transfection of CHO and insect cells optimised 
transfection reagents and conditions for each DNA construct have been evaluated 
according to the manufacturer’s instructions. HEK293-6E cells were transfected using 
linear polyethylenimine (PEI) with an average MW of 25 kDa. The polycationic PEI is the 
most efficient reagent for the delivery DNA into HEK293 cell lines (Huh et al., 2007). 
Additionally, DNA-PEI aggregates protect the nucleic acids from degradation by 
nucleases (Boussif et al., 1995). The protocols used in this work for the transfection of 
insect and mammalian cells are described below. The corresponding reagents are listed in 
Table 2-7 on page 34.  
Transfection of insect cells with plasmid DNA 
Insect cells in serum free suspension cultures were transfected with plasmid DNA for transient tests 
expression or the genomic integration of RMCE cassettes. For this purpose Lipofectin, Cellfectin (both 
Invitrogen) and Insect Gene Juice (Novagen) have been used in DNA to reagent ratios of 1:2 - 1:4 with a 
DNA dose of 1 - 2 µg/10
6
 cells. Complex formation was performed according to the manufacturer’s 
protocols: after dilution of DNA and reagent in appropriate amounts of medium the solutions were mixed 
and incubated at RT for 10 - 20 min to allow complex formation. A removal of transfection complexes after 
adding to the cell culture by a medium exchange was implemented if recommended. 
Transfection of insect cells with bacmids 
To generate recombinant viruses adherent Sf21 cells were transfected with recombinant bacmids of the 
MultiBac-system or EMBacY-bacmids, respectively. For transfection 0.75 × 10
6
 Sf21 cells from a culture 
supplemented with 5 %FCS per well were seeded on 6-well plates. For each transfection 10 µL Superfect 
(QIAGEN) and 5 µL isolated bacmid were diluted in a total volume of 200 µl and incubated for 20 min at RT 
prior to adding the mixture to the cells. Whereas the formation of transfection complexes was performed 
under strict absence of serum, the incubation of the cells with the complexes was performed in serum 
supplemented medium. After 2 h the transfection mixture exchanged by 2 mL fresh medium. The 
supernatant containing first generation virus was harvested 72 h post transfection. 
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Transfection of HEK293-6E 
Transfection of HEK293-6E was performed using optimised protocols provided by the NRCC, with a DNA 
dose of 0.2 µg per 10
6
 cells and a DNA:PEI ratio of 1:2. 25 µg plasmid DNA and 50 µg PEI were each diluted 
in 1.25 mL supplemented F17. After both solutions were mixed and incubated for 15 min at RT to allow 
complex formation, the mixture was quantitatively added to exponentially growing cells in 25 mL 
suspension culture with a density of 1.5 - 2 × 10
6
 cells/mL. Prior to complex formation the DNA was spiked 
with 5 % pTTo/GFP, allowing to monitor the transfection efficiency by flow cytometric measurements. 
 
2.5.6 Flow cytometry and preparative cell sorting 
Fluorescence based flow cytometry is a method for real time high-throughput analysis of 
cells in suspension. Cells are diluted in a hydrodynamically focussed sheath fluid and 
excited by a single wavelength laser which allows a simultaneous multimeric detection of 
particle size, granularity and fluorescence. It was evolved in 1972 (Julius et al., 1972) from 
a previously presented method which is based on the Coulter principle of cell size 
determination to separate cells (Fulwyler, 1965). In the prevalent optical based method the 
cell size is measured by a detector in the line of the beam (forward scatter), whereas 
granularity (side scatter) and fluorescence is simultaneously determined by perpendicular 
detectors (Figure 2-1, upper part). The data is analysed by a software and presented as 
histograms or two-dimensional scatter plots. Clusters of cells with similar properties can 
be identified which enables the definition of so called gates to mark certain 
subpopulations for evaluation purposes. Thereby, a determination of transfection 
efficiencies or viability is possible on the basis of the number of eGFP-positive cells or 
cells stained by propidium iodide, respectively. 
Besides analytic flow cytometers so called cell sorters can be used for preparative 
fluorescence activated cell sorting (FACS) according to measured properties of the cells. In 
this method cells belonging to certain subpopulations marked by gates in the evaluation 
software will be separated from the suspension during the sorting process. Therefore the 
liquid column of the cell solution is separated into single droplets by a vibrating 
piezoelectric crystal. It causes velocity fluctuations in the emerging liquid column which 
leads to growing disturbances of the surface tension. Immediately after the jet passes the 
laser beam it breaks into very uniform droplets each containing a single cell. These 
droplets are subsequently equipped with a positive or negative charge according to the 
gate the enclosed cell has been assigned to by the evaluation. Following to droplet 
formation, the cells pass through an electrostatic field, which causes deflection of charged 
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droplets which are collected in separate containers while uncharged droplets remain 
undeflected and are discarded. The automated sorting process includes the measurement 
of cell properties, data evaluation, signal feedback, separation of empty droplets or those 
containing cell aggregates as well as the sorting of positive cells in up to four different 
populations. State-of-the-art devices achieve typical acquisition rates of 25,000-70,000 
events per second, depending on the demands in purity and yield.  
 
 
Figure 2-1: Principle of flow cytometry and cell sorting 
Cells diluted in a sheath fluid pass a laser beam which allows a simultaneous detection of cell size (forward scatter), 
granularity (side scatter) and fluorescence by photomultipliers in the line of the beam and perpendicular to it, 
respectively. A piezoelectric element causes the jet to separate in droplets containing single cells immediately behind 
the laser beam. The droplets are electrically charged after passing the nozzle according to the data evaluation 
feedback. While passing through an electrostatic field, the charged droplets are deflected and thereby can be sorted 
into up to four different pools (modified work, original source: L. Gröbe, HZI). 
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In this work a Guava EasyCyte Mini System (Millipore) has been used for the 
determination of cell number, viability and efficiencies of both transfections and infections 
with recombinant baculoviruses. It is equipped with a 488 nm argon laser and 3 band-
pass filters for the detection of green, yellow and red emission signals. Preparative cell 
sorting was performed on a MoFlo high-speed cell sorter (Beckman Coulter) and a 
FACS Aria II™ cell sorter (Becton Dickinson) by Lothar Gröbe in the research group 
Experimental Immunology at the HZI. The FACS Aria II was equipped with two 
frequency-doubled diode-pumped solid-state laser with wavelengths of 488 nm and 
additionally 561 nm for the excitation of tdTomato. For the isolation of single cells an 
automated cell deposition unit sorting cells into a 96-well plate was used at the MoFlo 
system. Table 2-9 shows the configurations of each device used in this work. 
Determination of fluorescence using the Guava EasyCyte Mini was performed according 
to the protocol described in 2.5.2 without staining with propidium iodide. Preparative cell 
sorting was performed with aliquots of at least 3 × 107 cells, which were centrifugated at 
180 ×g for 4 min. The supernatant was sterilised by filtration and collected as conditioned 
medium. The cells were resuspended in 2 mL fresh medium supplemented with 10 % FCS 
and Penicillin, Streptomycin and Fungizon. Sorting was performed until 3 × 107 positive 
cells were collected in 5 mL medium supplemented with FCS and antibiotics. These cells 
were pelleted and resuspended in 2 mL conditioned medium suplemetented with FCS 
and antibiotics and seeded in a single well of a 6-well plate. After 24 hours medium was 
exchanged by conditioned medium. The cells were proliferated until confluency and 
passaged or expanded into 4 mL suspension culture. 
Table 2-9: Configuration parameters of flow cytometer 
Sorting device Marker protein Excitation laser Detector 
Guava EasyCyte Mini eGFP / YFP 488 nm 525/30 
 tdTomato 488 nm 583/26 
 mCherry 488 nm 680/30 
 
BD FACS Aria II eGFP 488 nm 525/50 
 tdTomato 561 nm 585/15 
 
Beckman MoFlo eGFP 488 nm 530/40 
 tdTomato 488 nm 580/30 
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2.5.7 Generation of producer cell lines by RMCE 
The delivery of RMCE donor-plasmids and the helper-plasmid harbouring the Flp 
recombinase into the CHO Lec3.2.8.1 derived RMCE master cell line SWI3-26 was 
performed by nucleofection. This is an electroporation-based method to deliver substrates 
into the cytoplasm and the nucleus of mammalian cells. Since it is a direct transfer this 
technique is independent of cell division for the transport of DNA into the nucleus. A 
proprietary variant commercialised by Lonza relies on a combination of cell line specific 
electroporation parameters and optimised reagents for different cell lines. The 
cotransfection of the master cell line and the subsequent isolation of producer cell lines 
was performed by Bahar Baser using the following protocol. 
Nucleofection of CHO Lec3.2.8.1 
1 × 10
6
 cells were resuspended in 100 µL of nucleofector-solution transfected with 1 µg donor- and 4 µg 
helper plasmid by using program U-24 according to manufacturer’s guidelines (Nucleofector Kit V, Lonza). 
Directly after electroporation the cells were resuspended in 500 µL prewarmed supplemented ProCHO5. 
The transfected cells were incubated over night at 37 °C and 150 rpm in a total volume of 2 ml per well of a 
12-well plate. 24 h post transfection the cells were seeded on a 100 mm culture dish in 10 mL CD-
Hybridoma medium and cultivated at 37 °C in a humidified atmosphere with 8 % CO2. To select for positive 
cell clones 2 mg/mL G418 was added after 5 days. Medium was replaced every 2 - 3 days until the cell 
clones were picked and transferred into 96-well plates after 2 - 3 weeks. If necessary, the cells were 
recloned by serial dilution (2.5.8). Clonal cell lines were adapted to suspension cultures in serum free 
ProCHO5 medium by adding 10 U/mL heparin (Sigma) during the first 2 passages. 
 
2.5.8 Single cell cloning  
Subsequent to preparative cell sorting or RMCE clonal cell lines were generated by serial 
dilutions in a 96-well flat bottom plate or alternatively by seeding 6,000 – 800,000 cells in 
60 mm cell culture dishes. For the serial dilution 0.5 × 104 cells/mL in 400 µL ExCell420 
medium were inoculated in well A1 and diluted 1:2 along the first column resulting in 
200 µL per well. A 1:2 dilution series across all columns was prosecuted also resulting in a 
total volume of 200 µL per well. In both cases the plates were incubated at 27 °C in a 
humidified atmosphere until colonies with a diameter of at least 25 cells where clearly 
visible. Those colonies were drawn into a microtiter pipette tip and passaged into a new 
96-well plate. When the cells reached confluency expansion was continued over several 
passages using 48-, 12-, 6-well plates and 60 mm dishes by detaching with trypsin or a 
rubber policeman. Finally, cells where transferred into suspension. 
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2.5.9 Viral titer determination by Plaque Assay 
Viral titer were determined using the plaque assay technique. It was originally developed 
to calculate the titers of bacteriophage stocks and modified by R. Dulbecco in 1952 for use 
in animal virology (Dulbecco, 1952). A monolayer of susceptible cells is infected by a 
series of 10-fold dilution of the virus solution. To prevent a distribution of the virus upon 
cell lysis, the medium is fixed by an overlay of low melting point agarose. Thus, virus 
particles can only infect neighbouring cells which subsequently leads to the generation of 
empty spots in the monolayer, the so called plaques. After several days neutral red is 
added to the monolayer to visualise the plaques caused by viral-dependent cell lysis. The 
cationic dye binds to negatively charged lysosomal membranes, thus staining only intact 
cells, whereas plaques are visible as white spots. The virus concentration is calculated in 
plaque forming units per mL (PFU/mL). 
In this work each virus was titered using three dilution stages prepared in ExCell420 
ranging from 10-4 – 10-6 for first generation virus from transfection supernatants and 10-5 –
 10-7 for virus amplificates. In each well of a 6-well plate 1.25 × 106 Sf21 cells were seeded. 
After the cells have been fully attached the medium was exchanged to remove residual 
FCS which inhibits virus entry. Subsequently, the cells were covered with 500 µL of the 
virus dilutions and incubated at 27 °C to allow infection. A virus with known titer and 
uninfected cells were used as controls. After 2 h the virus solution was exchanged by an 
overlay of ExCell420 supplemented with 1 % low melting point agarose, 5 % FCS and 
antibiotics. After the overlay has hardened the plates were incubated for 6 days at 27 °C. 
Afterwards, each well was stained with 350 µL of a 5 % neutral red solution for at least 
4 h. Only those wells with a countable number of plaques between 20 - 200 were used to 
calculate the virus titer by the equation 3. 
 
    Eq. 3 
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2.5.10 Virus amplification  
To amplify first generation virus harvested from transfection supernatants, Sf21 cells were 
seeded in a density of 0.5 × 106 cells/mL in 50 -200 mL serum free ExCell420 and 
incubated at 27 °C and 100 rpm. The cells were infected using 1 % (v/v) transfection 
supernatant or with an MOI of 0.1 if the titer was known. Cell number, viability and 
diameter were determined every 24 h. In case of viruses harbouring fluorescent proteins, 
the amount of fluorescent cells was measured at the Guava flow cytometer. The 
supernatant was harvested 48 h after the cells stopped proliferating and reached an 
average diameter of 20 -25 µm. Following centrifugation for 15 min at 5000 rpm to 
separate the cells the cleared supernatant was sterilised by filtration using a Stericup 
vacuum system (Millipore) with a 0.45 µm filter and stored at 4 °C until titer 
determination. 
2.5.11 Cryopreservation of baculoviruses in infected cells 
To prevent a loss of infectivity during long term storage, the viruses were preserved using 
the method of baculovirus infected insect cells (BIIC) (Wasilko et al., 2009). 300 mL of a 
Sf21 culture with a density of 1 × 106 cells/mL were infected with an MOI of 3 and 
cultivated at 27 °C and 100 rpm. When a significant increase in cell diameter was 
observed 24 hpi, the cells were harvested by centrifugation for 4 min at 180 ×g. The 
infected cells were subsequently resuspended in ExCell420 supplemented with 10 % 
DMSO and 45 % conditioned medium in a concentration of 1 × 107 cells/mL. Aliquotation 
in cryo tubes and deep freezing was performed as described in 2.5.4 on page 40. 
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2.6 Protein production and purification 
2.6.1 Plasmid based transient protein expression 
Transient expressions of the model proteins were performed to proof the functionality of 
the vectors pFlpBtM-I and pFlpBtM-II and to evaluate the expression rates of the model 
proteins in insect cells and HEK293-6E. The transfections were carried out according to 
2.5.5 on page 40. Cell number, viability and if applicable the fluorescence were probed 
every 24 h and samples of the culture supernatant as well as aliquots of 106 cells were 
taken for analysis and stored at -20 °C until further use. 
HEK293-6E cultures were expanded 48 h post transfection (hpt) with fresh medium to a 
total volume of 50 mL and supplemented with a final concentration 0.5 % tryptone (TN1). 
Additionally, 4.5 g/L glucose were added 72 hpt to compensate the metabolic 
consumption. To further increase the expression rate after the cell density has reached the 
stationary phase 96 hpt, 3.75 mM valproic acid (VPA) were added. VPA is a competitive 
inhibitor of histone deacetylases (HDAC). While it increases the expression rate it has also 
a negative influence on the proliferation rate, hence it is supplemented only in the late 
phase of the expression (Backliwal et al., 2008b). Transient expressions in insect cells have 
not been supplemented and were harvested after 4-7 days as soon as the cell number and 
viability began to decrease due to nutrient limitations.  
2.6.2 Protein expression in insect cell lines using BEVS  
For baculoviral protein production insect cells were seeded in 30 - 200 mL suspension 
cultures with initial cell densities between 0.5 × 106 and 1 × 106 cells/mL. MOIs between 
1 - 5 were chosen if titers have been determined before. Otherwise first generation virus 
stock was added in a total concentration of 10 %. Infection kinetics were monitored every 
24 h by the determination of the growth curves, cell diameter and percentage of 
fluorescent cells. As in plasmid based transient expression, samples of the culture 
supernatant as well as aliquots of 106 cells were taken for expression analysis and stored 
at -20 °C until further use. The supernatants and pellets were harvested as soon as the 
viability dropped below 80 % or after 7 days post infection at the latest. 
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2.6.3 Protein production in stable mammalian cell lines  
Small scale protein production in stable CHO Lec3.2.8.1 producer cell lines was 
performed in shake flasks at 37 °C and 100 rpm in humidified atmosphere with 5 % CO2. 
To obtain significant amounts of ECDmTLR2, a cultivation in an autoclavable stirred tank 
bioreactor with 2.5 L culture volume was performed by Nadine Konisch. The bioreactors 
were equipped with a double membrane stirrer for both bubble-free aeration via 8 m of 
hydrophobic polypropylene Accurel™ S6/2 membrane tubing (Membrana) and perfusion 
with internal cell retention via 8 m of hydrophilised, microporous membrane tubing of 
the same type (Lehmann et al., 1987; Blasey & Jäger, 1991). The process diagram is shown 
in Figure 2-2.  
 
 
Figure 2-2: Flow diagram of a stirred tank reactor for continuous cultivation of CHO Lec3.2.8.1 producer cell lines 
Flow diagram of a continuously perfused double membrane stirred tank reactor with bubble-free aeration for the 
stable production of recombinant protein by CHO Lec3.2.8.1 producer cells (source: V. Jäger, HZI). 
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Upon seeding in a 1:1 blend of ProCHO5 and ZKT-I media with an initial cell density of 
3 × 105 c/mL the production cell line was propagated in batch mode at 37 °C with a 
stirring speed of 45 rpm and a dissolved oxygen (DO) concentration of 40 % air saturation 
at pH 7.2. Upon reaching a cell density of approximately 4 × 106 after 4 days the perfusion 
mode was started with an initial rate of 2 L/d. During the following cultivation period 
over 8 days the perfusion rate was gradually increased to a final value of 7.5 L/d 
according to the metabolic consumption of glucose preventing a drop below 2.5 g/L. At a 
cell density exceeding 107 cells/mL, temperature was reduced to 32 °C. Samples of 2 mL 
were taken daily for routine in-process control. A total volume of 35 L cell-free 
supernatant could be obtained from a single production run. Following a 25-fold 
concentration by ultrafiltration it was diafiltrated against PBS using a Pellicon 2™ 
tangential flow system (Millipore) equipped with two 30-kDa cut-off cartridges.  
2.6.4 Cell lysis 
To analyse the expression kinetics aliquots of 1 × 106 cells were lysed by incubation in 150 
µL Cytobuster protein extraction reagent (Novagen) for 45 min at RT. To separate soluble 
and insoluble fractions the lysate was centrifuged for 15 min at 13,000 ×g. Both fractions 
as well as the culture supernatant were stored at -20 °C. 
For large scale extraction of intracellular proteins the cell pellets were resuspended in 
25 mL Lysis buffer (Table 2-10) and incubated on ice for 15 -30 min. Optionally, 
resuspended cells were disrupted by sonication. This was performed in a Sonopuls 
sonifier (Bandelin) equipped with a TT 13 FZ sonotrode using 80 W in intervals of 1 sec 
for 2 min. The lysate was centrifugated for 30 min at 30,000 ×g and 4 °C. The clear cell 
extract was transferred to a new falcon tube and stored at 4 °C until affinity purification. 
Table 2-10: Lysis buffer 
Composition Final concentration 
Sodium phosphate buffer pH 8 50 mM 
NaCl 300 mM 
Imidazole 5 mM 
IGEPAL CA-630 0,5 % 
β-mercaptoethanol 3 mM 
DNAse 0,2 µg/mL 
Leupeptine (only for lysis of insect cells) 100 µM   
Roche complete mini protease inhibitor tabled (EDTA free) 
  MATERIAL AND METHODS 
 51  
2.6.5 Affinity chromatography 
All model proteins expressed in this work were either equipped with poly histidine tags 
for capturing by IMAC or expressed as hFC fusions to be purified by Protein A affinity 
chromatography. For analytical small scale purification of His-tagged proteins Ni-NTA 
spin columns (QIAGEN) were used according to the manufacturer’s protocols. The 
preparative purification of proteins from culture supernatants or lysates of harvested cells 
was performed using a Profinia protein purification system (Biorad) with preset run 
parameters. Columns and buffer compositions are summarised in Table 2-11 and Table 
2-12. Prior to loading on the columns supernatants and cell lysates were filtrated using 
Minisart 0.45 µm syringe filters (Sartorius). To prevent stripping of Ni2+ ions from the 
IMAC column by chelating ions in the insect cell culture medium samples have been 
dialyzed before loading to the columns. 
Table 2-11: Affinity chromatography columns 
Column Column volume Cat. no. 
Bio-Scale Mini Profinity IMAC Cartridge 1 mL #732-4610 
Bio-Scale Mini Affi-Prep Protein A Cartridge 1 mL #732-4600 
Bio-Scale Mini Bio-Gel P6 Desalting Cartridge 10 mL #732-5304 
 
Table 2-12: Buffers for affinity chromatography 
Buffer Composition 
2× Cleaning solution 1 1 M NaCl, 100 mM Tris, pH 8 
4× Cleaning solution 2 2 M NaCl, 400 mM NaOAc, pH 4.5 
2× Storage solution (desalting column) 4 % benzyl alcohol 
2× Storage solution (ProtA column) 20 % ethanol 
5× Desalting buffer Phosphate buffered saline (PBS), pH 7 
5× Prot A binding/wash buffer Phosphate buffered saline (PBS), pH 7 
5× Prot A Elution buffer (citrate) 500 mM sodium citrate, pH 3 
2× IMAC Wash buffer 1 600 mM KCl, 100 mM KH2PO4, 10 mM Imidazole, pH 8 
2× IMAC Wash buffer 2 600 mM KCl, 100 mM KH2PO4, 20 mM Imidazole, pH 8 
2× IMAC Elution buffer 600 mM KCl, 100 mM KH2PO4, 500 mM Imidazole, pH 8 
Dialysis buffer 50 mM Tris-HCl, 500 mM NaCl, 1 mM NiCl2, 5 mM CaCl2 
 
 
MATERIAL AND METHODS 
 
 52  
2.7 Protein analytical methods 
2.7.1 Photometric quantification of protein concentrations 
Concentrations of purified protein solutions were obtained via the inline measurement of 
the Profinia device. Alternatively, they were determined using a NanoDrop ND-1000 
photometer. The measurement was performed with a sample volume of 2 µL after a 
calibration with a corresponding protein free buffer.  
Both the Profinia and the NanoDrop device indicate the absorbance scaled to a layer 
thickness of 1 cm. According to the Beer-Lambert law (Eq. 4) the absorbance value had to 
be divided by the mass extinction coefficient to calculate proper protein concentrations. 
Since the extinction at a wavelength of 280 nm is caused by the aromatic amino acids 
tryptophan and tyrosine, protein specific mass extinction coefficients were calculated for 
each protein by the VectorNTI software (Invitrogen).  
 
  Eq. 4 
c: protein concentration 
A280 dimensionless absorbance at 280 nm 
ε mass extinction coefficient [mL · mg
-1
 · cm
-1
] 
l: layer thickness [cm] 
 
 
2.7.2 Fluorometric quantification of eGFP concentrations 
A quantification of intracellular eGFP accumulation was performed by measuring 
fluorescence of cell lysates at a NanoQuant InfiniteM200 plate reader (Tecan). For an 
accurate acquisition a serial dilution of the cell lysates from 1:2 to 1:256 was prepared. An 
eGFP standard (Biovision) was used to set up a calibration curve ranging from 0.1 µg/L to 
1 µg/L to allow a quantification of protein yields from relative fluorescence intensities. 
The measurements were performed as duplicates in black F96 MicroWell™ plates (Nunc) 
using the parameters summarised in Table 2-13. 
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Table 2-13: Plate reader settings 
Parameter Value 
Shaking duration 2 s 
Shaking amplitude 2 mm 
Mode Fluorescence top reading 
Excitation wavelength 488 nm 
Emission wavelength 509 nm 
Excitation bandwidth 5 nm 
Emission bandwidth 5 nm 
Gain 10 Manual 
Number of flashes 50 
Flash frequency 400 Hz 
Integration time 20 µs 
Lag time 0 µs 
Settle time 0 ms 
Z-Position (manual) 20000 µm 
 
2.7.3 SDS-PAGE  
Denaturing polyacrylamide gel electrophoresis (Laemmli, 1970) was used to determine 
expression kinetics during the protein production as well as to evaluate purity and yield 
of purified proteins. Either Criterion™ precast gels (Biorad) or self-made gels composed 
of a lower resolving gel (12 % acrylamide) and a upper stacking gel (5 % acrylamide) were 
used (Table 2-14). Typically, 10 - 15 µL of the protein sample were mixed with 2 µL of a 
8× SDS loading buffer and heated for 5 min at 90 °C. The electrophoresis was performed 
at a constant voltage of 160 V until the dye front reached the end of the gel. Subsequently, 
the gel was washed with water to remove SDS and then stained with Instant Blue 
(Expedion) or a methanol based coomassie dye. The buffers used for SDS-PAGE are 
summarised in Table 2-15. 
Table 2-14: Compositions of SDS-PAGE gels (Volumes for 4 gels)  
Solution 12 % resolving gel 5 % stacking gel 
Acrylamide/bisacrylamide 30 % (v/v) 8.0 mL 0,75 mL 
4× lower buffer 5.0 mL - 
4× upper buffer - 1.25 mL 
10 % SDS 0.2 mL - 
H2O 6.8 mL 2.95 mL 
TEMED 20 µL 15 µL 
40 % APS 30 µL 15 µL 
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Table 2-15: SDS-PAGE buffers and reagents 
Buffer Composition 
4× Upper buffer 0.5 M Tris-HCl pH 6.8, 0.4 % SDS (v/v) 
4× Lower buffer 1.08 M Tris-base, 0.42 M Tris-HCl, pH 8.8 
SDS running buffer 3 g/L Tris-base, 14.4 g/L Glycin, 1 g/L SDS, pH 8.3 
Coomassie staining solution 50 % Ethanol, 10 % acetic acid, 0.25 % Coomassie R-250 
Coomassie destaining solution 50 % Ethanol, 10 % acetic acid 
 
2.7.4 Native PAGE 
In a native polyacrylamide gel electrophoresis protein samples are separated without 
denaturing the secondary, tertiary and quaternary structures. Thus, the migration speed is 
not only dependent on the protein mass, but also influenced by net charge of the protein 
surface (determined by the isoelectric point and the pH of the buffer) and the 
hydrodynamic radius (i.e. the shape and conformation of the protein). To ensure that the 
proteins migrate to the cathode, a slightly negative charge is mediated by Coomassie  
G-250 without denaturing the proteins.  
In this work the NativePAGE Novex 4-16 % Bis-Tris gel system kit (Invitrogen) was used 
which is based on the principle of Blue Native PAGE (Schagger & von Jagow, 1991). Since 
the migration speed is influenced by ion strength of the buffer (Gallagher, 2001), a buffer 
exchange against 50 mM Tris was performed using Vivaspin sample concentrators (GE 
Healthcare). As a size marker, the HMW Native (66-669 kDa) standard of the HMW 
Calibration Kit for native PAGE (Amersham) was used. The electrophoresis was 
performed according to the manufacturer’s instructions at a constant voltage of 150 V for 
120 min.  
2.7.5 Western blot 
For a specific detection of proteins Western blots followed by immunostaining were 
performed. A BioRad Trans-Blot-SD device was used to transfer protein samples 
separated in SDS-PAGE to a polyvinylidene difluoride membrane (Immobilon-P, 
Millipore) by a semi dry blotting procedure (Kyhse-Andersen, 1984). The buffers and 
antibodies used for this method are summarised in Table 2-16. The gels and 2 pieces of 
gel-sized Whatman paper were equilibrated for 10 min in transfer buffer. The PVDF-
membrane was activated in 100 % methanol for 5 sec, rinsed with water and briefly 
equilibrated in transfer buffer for 10 min. Subsequently, the gel was placed onto the 
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membrane avoiding air bubbles to be enclosed. For the transfer, both were placed 
between two layers of soaked Whatman paper onto the anode of the blot apparatus. The 
blot was run with 14 V for 30 min. To saturate free binding sites the membrane was 
incubated for 1.5 h in a blocking solution of 5 – 10 % skim milk powder in TBS-T. 
Following a washing procedure in TBS-T (3 × 5 min), the membrane was incubated with 
antibodies against polyhistidine- or hFc-tags overnight at 4 °C. Prior to the incubation in 
with the secondary antibody, another washing step was performed. If needed, 1 % skim 
milk powder was added to the antibody solutions to prevent unspecific binding. To 
visualise the proteins specifically bound by alkaline phosphatase conjugated antibodies 
the BCIP/NBT Color Development Substrate from Promega was used according to the 
manufacturer’s guidelines.  
Table 2-16: Buffers and reagents for Western blots 
Buffer Composition 
Transfer buffer 25 mM Tris-base, 192 mM Glycin, 15 % Methanol, pH 8 
TBS-T 20 mM Tris-base, 150 mM NaCl, 0.05 % (v/v) Tween, pH 8 
AP-buffer 100 mM Tris 100 mM NaCl, 5 mM MgCl2, pH 9.5 
BCIP 50 mg/mL BCIP in 100 % dimethylformamide 
NBT 50 mg/mL NBT in 70 % dimethylformamide. 
Antibody Type Concentration Supplier 
His-Tag antibody (mouse) primary 1:2000 in TBS-T Novagen #70796 
Goat-anti-human IgG (H+L)-AP primary 1:5000 in TBS-T Promega #S3821 
StrepMAB-Classic (mouse) primary 200 ng/mL in PBS + 0,2% BSA IBA 2-1507-001 
Goat-anti-mouse IgG (H+L)-AP secondary 1:7500 in TBS-T Promega #S372B 
 
2.7.6 MALDI-TOF 
MALDI-TOF (Matrix Assisted Laser Desorption Ionisation - Time-Of-Flight) mass 
spectrometry (MS) was used to identify proteins fragments of SDS-PAGE samples. After a 
tryptic digest, proteins were co-crystallised with organic acids. Desorption of protein 
fragments is triggered by a UV laser beam followed by an ionization mediated by 
protonation of the peptides. Time-of-flight measurements reveal mass-to-charge ratio of 
the ions. This information can be used for protein identification by comparing the data 
with the MASCOT database. The analyses were carried out in the research group Cellular 
Proteome Research at the HZI. 
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2.7.7 N-terminal sequencing 
For a detailed characterization of protein fragments the N-termini were sequenced by 
automated Edman degradation (Edman & Begg, 1967). The protein samples were 
separated by SDS-PAGE and transferred onto a PVDF membrane specialised for 
sequencing purposes (Immobilon PSQ, Millipore) as described in 2.7.5 on page 54. Protein 
bands were cut out after visualization by Coomassie staining. The N-terminal sequencing 
was performed using the 494A HT Protein Sequencer (Applied Biosystems) by Beate 
Jaschok-Kentner in the department of Molecular Structural Biology at the HZI.  
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3 Results 
The initial design of a multi-purpose vector aimed at its use for transient expression in 
insect cells as well as a donor vector for the BEVS and for RMCE in CHO Lec3.2.8.1 master 
cell lines. Thus, it was named pFlp-Bac-to-Mam (here referred to as pFlpBtM-I) to 
emphasise its properties as a shuttle vector for baculoviral and mammalian expression by 
Flp mediated cassette exchange. The construction and evaluation of this vector is 
presented in chapters 3.1 and 3.2. For the proof of concept studies, protein expression was 
determined by analytical SDS-PAGE, Western blots and by determining fluorescence via 
flow cytometry and fluorescent microscopy. A second improved version (pFlpBtM-II) was 
generated by the incorporation of genetic elements for transient expression in HEK293-6E 
cells (chapter 3.3). Subsequent to the proof of concept (chapter 3.4) the vector was used for 
comparative expression and purification studies of model proteins in different hosts 
(chapter 3.5). Finally, the integration of a RMCE based system for stable expression of 
heterologous proteins in Sf21 and Hi5 cells is presented in chapter 3.6. 
 
3.1 Construction of pFlpBtM-I 
The generation of pFlpBtM-I followed a three-step modification of an in-house variant of 
the pFastBac donor vector (Invitrogen) as shown in Figure 3-1. Firstly, the polyhedrin 
promoter of pFastbac-H8PPFlag was replaced by a 1294 bp PCR-fragment of pIEx/Bac5 
(Novagen) upon a BbsI-NsiI digest. It comprises the AcMNPV immediate early promoter 
ie1 and its enhancer hr5 for transient expression and the very late baculoviral p10 
promoter. The resulting plasmid pFB-ie10-H8PPFlag was confirmed by analytical 
restriction digest and sequencing of the corresponding plasmid segment. Subsequently, 
the BbsI site was eliminated by site directed mutagenesis, as this enzyme should be used 
for the seamless integration of target gene sequences into to MCS of the final vector. The 
elimination of the restriction site was again checked by analytical restriction digest and 
sequencing. Finally, a 1285 bp PCR-fragment containing the complete FRT-cassette from 
pFS-sighis-PGKd flanked by 5’-BamHI and 3’-AvrII was generated. The parental pFS-
sighis-PGKd is a mutant of GenBank JF313343, in which the BamHI site is eliminated via 
fill in and ligate reactions. The PCR-product was integrated into pFB-ie10-H8PPFlag upon 
digestion with BamHI-AvrII, thereby eliminating the original MCS in the target plasmid. 
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Figure 3-1: Cloning strategy for the construction of pFlpBtM-I 
A fragment containing the baculoviral immediate early promoter 1 (ie1) and the homology region 5 enhancer (Hr5) as 
well as the very late p10 promoter was amplified by PCR from pIEx/Bac5 and integrated into pFastBac-H8PPFlag upon 
deletion of the original polyhedrin promoter by BbsI-NsiI digest. Subsequently, the BbsI site in the resulting 
intermediate pFB-ie10-His8PPFlag was eliminated by a site directed mutagenesis. The MCS of the pFB-ie10-
His8PPFlag_qc mutant (qc = Quickchange) ranging from BamHI-AvrII was exchanged by the RMCE cassette 
comprising a pair of heterologous FRT sites, the PGK promoter and a start codon for the selection trap and a MCS with 
an IgG signal peptide, a C-terminal His6 tag and the SV40 polyA. The cassette was generated as a PCR-fragment with 
flanking restriction sites. 
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The RMCE cassette contains an upstream FRT3-mutant, an IgG signal peptide, two 
opponent BbsI-sites, a C-terminal His6 tag and a SV40 polyadenylation signal (pA). 
Additionally, the PGK promoter and the ATG start codon for the selection trap as well as 
the second FRTwt site are located within the cassette downstream of the SV40 pA 
element. The resulting pFlpBtM-I was again confirmed by sequence analysis and 
analytical restriction digest. Figure 3-2 shows a schematic map of the final construct 
composed of the three sections from different parental plasmids. 
 
 
Figure 3-2: Schematic map of pFlp-Bac-to-Mam-I 
Vector map of pFlpBtM-I with elements for recombination, expression, screening and replication. Sections originating 
from different parental vectors are highlighted in orange (pFastBac), blue (pFS-sighis-PGKd) and green (pIEx/Bac5), 
respectively. The promoter region contains the baculoviral immediate early ie1 and late p10 promoters. 
 
The design of the vector is based on the overlap of the regions for Tn7 transposition and 
RMCE. The Tn7 sites which mediate the transposition into the baculoviral genome, flank a 
3576 bp large region containing a Gentamicin resistance for the screening of positive 
integrations into the bacmid DNA, the promoter region, the MCS and additional elements 
for RMCE. Those are the PGK promoter, the ATG start codon for the selection trap and 
the FRT sites upstream of the MCS and directly behind the ATG. Thus, no prokaryotic or 
baculoviral elements are integrated into the host cell genome upon RMCE, whereas the 
elements needed for the RMCE will be integrated into the bacmid DNA upon 
transposition (Figure 3-3). Furthermore, the integration of the baculoviral immediate-early 
promoter 1 enables the use as an expression vector for direct transient expression in Hi5 
or Spodoptera derived cell lines. 
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Figure 3-3: Regions for transposition and RMCE in pFlp-Bac-to-Mam 
The multi-purpose vector pFlpBtM contains FRT sites for the use as a donor vector for Flp-recombinase mediated 
cassette exchange and Tn7-transposition sequences for the generation of recombinant bacmids. The PGK promoter is 
used for a selection-trap method to screen for positive clones. FRT sites flank the region, which is integrated into the 
RMCE locus in the master cell line. It contains the MCS and a downstream PGK promoter for the selection trap method 
to screen for recombined cell clones. A larger section of the plasmid comprising a Gentamicin-resistance gene for the 
selection of recombinant bacmids and the promoter region is integrated into the bacmids by Tn7-based transposition. 
The promoter region contains the early viral ie1 promoter and the hr5 enhancer which drive constitutive expression in 
Sf21 and Hi5 as well as the very late p10 promoter which is only active in the late phase of viral infection. 
 
 
3.2 Evaluation of pFlpBtM-I 
To determine the applicability of the constructed vector for transient, viral and stable 
expression, test expressions of fluorescent model proteins have been performed. 
Therefore, genes of eGFP (gb ADD98904.1), mCherry (gb AY678264) and the ECD of 
mTLR2 were integrated into the plasmid. A set of opposing non palindromic Type IIS 
endonucleases for the integration of target proteins facilitate seamless in frame fusion of 
the target gene to the N-terminal IgG signal peptide and the C-terminal polyhistidine tag 
of the vector. By attaching BbsI sites, or any other type IIS restriction site, to the gene of 
interest by a PCR amplification any desired overhang can be generated for the seamless 
integration. However, for the intracellular accumulation of target proteins the 
corresponding gene has to be integrated into pFlpBtM through a PCR-fragment flanked 
by a 5’-NcoI site. By cutting the pFlpBtM vector with NcoI the IgG signal peptide is 
excised. The same strategy has been used for ECDmTLR2 which was integrated with its 
authentic signal peptide. A detailed presentation of the MCS and the integration strategy 
is shown in Figure 3-4. Proper integration of the model proteins has been confirmed by 
analytical restriction digests and sequence analyses. 
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Figure 3-4: MCS of pFlp-Bac-to-Mam-I  
A: Sequence of the MCS of pFlpBtM-I. The IgG signal peptide sequence is indicated in blue, the translation is stated 
above. The two opposing BbsI recognition sites are marked in red and their resulting overhangs are indicated by the 
grey lines. B: Seamless integration of genes can be performed using the two BbsI sites since they are non-palindromic 
Type IIS endonucleases. This integration strategy generates an in-frame fusion to the signal peptide and the His6 tag. 
For this method PCR-primers attaching any Type IIS restriction site of choice are necessary that append compatible 
overhangs to the gene of interest. The resulting overhangs are part of the signal peptide (blue) and the His6 (purple), 
respectively. C: A 5’- NcoI site can be used for the deletion of the signal peptide. The 3’ integration is the same as 
described above. GOI = gene of interest, IgG-SP = signal peptide, n,x = arbitrary bases, black lines indicate the cutting 
position and resulting overhangs of restriction nucleases. 
A
B
C
NcoI                                       BbsI
CCACCATGGGC...IgG-SP..CTCCTAGTCTTCAGATCTGCTAGCGAAGACTTCATCAT..6xHis
GGTGGTACCCG....53bp...GAGGATCAGAAGTCTAGACGATCGCTTCTGAAGTAGTA.......
BbsI
NcoI                  
XXXXCCATGG...GOI....CATCXXGTCTTCXXXX
XXXXGGTACC..........GTACXXCAGAAGXXXX
BbsI
BbsI                  
XXXXGAAGACXXCTCC...GOI....CATCXXGTCTTCXXXX
XXXXCTTCTGXXGAGG..........GTACXXCAGAAGXXXX
BbsI
NcoI                                       BbsI
CCACCATGGGC...IgG-SP..CTCCTAGTCTTCAGATCTGCTAGCGAAGACTTCATCAT..6xHis
GGTGGTACCCG....53bp...GAGGATCAGAAGTCTAGACGATCGCTTCTGAAGTAGTA.......
BbsI
NcoI
~~~~~~
M  G   W  S  C  I   I  L  F   L  V  A   T  A  T  G 
ACTTCGAATT TCCGGTCGCC ACCATGGGCT GGAGCTGCAT CATTCTGTTC CTCGTGGCTA CAGCCACCGG
TGAAGCTTAA AGGCCAGCGG TGGTACCCGA CCTCGACGTA GTAAGACAAG GAGCACCGAT GTCGGTGGCC
NheI BbsI
~~~~~~ ~~~~~~
V  H  S                                 H   H  H  H   H  H  *
TGTTCACTCC TAGTCTTCAG ATCTGCTAGC GAAGACTTCA TCATCATCAC CACCACTGAA CGCGTATTTA
ACAAGTGAGG ATCAGAAGTC TAGACGATCG CTTCTGAAGT AGTAGTAGTG GTGGTGACTT GCGCATAAAT
~~~~~~
BbsI
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3.2.1 Transient expression in Sf21 
Plasmid based transient transfection of insect cell cultures has not been established in the 
PSPF before. Therefore, initial screenings to optimise transfection efficiencies by 
comparative test expressions with different transfection reagents, conditions and cell lines 
had to be performed. Moreover, preceding experiments had to be carried out to facilitate 
an efficient downscaling to prosecute transfection in small scale cultures of less than 
15 mL for economic reasons. The optimisations of the culture conditions and transfection 
protocols as well as subsequent test expressions were carried out with technical assistance 
of Carmen Lorenz during her practical term under the author’s direction. Following the 
results of the optimisations, transfections of Sf21 with plasmid DNA were performed in 
4 - 10 mL cultures with an initial cell density of 1×106 cells/mL in TPP bioreactor tubes. A 
DNA dose of 1.5 µg per 1×106 cells was used with a DNA/Lipofectin ratio of 1:2. 
Transfection rates of more than 50 % were confirmed by flow cytometric analyses (data 
not shown). However, only weak fluorescence could be observed by fluorescence 
microscopy (Figure 3-5).  
 
Figure 3-5: Fluorescence microscopy of Sf21 transfected with pFlpBtM-I-mCherry and –eGFP 
Pictures were taken 48 h post transfection under white light and illuminated by a HBO50 mercury-vapor lamp using 
Zeiss filter sets 44 (eGFP) and 25 (mCherry), respectively. The exposure time for fluorescence detection was 6 s. 
 
The expression efficiency was additionally assessed by SDS-PAGE and Western blotting 
of cell lysates and culture supernatants. Coomassie stained gels and Western blots after 
detection with an α-His primary antibody of the expression of mCherry and ECDmTLR2 
are shown in Figure 3-6.  
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Figure 3-6: SDS-PAGE and Western blots of intracellular fractions and supernatants of transfected Sf21 
Samples of non-transfected cells (0h) and between 24 h and 96 h post transfection were taken. The culture 
supernatant (SN) as well as cell lysates (IC) or soluble (S) and insoluble (IS) intracellular fractions were analysed by SDS-
PAGE. Western blots were incubated with a His-Tag primary antibody and a goat-anti-mouse IgG (H+L)-AP conjugated 
secondary antibody. The model proteins should give signals at 28 kDa (mCherry) and 67 kDa (ECDmTLR2), 
respectively. M = PageRuler™ Protein Ladder [kDa] 
 
Notably, although expression of the fluorescent model proteins could be detected by flow 
cytometry and fluorescence microscopy, no bands of the heterologous proteins could be 
identified on the SDS-PAGE. Moreover, no explicit signals of the target proteins were 
achieved by immunostaining despite extended incubation with the detection substrates. 
Signals which might correlate with the expected protein sizes are relatively faint 
compared to unspecific signals of host cell proteins which are a result of the rather low 
specificity of the α-His antibody. To determine whether the low expression rate is caused 
by either the expression method, the vector architecture or a specific characteristic of the 
model proteins, test expressions in the BEVS were performed.  
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3.2.2 Generation of recombinant bacmids and baculoviral expression 
The identical pFlpBtM-I constructs harbouring eGFP, mCherry and ECDmTLR2 
respectively that were used in transient expression have been employed to generate 
recombinant bacmids. For the expression of mCherry and ECDmTLR2, host strains 
containing an EMBacY bacmid have been used which harbours an YFP gene for 
monitoring infection kinetics. In contrary, pFlpBtM-I-eGFP was integrated into 
conventional MultiBac bacmids since fluorescence of eGFP and the bacmid encoded YFP 
would not be distinguishable. Blue-white selection of positive clones, the isolation of 
recombinant bacmid DNA and confirmation of integrations by analytical PCR were 
conducted according to the MultiBac manual. Upon transfection of adherent Sf21 cells 
with the generated bacmids the resulting baculoviral expression of the model proteins 
was confirmed by fluorescence microscopy (Figure 3-7).  
 
 
Figure 3-7: Fluorescence microscopy of Sf21 transfected with pFlpBtM-I derived recombinant bacmid DNA 
Pictures were taken 9 days post transfection under white light and illuminated by a HBO50 mercury-vapor lamp using 
Zeiss filter sets 44 (eGFP/YFP) and 25 (mCherry), respectively. The exposure time for fluorescence detection was 1 s. 
EMBacY variants show fluorescence in the green filter due to the encoded YFP. Cells infected by EMBacY-pFlpBtM-I-
mCherry and MultiBac-pFlpBtM-I-eGFP produce significant amounts of the reporter genes. Fluorescence of eGFP is 
brighter than YFP due to the specifications of the filter set and the higher quantum yield of the protein. 
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To verify the infectivity and expression capability of fully assembled viruses, large scale 
test expressions were performed following a virus amplification of the harvested 
transfection supernatants. A titer determination by plaque assay allowed using a specific 
MOI of 2. The growth kinetics and variations in cell diameter of the corresponding test 
expressions are shown in Figure 3-8. 
 
 
Figure 3-8: Growth kinetics and cell diameter of Sf21 cells infected with pFlpBtM-I derived baculoviruses  
0.5 × 10
5
 cells/mL were infected with an MOI of 2. Significant increase in cell diameter of approximately 20 % and initial 
stop of proliferation upon transfection indicate a successful infection. Consequently, a decline of viability beginning 
48 hpi is observed. 
 
The kinetics of both the virus amplification (data not shown) and the expression indicate 
that the viruses which were generated with pFlpBtM-I as donor vector are fully infective, 
as proliferation stopped immediately upon infection. The expression and intracellular 
accumulation of the fluorescent reporter proteins was clearly visible by the staining of the 
culture. By analogy to the transient expression in Sf21 SDS-PAGE and immunoblotting of 
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cell lysates and culture supernatants were performed and exemplary shown for mCherry 
and ECDmTLR2 in Figure 3-9. 
 
 
Figure 3-9: SDS-PAGE and Western blots of intracellular fractions and supernatants of Sf21 infected with 
recombinant baculoviruses generated with pFlpBtM-I as donor vector 
Samples of culture supernatant (SN) as well as cell lysates (IC), soluble (S) and insoluble (IS) intracellular fractions from 
non-transfected cells (0h) and from sampling between 24 h and 96 hpi were analysed. Western blots were incubated 
with a His-Tag primary antibody and a goat-anti-mouse IgG (H+L)-AP conjugated secondary antibody. The model 
proteins should give signals at 28 kDa (mCherry) and 67 kDa (ECDmTLR2), respectively. In both expressions strong 
bands of BSA at 66 kDa are present. M = PageRuler™ or PageRuler™ Plus Prestained Protein Ladder [kDa] 
 
Intracellular accumulation of soluble mCherry could be validated by coomassie stained 
gels as well as by specific signals on Western blots. Likewise, characteristic signals of 
eGFP were seen on the corresponding gels and blots (data not shown). In contrary, 
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expression of ECDmTLR2 could not be clearly identified on SDS-PAGE since serum 
protein from the virus supernatant is superposing the expected size range of the 
ECDmTLR2 of 67 kDa (MW of BSA = 66.4 kDa). However, Western blot analysis 
undisputedly proved the expression of the model protein. Conspicuously, although the 
protein contains a signal peptide and thus should be secreted, the predominant amount of 
the recombinant protein remains in the insoluble fraction. Despite the protein specific 
occurrence of insoluble material the production of all three model proteins was clearly 
demonstrated using pFlpBtM-I derived recombinant viruses. Thus, the plasmid’s 
suitability to be used as a donor vector for baculoviral expression in insect cells could be 
confirmed. The next step was consequently to demonstrate the applicability of pFlpBtM-I 
as a donor vector for RMCE. 
3.2.3 Flp-recombinase mediated cassette exchange 
Due to the labour intensive clonal isolation procedure, the cassette exchange was tested 
with only one of the model proteins. The construct pFlpBtM-I-mCherry was chosen since 
its expression upon stable integration in the genuine CHO Lec3.2.8.1 production cell line 
can be detected most easily. Upon transfection of the master cell clone SWI3-26 with 
pFlpBtM-I-mCherry, G418 resistant cell clones were isolated and propagated as clonal 
isolates. The expression of the reporter protein in the resulting producer cell line was 
confirmed by fluorescence microscopy as shown in Figure 3-10. Stability and 
homogeneity of the genomic protein expression was additionally analysed by flow 
cytometry. Figure 3-11 shows the fluorescence profiles of the parental master cell line 
SWI3-26 and the final producer clone 12 weeks post transfection. 
The data confirmed the microscopic observation of homogeneous expression of mCherry 
throughout the population. Additionally, no differences in recombination efficiency as 
well as in the robustness and stability between the producer cell lines generated with 
conventional targeting vectors or pFlpBtM-I could be observed. Accordingly, the results 
demonstrate that the new multipurpose vector can be used for RMCE without any 
constraints.  
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Figure 3-10: CHO Lec3.2.8.1 RMCE master cell line before and after cassette exchange with pFlpBtM-I-mCherry 
The RMCE master cell line CHO Lec3.2.8.1 SWI3-26 homogeneously expresses the reporter protein eGFP (left). Upon 
cassette exchange with pFlpBtM-I-mCherry, the resulting producer cell clone stably expresses mCherry with no eGFP 
background (right). The exposure time for fluorescence detection was 1 s. 
 
 
Figure 3-11: Dot plots and histograms of CHO Lec3.2.8.1 before and after RMCE with pFlpBtM-I-mCherry 
Fluorescence of the CHO Lec3.2.8.1 RMCE master cell line SWI3-26 (left) and the producer cell line after the cassette 
exchange with pFlpBtM-I-mCherry (right) was assessed at the Guava EasyCyte Mini cytometer with an excitation 
wavelength of 488 nm. Both dot plots (upper row) and histograms (lower row) demonstrate the exchange of eGFP by 
the reporter mCherry. 
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3.3 Construction of pFlpBtM-II 
The results of the expression studies with pFlpBtM-I demonstrated that plasmid based 
transient expression in Sf21 is possible, but protein yields are insufficient for preparative 
protein production for crystallization or biochemical analyses. Yet, the plasmid proved to 
be particularly suitable to act as a donor for RMCE and the BEVS. The construction of an 
improved second generation of pFlpBtM was therefore performed by the integration of 
genetic elements conferring applicability for transient expression in the efficient 
mammalian HEK293-6E cell line instead of lepidopteran cells. The remodelling was 
performed in a three step cloning procedure developed by the author: firstly, a tripartite 
promoter fragment including a CMV promoter together with a corresponding 
cytomegaloviral immediate early enhancer was integrated; secondly, the Epstein-Barr 
virus oriP for episomal replication in the EBNA-1 expressing host cell line was added to 
the backbone and finally an improved MCS was incorporated. The cloning and 
subsequent proof-of-concept in HEK293-6E and BEVS were carried out under the author’s 
direction in collaboration with Carmen Lorenz. 
Initially, a PCR-fragment of the promoter region of pTriEx (Novagen) was synthesised 
comprising the immediate early promoter and enhancer of the cytomegalovirus, the 
baculoviral late P10 and a combination of the T7 phage promoter and the lac operator. 
EcoRV and BamHI sites were attached by the PCR-primer design. This fragment was 
integrated into pFlpBtM-I upon the excision of a section containing the baculoviral ie1 
promoter, the hr5 enhancer and the late baculoviral p10 promoter by ZraI-BamHI digest 
(Figure 3-12). However, all clones that had been identified as positives in analytical 
restriction digest showed a deletion of 61 bp within the intron region as confirmed by 
sequence analyses. Hence, this deletion had to be a result of an incorrect PCR-product due 
to a looping out of the highly repetitive intron sequence during elongation. Since 
upstream and downstream sequences had been integrated correctly, the full length intron 
could be incorporated by a NdeI-PacI restriction fragment of the parental pTriEx. The 
resulting intermediate vector was named pFlpBtM-TriEx. 
RESULTS 
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Figure 3-12: Exchange of the promoter fragment in pFlpBtM-I 
The original promoter fragment containing the baculoviral ie1 promoter and the hr5 enhancer besides the late 
baculoviral p10 promoter was excised by ZraI-BamHI digest. A PCR-fragment of the promoter region of pTriEx-7 
(Novagen) was generated with flanking EcoRV-BamHI sites. This section contains the CMV promoter for expression in 
mammalian cells, the p10 promoter for baculoviral expression and an inducible T7-lac promoter for prokaryotic 
expression. Sequencing revealed a deletion of 61 bp within the Intron which was corrected by the exchange of a NdeI-
PacI restriction fragment of the right length. The intermediate product was termed pFlpBtM-TriEx. 
 
Prior to the exchange of the backbone of pFlpBtM-TriEx by the backbone of pTT5 
containing the oriP sequence, the template had to be modified since it contains NcoI and 
BbsI restriction sites which have to be used as unique sites in the MCS. Therefore, NcoI 
was eliminated by site directed mutagenesis. To remove the BbsI site in pTT5-Ncomut, a 
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PCR-fragment of the section between XmaI-BbsI was generated and subsequently 
integrated into the vector. Due to the orientation of the BbsI sequence, the corresponding 
reverse primer was constructed to eliminate the BbsI site upon reintegration. 
 
 
Figure 3-13: Modification of the pTT5 backbone and its integration into pFlpBtM-TriEx 
NcoI in the backbone of pTT5 was mutated by site directed mutagenesis, whereas a PCR-fragment of the section 
between XmaI-BbsI was generated and subsequently integrated into the vector. The reverse primer was designed in a 
way that the BbsI site was eliminated due to its orientation. The eliminated restriction sites are highlighted in yellow. 
The backbone of pFlpBtM-TriEx was excised by NaeI-SapI digest and replaced by a PCR-fragment of the modified 
pTT5 backbone with flanking EcoRV-SapI sites. The resulting vector was named pFlpBtM-II(beta). 
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The resulting pTT5-Nco-Bbsmut was used as a template to synthesise a PCR-fragment of 
the backbone sequence with flanking EcoRV and SapI sites. It was subsequently 
integrated into pFlpBtM-TriEx upon excision of its original backbone by NaeI-SapI digest. 
The resulting pFlpBtM-II(beta) (Figure 3-13, page 71) comprises all elements for its use in 
RMCE, BEVS and transient expression in HEK293-3E, and thus was used for the proof-of-
concept studies as presented in chapter 3.4. In parallel, the final pFlpBtM-II version was 
generated by the integration of a remodelled RMCE cassette as shown in Figure 3-14. 
 
 
Figure 3-14: Modification of the FRT-cassette in pFlpBtM-II 
The complete FRT-cassette ranging from the p10 promoter and the downstream FRTwt sequence has been 
synthesised to implement unique restriction sites flanking the FRT sites and the PGK promoter and to include a One-
STrEP affinity tag separated from the modified MCS by a TEV protease cleavage site. Moreover, a Shine-Dalgarno 
sequence was incorporated between FRT3 and the NcoI site necessary for expression in E. coli. The fragment was 
integrated into pFlpBtM-II(beta) by digestion and ligation via BamHI-AvrII sites (highlighted in yellow). 
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The synthesised sequence contained a One-STrEP affinity tag, additional restriction sites 
within the MCS and flanking the elements used for recombination as well as a Shine-
Dalgarno sequence to enhance translation in E. coli. It was integrated into pFlpBtM-
II(beta) upon excision of the corresponding original fragment by BamHI-AvrII. Figure 
3-15 shows a schematic map of the final construct and highlights the sections derived 
from different parental vectors from which it was composed of.  
 
 
Figure 3-15: Schematic map of pFlp-Bac-to-Mam-II 
A: Vector map of pFlpBtM-II with elements for recombination, expression, screening and replication. Sections 
originating from different parental vectors are highlighted in orange (pFastBac), blue (synthetic fragment based on 
pFS-sighis-PGKd), green (pTriEx-7) and purple (pTT5), respectively. B: Comparison of promoter regions of pFlpBtM-I 
and pFlpBtM-II. The immediate early AcMNPV promoter ie1/hr5 and the very late P10 in pFlpBtM-I drive protein 
expression in transient and baculoviral expression, respectively. To enable transient expression in mammalian cells 
pFlpBtM-II includes the CMV promoter/enhancer instead. An additional lac-controlled T7 promoter should allow for 
protein expression in E. coli. 
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3.4 Evaluation of pFlpBtM-II 
To proof the applicability of pFlpBtM-II in different expression systems, the fluorescent 
model proteins eGFP, mCherry and tdTomato were used as reporters. The vector 
constructs were generated as described in Figure 3-4 C on page 61 by cloning the 
corresponding genes from pFlpBtM-I into pFlpBtM-II(beta). The resulting constructs were 
fusions with a C-terminal His6 tag without the IgG signal peptide to achieve intracellular 
accumulation. 
3.4.1 Transient Expression in HEK293-6E 
The evaluation pFlpBtM-II(beta) constructs in transient expression in HEK293-6E was 
performed as described in 2.6.1. Deviating from the protocol no pTTo/GFP control 
plasmid was added to prevent interfering fluorescence signals. Growth kinetics and 
fluorescence characteristics are presented in Figure 3-16. Transfection rates of more than 
80 % could be achieved for eGFP and tdTomato constructs. In contrast, pFlpBtM-II(beta) 
driven expression of mCherry could only be detected in approximately 50 % of the cells 
by flow cytometry. This is an effect of the innate weak brightness of mCherry and 
improper excitation by the 488 nm laser in the Guava EasyCyte™. Thus, only those cells 
which took up a higher plasmid dose and therefore accumulate more reporter protein are 
detected by the cytometer. In turn, fluorescence microscopic observations revealed similar 
transfection rates and fluorescence intensities among all three constructs since optimal 
excitation and emission parameters provided by the filter sets at the microscope allow for 
accurate signals (Figure 3-17, page 76). 
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Figure 3-16: Growth kinetics and fluorescence of HEK293-6E transfected with pFlpBtM-II(beta) constructs 
Three days upon seeding of 0.5 × 10
6
 cells/mL HEK293-6E were transfected with complexes of 25 µg plasmid and 50 µg 
PEI. The culture was expanded to 50 mL 48 h post transfection and supplemented with 0.5 % tryptone. To compensate 
the metabolic consumption 4.5 g/L glucose were added 72 hpt. Addition of 3.75 mM valproic acid to enhance 
transcription rate 96 hpt caused a decrease of viability due to its cytotoxicity. Fluorescence was determined at a Guava 
EasyCyte flow cytometer using a 488 nm laser for extinction.  
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Figure 3-17: Fluorescence microscopy of HEK293-6E transfected with pFlpBtM-II(beta) constructs 
Pictures were taken 96 h post transfection under white light and illuminated by a HBO50 mercury-vapor lamp using 
Zeiss filter sets 44 (eGFP) and 25 (mCherry/tdTomato), respectively. The exposure time for fluorescence detection was 
1 s. 
 
The overexpression of the model proteins could not only be detected by flow cytometry 
and fluorescence microscopy, but also was evident by stained cultures. A photo of cell 
pellets of HEK293-6E 96 h post transfection is shown in Figure 3-18. They exhibit the 
characteristic colours of mCherry, tdTomato and eGFP even in daylight without excitation 
by specific wavelength.  
 
 
Figure 3-18: Cell pellets of HEK293-6E upon transfection with pFlpBtM-II(beta) constructs 
Cell pellets of 1 × 10
6
 cells harvested 96 h post transfection with pFlpBtM-II(beta)-mCherry (left), -tdTomato (middle), 
and -eGFP (right).  
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Likewise, the reporter proteins could be detected on coomassie stained SDS-PAGE gels of 
cell lysates (Figure 3-19). Significant accumulation of the model proteins can be detected 
approximately 48 h post transfection. Starting 96 hpt proteins also appear in the culture 
supernatant due to cell lysis caused by the cytotoxic effect of valproic acid. 
 
 
Figure 3-19: Intracellular fractions and supernatants of HEK293-6E transfected with pFlpBtM-II (beta) constructs 
Samples of culture supernatant (SN) as well as cell lysates (IC) or soluble (S) and insoluble intracellular fractions from 
non-transfected cells (0h) and from sampling between 24 and 168 hpt were analysed. The model proteins give signals 
at 28 kDa (eGFP & mCherry) and 56 kDa (tdTomato) , respectively. M = PageRuler™ Protein Ladder [kDa] 
 
To further evaluate the production of the model proteins and their quality, small scale 
affinity chromatography of cell lysates was performed. Upon chemical disruption of 
5 × 106 cells the soluble fraction was applied to QIAGEN Ni-NTA spin columns. SDS-
PAGE analyses of the IMAC fractions are presented in Figure 3-20. 
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Figure 3-20: IMAC fractions of HEK293-6E lysates after transfection with pFlpBtM-II(beta) constructs 
5 × 10
6
 HEK293-6E transfected with pFlpBtM-II(beta)-eGFP (left), -mCherry (middle) and -tdTomato (right) have been 
harvested 196 h post transfection. Lysates were purified using QIAGEN Ni-NTA spin columns. The full length model 
proteins give signals at 28 kDa (eGFP & mCherry) and 56 kDa (tdTomato), respectively. M = PageRuler™ Protein 
Ladder [kDa], L = lysate, FT = flow through, W = wash fraction, E = eluate 
 
A significant enrichment of the recombinant His-tagged model proteins in the eluate 
could be achieved. However, due to the simplicity of the spin column purification 
noteworthy contamination with nonspecific bound proteins with high molecular weights 
occurred. Notably, in the purification of mCherry and tdTomato fragments smaller than 
the full length proteins have also been enriched. Each of these proteins could be identified 
as a fragment of the corresponding model proteins by MALDI-TOF mass spectrometry 
(data not shown). Strikingly, a comparison of the theoretical fragment size according to 
the first amino acid of the fragments determined by N-terminal sequencing with the 
apparent size of the fragments in the gel revealed, that two fragments of each protein 
must also have been truncated by C-terminal degradation (indicated by asterisks in Table 
3-1). Since the C-terminal His6 tag was utilised for the purification, the tdTomato 
fragments could only be enriched as protein dimers via co-purification. This is not 
possible for the mCherry fragments, since mCherry is an obligate monomer. Therefore, 
those fragments had to be caused by intramolecular nicking. This was confirmed by a 
native PAGE where both proteins migrated as untruncated monomeric molecules (Figure 
3-21). Only denaturing conditions in SDS-PAGE cause the molecules to disassemble into 
the observed fragments. Since the fragmentation also occurred upon expression in both 
insect cells and CHO Lec3.2.8.1 (cf. chapter 3.5.1) this phenomenon is protein specific. As 
a result, the tremendous overexpression of the model protein proved the unrestricted 
applicability of pFlpBtM-II for transient expression in HEK293-6E.  
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Table 3-1: Identification of protein fragments by N-terminal sequencing 
Protein fragment size (gel) # of N-terminal calculated size  
  [kDa] amino acid [kDa] 
tdTomato ~ 55 2 55 
(483 aa) ~ 40 198 32* 
 ~ 35 165 35 
 ~ 30 185 34 
 ~ 27 247 27 
 ~ 22 382 19 
 ~ 10 247 27*   
mCherry ~ 28 2 28 
(243 aa) ~ 22 75 19* 
 ~ 10 2 28* 
 
 
Figure 3-21: Native Page of mCherry and tdTomato after purification by IMAC 
mCherry and tdTomato purified by IMAC from cell lysates of HEK293-6E were applied on a Blue Native PAGE. Under 
native conditions no truncated fragments of either protein occurred. 
 
 
3.4.2 Generation of recombinant bacmids 
In analogy to the evaluation of pFlpBtM-I in BEVS as presented in 3.2.2, recombinant 
baculoviruses were generated using pFlpBtM-II(beta)-eGFP, -mCherry and -tdTomato as 
donor vectors according to the described protocols. EMBacY derived viruses were 
employed for the expression of tdTomato and mCherry whereas a MultiBac bacmid was 
used for the expression of eGFP again. Subsequent to the screening for positive 
recombinants by blue-white selection and analytical PCR, Sf21 cells were transfected with 
isolated bacmids. Following the amplification of virus harvested from the transfection and 
titer determination, test expressions in Sf21 were performed using an MOI of 2. Infection 
kinetics were consistent with those observed in the test expressions with pFlpBtM-I (page 
65). Flow cytometric measurements and fluorescence microscopy confirmed infection 
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rates of more than 90 % (Figure 3-22). The overexpression and intracellular accumulation 
of the proteins were also indicated by the characteristic staining of both the culture and 
cell pellets and by the presence of prominent bands on SDS-PAGE gels (Figure 3-23). 
 
 
Figure 3-22: Fluorescence microscopy of Sf21 infected with pFlpBtM-II(beta) derived recombinant baculoviruses 
Pictures were taken 48 h post transfection under white light and illuminated by a HBO50 mercury vapour lamp using 
Zeiss filter sets 44 (eGFP/YFP) and 25 (mCherry/tdTomato), respectively. The exposure time for fluorescence detection 
was 500 ms. Due to the specifications of the filter set and the higher quantum yield of eGFP the fluorescence of this 
protein appears brighter compared to YFP expressed by the EMBacY-derived viruses in this pictures. 
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Figure 3-23: Intracellular fractions and supernatants of Sf21 infected with pFlpBtM-II(beta) derived viruses 
Samples of culture supernatant (SN) as well as cell lysates (IC) or soluble (S) and insoluble intracellular fractions from 
non-infected cells (0h) and from sampling between 24 and 168 hpt were analysed. The model proteins give signals at 
28 kDa (eGFP & mCherry) and 56 kDa (tdTomato), respectively. M = BioRad Precision Plus Protein Standard [kDa] 
 
Western blots confirmed that the indicated bands result from the overexpression of the 
model proteins (data not shown). Moreover, the Western blots revealed the occurrence of 
the truncation fragments of mCherry and tdTomato which were observed in the 
purification of the proteins after expression in HEK293-6E before, thereby probating that 
the fragmentation is a protein specific phenomenon. These results evidently show that the 
improved pFlpBtM-II(beta) is likewise suitable for the use as a donor vector for protein 
expression in the BEVS. 
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3.4.3 RMCE 
The modifications which were performed to generate pFlpBtM-II(beta) do not affect the 
section of the vector that is recombined during RMCE. Consequently, the cassette 
integrated into the master cell genome in both versions is identical. However, to exclude 
any influence of the altered vector backbone on its efficiency the applicability of pFlpBtM-
II(beta) as a donor vector for RMCE has been assessed again. To investigate whether the 
gene length has any influence on the RMCE success tdTomato was used as a reporter gene 
in this experiment. As it is a dimer of DsRed, its gene is twice as large as the previously 
tested mCherry. However, no complications during the procedure occurred and the 
generation of a clonal producer cell line was accomplished within 12 weeks. Stability and 
homogeneity of the genomic expression was again analysed by fluorescence microscopy 
and flow cytometry. The corresponding microscopic pictures, dot plot and histogram are 
shown in Figure 3-24. 
 
 
Figure 3-24: Fluorescence characteristics of the CHO Lec3.2.8.1 tdTomato producer line  
Yellow fluorescence due to stable expression tdTomato in CHO Lec3.2.8.1 after cassette exchange with pFlpBtM-
II(beta)-tdTomato was assessed at the Guava EasyCyte Mini cytometer and fluorescence microscopy. Upon excitation 
with a 488 nm laser, strong yellow fluorescence is observed whereas no green fluorescence could be detected in both 
dot plot (upper left) and histogram (upper right). In contrary to the previous pictures the tdTomato specific filter set 
Zeiss 43 HE was available to determine the expression of the reporter. The pictures were taken upon illumination by a 
HBO50 mercury-vapor lamp with an exposure time of 500 ms (bottom, picture taken by Bahar Baser). 
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3.5 Production of model proteins 
Based on the successful proof-of-concept of pFlpBtM-II as a multi host donor- and 
expression vector for protein production in mammalian cells and the BEVS, comparative 
test expressions were performed to demonstrate its applicability for an evaluation of the 
optimal expression strategy and the most suitable expression host for different target 
proteins. Therefore, mCherry, single-chain Fv-hFc constructs and ECDmTLR2 have been 
produced in larger scale in the diverse hosts and subsequently purified by affinity 
chromatography to evaluate the quality and yield of the products. To ensure reproducible 
data, the non-stable expressions were performed in duplicates or triplicates. Additionally, 
pFlpBtM-II was used for an intensive screening for expressible constructs of the ECD of 
human TLR5, which has not been purified before. 
3.5.1 mCherry 
Transient productions of mCherry in HEK293-6E and viral expressions in Sf21 have been 
performed in 50 - 100 mL scale using pFlpBtM-II(beta)-mCherry as expression vector and 
corresponding bacmids derived thereof. Transfection rates of >70 % were achieved in 
plasmid based transient expression in HEK293-6E cells. Likewise, more than 90 % of the 
Sf21 cells fluoresced 72 hpi indicating proper infection with recombinant pFlpBtM-
derived virus (data not shown). To assess volumetric yields of stably expressed protein 
accumulated in the CHO Lec3.2.8.1, the producer cell line generated by RMCE with 
pFlpBtM-II(beta)-mCherry was expanded to 25 mL and equally harvested. His-tagged 
mCherry was captured from cell lysates by Ni-NTA affinity chromatography using a 
Profinia™ system (BioRad) followed by a desalting step. Exemplary chromatograms of 
the purification upon expression in HEK293-6E and BEVS are shown in Figure 3-25.  
Average volumetric yields of repeated expressions are summarised in Figure 3-26. 
Notable amounts of 52 mg/L and 42 mg/L could be achieved by transient expression in 
HEK293-6E and baculoviral expression in Sf21, respectively with low standard deviations 
of only 11 – 16 % within the repetitions. In contrast, stable expression yielded only 
10 mg/L of intracellular accumulated mCherry.  
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Figure 3-25: Purification of mCherry by IMAC 
Cell lysates of 100 mL HEK293-6E transfected with pFlpBtM-II(beta)-mCherry (left) and Sf21 infected with EMBacY-
pFlpBtM-II(beta)-mCherry (right) were applied to a BioRad Profinia system equipped with a Profinity IMAC Cartridge 
and a Bio-Gel P6 Desalting Cartridge. Green lines represent absorption at 280 nm directly behind the IMAC column 
whereas the blue lines represent absorption of the eluate upon desalting. The collected peak is highlighted in grey.  
 
 
Figure 3-26: Average volumetric yields of mCherry  
Average yields were calculated from the concentration of captured protein factoring the specific absorption coefficient 
and the original culture volume. The error bars indicate the standard deviation from triple data acquisition. 
 
Samples of the IMAC fractions were further analysed by SDS-PAGE as shown in Figure 
3-27. Minor contamination by non-specifically bound host cell protein and the 
characteristic mCherry “nicking-fragment” at ~22 kDa were detected in the eluate 
fractions of the purification from all three sources. Thus, further polishing steps including 
ion exchange or size exclusion would be necessary upon expression in each system to 
obtain crystallization grade full-length protein. The results show that in this case transient 
and viral expression is superior to the labour intensive generation of stable producer cell 
lines since higher yields of mCherry can be produced with similar purity and quality. 
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Figure 3-27: SDS-PAGE of cell lysates and IMAC fractions of mCherry purification 
Samples of the cell lysates and fractions from the IMAC purification of mCherry upon transient expression in HEK293-
6E (left), baculoviral expression in Sf21 (middle) and stable expression in CHO Lec3.2.8.1 (right). (M = PageRuler™ 
Protein Ladder [kDa], L = cell lysate, FT = flow through, W = wash fraction, E = eluate) 
 
3.5.2 Single-chain Fv-hFc 
The single-chain Fv-hFc fusion construct scFv-hIgGFc-4E3 has been provided by Thomas 
Schirrmann in a pCMV vector (Figure 3-28 A). It is a conventional mammalian expression 
vector lacking the EBV oriP for the use in HEK293-6E cells. In consequence, relatively low 
yields of only 2 - 4 mg/L were previously achieved in transient expression in adherent 
HEK293T (Menzel et al., 2008). In this work the model protein was used for the 
benchmarking of pFlpBtM-II(beta) in comparison with both its original parental vector 
pCMV and pTT5, the standard expression vector for the HEK293-6E system provided by 
the NRCC. Therefore, a NcoI-XbaI restriction fragment of the corresponding gene was 
cloned into pFlpBtM-II(beta) upon digestion with NcoI-NheI. Thereby, the IgG signal 
peptide in the target vector was eliminated and the C-terminal His6-tag was excluded 
from the ORF (Figure 3-28 B). To integrate the scFv-hIgGFc construct into pTT5 a PCR-
fragment of the gene flanked by EcoRI-BamHI was generated and ligated into the target 
vector upon digestion with the corresponding enzymes (Figure 3-28 C). All constructs 
were confirmed by analytical restriction digests and sequence analyses. 
Transfection rates of up to 75 % were achieved in HEK293-6E, as determined by flow 
cytometry and cotransfection of the pTTo/GFP control plasmid. Hence, production runs 
with transfection efficiencies lower than 25 % have not been included in the statistical 
evaluation of the protein yields. 
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Figure 3-28: scFv-hIgG1Fc in different expression vectors 
The scFv-hIgG1Fc construct was obtained in its original expression vector pCMV (A). For comparative expression in 
HEK293-6E cells it was cloned into pFlpBtM-II(beta) (B) and pTT5 (C). pFlpBtM-II(beta)-scFv-hIgGFc was also used to 
generate recombinant bacmids for baculoviral expression of the immunoglobulin. 
 
In addition to the transient expression in HEK293-6E the scFv-construct was also 
produced in the BEVS to compare the achievable volumetric yields of the model protein 
scFv in both expression systems. Therefore, recombinant bacmids were generated using 
pFlpBtM-II(beta)-scFv-hIgG1Fc as donor vector. Baculoviral expression in both Sf21 and 
Hi5 was performed with titered 2nd generation virus using an MOI of 2 resulting in 
infection rates of more than 98 % in Sf21 and 76 % in Hi5, respectively (data not shown).  
The model protein was captured from the culture supernatants after expression in the 
BEVS and HEK293-6E by Protein A affinity chromatography with the BioRad Profinia™ 
Purification system. Upon binding to the Bio-Scale Mini Affi-Prep Protein A Cartridge, 
the scFv-construct was eluted via a pH shift followed by a desalting step on a Bio-Scale 
Mini Bio-Gel P6 cartridge. Figure 3-29 shows typical chromatograms of the purification 
runs. 
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Figure 3-29: Purification of scFv-hIgGFc by ProtA affinity chromatography 
Supernatants of 50 mL cultures of Sf21 infected with EMBacY-pFlpBtM-II(beta)-scFv-hIgGFc (left) and HEK293-6E 
transfected with pFlpBtM-II(beta)-scFv-hIgGFc (right) were applied to the BioRad Profinia system equipped with a Affi-
Prep Protein A Cartridge and a Bio-Gel P6 Desalting Cartridge. Green lines represent absorption at 280 nm directly 
behind the IMAC column whereas the blue lines represent absorption of the eluate upon desalting. The collected peak 
is highlighted in grey. 
 
Average volumetric yields of the scFv-construct from repeated expressions in both host 
systems are summarised in Figure 3-30. Via transient expression in HEK293-6E using 
pFlpBtM-II(beta) yields of ~ 50 - 120 mg/L were achieved. The average of 90 mg/L 
corresponds to 90 % of the amount that was captured upon expression with the optimised 
pTT5 vector, by which ~ 90 - 130 mg/L were produced. Expressions driven by the 
conventional pCMV yielded only about ~ 50 - 100 mg/L (average 69 mg/L). Although 
this amount achieved by PEI mediated transfection of HEK293-6E suspension cells 
represents a 20-fold improvement compared to the previously reported expression in 
adherent HEK293-T, the effect of missing episomal replication mediated by the EBV oriP 
on the protein yield is evident.  
 
Figure 3-30: Average volumetric yields of scFv-hIgG1Fc-4E3  
Average yields were calculated from the concentration of captured protein factoring the specific absorption coefficient 
and the original culture volume. The error bars indicate the standard deviation from triple data acquisitions. 
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Figure 3-31 shows an SDS-PAGE gel of culture supernatants and fractions of the 
chromatography of exemplary production runs. 
 
 
Figure 3-31: SDS-PAGE of supernatants and ProtA affinity chromatography fractions of scFv-hIgGFc purification 
Samples of the culture supernatants and fractions from the affinity chromatography of scFv-hIgGFc upon transient 
expression in HEK293-6E (left) and baculoviral expression in Sf21 (right). (M = PageRuler™ Protein Ladder [kDa], 
L = cell lysate, FT = flow through, W = wash fraction, E = eluate). 
 
Unlike the production of mCherry, which yielded similar amounts of the model protein in 
both HEK293-6E and the BEVS, significant differences in the yields were observed for the 
scFv-construct between both systems. Whereas accumulation of scFv in the culture 
supernatant was clearly visible in HEK293-6E expression even prior to the affinity 
purification, that was not the case for insect culture supernatants. Likewise, only between 
1 - 3 mg/L of the model protein were captured in both Sf21 and Hi5. To determine 
whether improper secretion is causing the low yields of recombinant protein into the 
supernatant as observed with ECDmTLR2 (cf. chapter 3.2.2, page 64) Western blot 
analyses of cell extracts were performed (Figure 3-32). However, the results show that 
about 80 % of the expressed model protein are well secreted and no major intracellular 
accumulation of insoluble material occurred.  
 
 
Figure 3-32: Western blot for tracing scFv-hIgGFc accumulation upon expression in Sf21 
Samples of 1 × 10
6
 cells were taken of non-infected Sf21 and 2, 4 and 7 days post infection with EMBacY-pFlpBtM-
II(beta)-scFv-hIgGFc. Supernatants (SN) and intracellular soluble (S) and insoluble fractions (IS) were applied to SDS 
PAGE and subsequently blotted. Detection was carried out by an goat-anti-human IgG (H+L)-AP conjugate antibody 
(Promega #S3821). M = PageRuler™ Plus prestained Protein Ladder [kDa]. 
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3.5.3 mTLR2 
The ECD of mTLR2 has been expressed in insect cells for structural analyses before (Jin et 
al., 2007; Kang et al., 2009). However, those publications report that the expression was 
only possible as VLR-hybrid constructs. Notably, no expression characteristics were 
presented in those reports and as far as any information is given only low yields of 
soluble protein were achieved. In contrast, a construct comprising the first 593 amino 
acids of the ECD of mTLR2 has been expressed in our lab before in the BEVS using 
conventional pFastBac plasmids. Volumetric yields of up to 1 mg/L were achieved with 
this construct upon purification of heterologous protein from culture supernatants (van 
den Heuvel, personal communication). Yet, significant amounts of the protein remained 
in the cytoplasm and accumulated in the insoluble fraction (as likewise observed in the 
test expressions using pFlpBtM-I in chapter 3.2.2 on page 64ff). Therefore, this construct 
served as a model protein for an evaluation of alternative expression strategies to enhance 
both protein yield and quality using pFlpBtM variants. 
Expression of ECDmTLR2 in the BEVS was reproduced after generating recombinant 
EMBacY-derived viruses using pFlpBtM-II-ECDmTLR2 as donor vector. Upon virus 
amplification and titer determination, expression in 100 mL culture was performed using 
an MOI of 2. The same expression characteristics as previously observed with a significant 
portion of intracellular and insoluble heterologous protein could be confirmed by Western 
blot analysis of samples taken 96 hpi (Figure 3-33, upper row). IMAC of diafiltrated insect 
cell culture supernatant led to a noticeable enrichment of secreted ECDmTLR2 so that a 
detection on SDS-PAGE was possible. However, significant amounts of non-specifically 
bound host cell proteins were found in the eluate fraction and impeded a determination 
of the volumetric yield of ECDmTLR2. Hence, subsequent polishing steps are necessary 
upon expression in BEVS. 
In the transient expression of ECDmTLR2 in HEK293-6E transfection rates of more than 
55 % were confirmed by cotransfection of the pTTo/GFP control plasmid. According to 
the baculoviral expression, Western blot analyses were performed to assess and localise 
the protein accumulation 96 h post transfection. The results show, that despite the non-
lytic character of the system both expression and secretion of ECDmTLR2 in HEK293-6E 
cells was not enhanced compared to the BEVS. In fact, the protein was detected solely in 
the insoluble fraction (Figure 3-33, middle row, left). Even upon concentration of the 
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secreted ECDmTLR2 via IMAC of culture supernatants, the protein in the eluate fraction 
could only be detected by Western blots (Figure 3-33, middle row, right). Yet, the protein 
concentration in the eluate fraction was too low for an accurate determination of the yield. 
 
 
Figure 3-33: SDS-PAGE and Western blot analyses of the expression and purification of ECDmTLR2 
The model protein was expressed in BEVS using an EMBacY-pFlpBtM-II-ECDmTRL2 virus, in HEK293-6E transfected 
with pFlpBtM-II(beta)-ECDmTRL2 and stable CHO Lec3.2.8.1 producer cell lines generated upon RMCE with pFlpBtM-
I-ECDmTLR2. The upper row shows a Western blot of the supernatant (SN) and soluble (S) and insoluble (IS) fraction of 
1 × 10
6
 Sf21 96 hpi (left) and a SDS-PAGE gel of the IMAC fractions of dialyzed supernatant upon harvest. 
Corresponding samples of the transient expression in HEK293-6E are shown in the middle row including a Western blot 
of the IMAC fractions. The lower row shows the SDS-PAGE of samples of the IMAC fractions of concentrated culture 
supernatant upon fermentation of CHO Lec3.2.8.1 producer cell lines. Western blots were incubated with a His-Tag 
primary antibody and a goat-anti-mouse IgG (H+L)-AP conjugated secondary antibody. FT = flow through, W = wash, 
E = eluate, M = Precision Plus (Biorad) or PageRuler Plus Prestained (Fermentas) protein standard [kDa] 
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Whether stable expression of ECDmTLR2 in CHO improves both protein quality and 
yield was assessed upon the generation of a clonal producer cell line by RMCE with 
pFlpBtM-I-ECDmTLR2 as donor vector. Since the yield in genomic expression was 
expected to be low, the cultivation was performed in continuous fermentation in a 
bioreactor as described in 2.6.3 to accumulate significant amounts of the target protein. 
35 L harvested culture supernatant were dialyzed and concentrated 25-fold by 
diafiltration. A 230 mL aliquot of this concentrate was used for the subsequent 
purification of secreted ECDmTLR2 by IMAC by which an absolute amount of ~ 1 mg 
ECDmTLR2 could be obtained in the eluate (Figure 3-33 bottom row). This corresponds to 
a volumetric yield 0.2 mg/L based on the original volume of harvested perfusion 
supernatant. Moreover, a 5-fold higher yield of more than 1 mg/L was achieved in 1 L 
batch cultivations. These amounts are not only comparable with those reached in 
preceding large scale purifications of ECDmTLR2 expressed in the BEVS, the stable 
production n CHO cells also provides the target protein in a constantly high quality 
necessary for subsequent structural and biochemical analyses. The multiparallel 
expression evaluation using pFlpBtM thereby enabled the identification of stable 
expression as the most suitable technique for the production of the particular challenging 
ECDmTLR2 target. 
3.5.4 Screening for expressible constructs of ECDhTLR5 variants 
In parallel to the work on the pFlpBtM project the expression and purification of the ECD 
of human TLR5 for structural analyses was pursued. While the X-ray structures of TLR1, 
TLR2, TLR3, TLR4 and TLR6 have been already solved, TLR5 still remains a promising 
target for structural biology. At the beginning of the work, a construct comprising the N-
terminal amino acid 1 - 640 based on database prediction of the domain border was 
provided. The construct was generated in conventional pFastBac plasmids with C-
terminal His8 and human-Fc tags for detection and purification. It was expressed in the 
BEVS both with its authentic signal peptide and alternatively using the gp67 secretion 
signal of Spodoptera frugiperda. However, similar to the expression of ECDmTLR2, the 
protein was poorly secreted and accumulated as insoluble material in the intracellular 
fraction upon baculoviral expression in both Sf21 and Hi5. The deletion of the 23.6 kDa 
hFc-tag which might have inhibited the proper secretion in insect cells did not provide 
any improvements in solubility (Figure 3-34). 
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Figure 3-34: Western blots of ECDhTLR5 expression in BEVS 
ECDhTLR5 was expressed as a C-terminal His8 fusion protein in the BEVS with or without a c-terminal human Fc-tag to 
analyse its influence on the secretion of the protein. Different constructs with its authentic signal peptide (ss) or the 
gp67 (gp) secretion signal were tested. From each expression samples of 10
6
 cells were taken 96 hpi and the 
supernatants (SN) as well as soluble (S) and insoluble (IS) intracellular fractions were analysed by Western blots using a 
His-Tag antibody and a secondary goat-anti-mouse IgG (H+L)-AP conjugate (A & B). Constructs with the hFc-tag were 
additionally incubated with a goat-anti-human IgG (H+L)-AP conjugate (C). 
 
As the length of the original insoluble constructs based solely on putative database 
prediction of the domain border, a novel ECDhTLR5 construct with an alternative C-
terminus was designed to achieve soluble expression and secretion. An alignment of the 
sequence of the full length human TLR5 and a soluble homolog of the ECD of TLR5 from 
the rainbow trout (Tsujita et al., 2006) revealed a section of 50 amino acids at the domain 
border which is missing in the fish orthologs. In contrary, a 15 amino acid long C-terminal 
fragment behind this gap shows significant homology again (Figure 3-35 A). Based on this 
analysis, a chimeric variant was designed including the first 621 amino acids of 
ECDhTLR5 followed by the 19 amino acid rainbow-trout C-terminus. An alignment of 
this construct termed ECDhTLR5-rtC and the original variant is shown in Figure 3-35 B. 
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Figure 3-35: Sequence alignment of soluble rainbow trout TLR5 with human TLR5 and the chimeric construct 
A: human TLR5 is aligned with the soluble variants of the rainbow trout rtTLR5 (Oncorhynchus mykiss, “oncmy”) and 
the atlantic salmon (Salmo salar, “salsa”). The sequence identity of the ECD of human TLR5 and the soluble rtTLR5 is 
27 % with 37.1 % positives. B: Based on the findings of the alignment, a chimeric construct (middle row) comprising the 
first 621 aa of human TLR5 (upper row) and the 19 aa rtTLR5 C-terminus (lower row) was generated. 
 
Since the multipurpose vector pFlpBtM was not available at this stage the new construct 
had to be cloned into different conventional expression vectors by a series of cloning 
steps. Firstly, a synthetic 638 bp fragment containing parts of the ECDhTLR5 and the 
novel rtC-terminus flanked by XbaI and NotI was integrated into a pIEX vector 
harbouring the original construct upon excision of a corresponding wildtype segment. 
The resulting pIEX-sshTLR5-rtC-H8 was utilised for transient test expression in Sf21. 
Additionally, the chimeric hTLR5-H8-rtC construct was integrated as PCR-fragments with 
necessary flanking restriction sites into the vectors pTT and pFastBac for transient 
expression in HEK293-6E and the generation of recombinant MultiBac bacmids for 
baculoviral expression, respectively. However, transient expression of the construct in 
both Sf21 and HEK293-6E did not result in any detectable amounts of the protein. Upon 
baculoviral expression Western blot signals were again only observed in the insoluble 
intracellular fraction (data not shown).  
As the expression of the chimeric construct did not enhance the solubility of the target 
protein either, a completely new strategy had to be employed to generate constructs 
which enable the production of soluble protein. Therefore, a structure model of the 
domain was predicted to identify secondary structure elements to design additional 
truncated constructs Figure 3-36. 
                    |620                   |640          |660          
    hTLR5-H8  LNHTNVTIAGP-PADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKHHHHHHHH- 
hTLR5-rtC-H8  LNHTNVTIAGP-PADIYCVYPDSFSGVSLLNYSKVITEKYPKPSLTKIHHHHHHHH 
      rtTLR5  MNRTNVTFPDPGVAEFSCEFPSDLHGVSLLNYSKVITEKYPKPSLTKI-------- 
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Figure 3-36: Predicted structure of the ECD of human TLR5 
Structure prediction of ECDhTLR5 was performed using the CPHmodels server via remote homology modeling. The 
ECD of human TLR3 (PDB ID: 1ziw_A, identity 23.41 %) served as a template. The final model was kindly created by 
Joachim Reichelt using the PyMOL software. The diameter of the concave structure is indicated by the dashed line [Å]. 
 
Ordered structure prediction was possible only to amino acid 591. Consequently, a 
truncated construct comprising amino acids 1 – 591 was planned. Moreover, the model 
exhibits a significant gap within the parallel beta sheets typically formed by hydrophobic 
amino acids on the concave surface of LRR proteins between M220 and M265. Here, a 
disordered loop indicates a flexible region within the otherwise predominantly rigid 
solenoid structure. Remarkably, this section is part of the flagellin binding region which 
was proposed by functional studies in a 228 aa large central region between amino acids 
174 - 402 (Andersen-Nissen et al., 2007). Since this flexible region might inhibit proper 
protein folding, an N-terminal truncated construct beginning directly behind this section 
at M265 was designed as well. 
Expression and subsequent crystallization of the ECDs of TLR1, TLR2, TLR3, TLR4 and 
TLR6, had been successfully performed by means of the LRR hybrid technology. 
Consequently, this method was also used in this work to generate novel constructs of 
ECDhTLR5. Therefore, 5 LRR hybrids with the C-terminal portion of hagfish variable 
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lymphocyte receptor VLRB6 comprising amino acids 133 - 200 were planned according to 
annotated LRR motifs (Matsushima et al., 2007). The junctions were designed within the 
LRR 18-21 as shown in Figure 3-37 resulting in constructs comprising amino acids 1-480, 
1-509, 1-533, 1-555 and 1-576. Furthermore, a short N-terminal fragment ending directly 
before LRR7 at amino acid 195 and thus upstream of the disordered region identified in 
the structure model was generated as well. This construct was also linked to the VLRB6-
C-terminus but without generating a LRR-hybrid.  
 
 
Figure 3-37: Sequence of the ECD of human TLR5 
LRR motifs (LxxLxLxxNxL) are indicated in red, in which "L" usually is leucine (L), isoleucine (I), valine (V) or 
phenylalanine (F) and "N" is asparagine (N), threonine (T), serine (S) or cysteine (C) and "x" is any amino acid. In those 
LRR motifs used for the VLR-hybrids, the amino acids exchanged by the linkage are marked in yellow. The signal 
peptide is highlighted in blue. 
 
A streamlined parallel construction of the mutants was facilitated by the preceding 
generation of an entry vector. It contained a synthesised VLRB6 fragment flanked by 
unique restriction sites and downstream One-STrEP-His8 sequences separated by a TEV 
protease cleavage site for improved detection and purification. Since the construction and 
evaluation of pFlpBtM-II was still ongoing at this stage a pTT5 backbone was used for this 
purpose as shown in Figure 3-38. PCR-products of the ECDhTLR5 truncations were 
generated and integrated with technical assistance by Claudia Wylegalla. The fragments 
were flanked by BamHI-NheI restriction sites allowing for the integration in the linearised 
recipient upstream of the VLR fragment by BamHI-NheI digest or alternatively by 
replacing it upon digestion with BamHI-XbaI.  
    1 MGDHLDLLLG VVLMAGPVFG IPSCSFDGRI AFYRFCNLTQ VPQVLNTTER 
   51 LLLSFNYIRT VTASSFPFLE QLQLLELGSQ YTPLTIDKEA FRNLPNLRIL 
  101 DLGSSKIYFL HPDAFQGLFH LFELRLYFCG LSDAVLKDGY FRNLKALTRL 
  151 DLSKNQIRSL YLHPSFGKLN SLKSIDFSSN QIFLVCEHEL EPLQGKTLSF 
  201 FSLAANSLYS RVSVDWGKCM NPFRNMVLEI LDVSGNGWTV DITGNFSNAI 
  251 SKSQAFSLIL AHHIMGAGFG FHNIKDPDQN TFAGLARSSV RHLDLSHGFV 
  301 FSLNSRVFET LKDLKVLNLA YNKINKIADE AFYGLDNLQV LNLSYNLLGE 
  351 LYSSNFYGLP KVAYIDLQKN HIAIIQDQTF KFLEKLQTLD LRDNALTTIH 
  401 FIPSIPDIFL SGNKLVTLPK INLTANLIHL SENRLENLDI LYFLLRVPHL 
  451 QILILNQNRF SSCSGDQTPS ENPSLEQLFL GENMLQLAWE TELCWDVFEG 
  501 LSHLQVLYLN HNYLNSLPPG VFSHLTALRG LSLNSNRLTV LSHNDLPANL 
  551 EILDISRNQL LAPNPDVFVS LSVLDITHNK FICECELSTF INWLNHTNVT 
  601 IAGPPADIYC VYPDSFSGVS LFSLSTEGCD EEEVLKSLKH HHHHHHH 
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As soon as pFlpBtM-II(beta) was available all constructs were transferred into the multi-
host expression vector as NcoI-MluI restriction fragments. Schematic illustrations of the 
resulting 8 new constructs as well as the preceding variants are summarised in Figure 
3-39.  
 
 
Figure 3-38: Construction VLR hybrids and truncations of ECDhTLR5 
A fragment of the C-terminal amino acids 133 – 200 of hagfish VLR6 fused with a TEV-STrEP-H8 tag was synthesised 
and incorporated into a pTT plasmid. PCR-fragments of different truncated variants of ECDhTLR5 were generated and 
integrated as LRR-hybrid fusions to the VLR (upon BamHI-NheI digest) or replacing the VLR domain (upon BamHI-XbaI 
digest), respectively. As soon as the pFlpBtM-II(beta) was available, all constructs were transferred into the new 
multipurpose expression vector as NcoI-XhoI fragments. 
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Figure 3-39: Schematic view of all 12 ECDhTLR5 variants expressed in this work 
Initially, constructs comprising the amino acids 1 - 640 of ECDhTLR5 were expressed with a C-terminal hFc-tag and 
either its authentic signal peptide (ss) or the S. frugiperda gp67 secretion signal. To enhance solubility, a variant 
without the hFc-tag and a chimeric protein consisting of aa 1 - 621 and the C-terminal portion of rainbow trout soluble 
TLR5 (rtC) were constructed. Finally, a series of truncated and VLR fusion constructs were designed according to 
structure modelling and LRR motif predictions. Those 8 constructs were generated in an entry vector and transferred 
into pFlpBtM-II(beta) to screen for soluble expression and subsequent large scale expression. 
 
The initial screening for soluble constructs was carried out by transient transfection of 
HEK293-6E. Average transfection rates of duplicate experiments with each construct were 
between 15 - 40 %. To detect expression of the variants and localise their accumulation, 
Western blots of supernatants and cell lysates were performed using both His-Tag and 
StrepMAB primary antibodies, respectively. As observed in transient expression of 
ECDmTLR2 and the previously tested ECDmTLR5 constructs, only weak signals were 
obtained. Especially with the His-Tag antibody a significant background of unspecific 
binding due to long incubations occurred (Figure 3-40). Moreover, most of the constructs 
predominantly yielded in insoluble material and were not secreted at all.  
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Figure 3-40: Western blots to detect expression of ECDhTLR5-VLR variants in transfected HEK293-6E 
Supernatants (SN) and cell lysates (soluble: S, insoluble: IS) of 10
6
 HEK293-6E cells transfected with pFlpBtM-II(beta) 
harbouring different ECDhTLR5 variants were taken 48, 96 and 168 hpt and analysed by Western blots using a His-Tag 
or StrepMAB antibody and a secondary goat-anti-mouse IgG (H+L)-AP conjugate. 
 
Only the short N-terminal fragment hTLR5_1-195_VLR and the mutant hTLR5_265-591 
without signal peptide or VLR fusion were detected in the supernatants or in the soluble 
fractions, respectively. In addition hTLR5_1-509_VLR and hTLR5_1-555_VLR exhibited 
significant overall expression and were slightly detectable in the soluble fraction, as well. 
Based on these observations, those four variants were selected to be further tested in 
baculoviral expression. The generation of recombinant EMBacY bacmids could be carried 
out directly with the pFlpBtM-II(beta) constructs. A 50 mL culture with 1 ×106 Sf21 cells 
per mL were infected with 10 % 2nd generation virus and incubated for 96 h thereby 
achieving infection rates of approximately 90 % (data not shown).  
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Again, protein expression was assessed by Western blots of culture supernatants and 
intracellular fractions. The results are shown in Figure 3-41. 
 
 
Figure 3-41: Western blots to detect baculoviral expression of ECDhTLR5-VLR variants in Sf21 
Four ECDhTLR5 variants that exhibited soluble expression in HEK293-6E cells were produced in the BEVS. From each 
expression samples of 10
6
 cells were taken 48 and 96 hpi as well as from non-transfected cells. The supernatants (SN) 
soluble (S) and insoluble (IS) intracellular fractions were analysed by Western blots using a His-Tag antibody and a 
secondary goat-anti-mouse IgG (H+L)-AP conjugate (M = PageRuler Plus Prestained [kDa]). 
 
The Western blots of the baculoviral expression confirmed the results of the production in 
HEK293-6E. All constructs yielded predominantly insoluble material and only the short 
constructs 1-195_VLR-STrEPH8 and 265-591_STrEPH8 could be detected in the soluble 
fraction. Notably, in contrast to the transient expression in HEK293-6E, no secreted 
hTLR5_1-195_VLR-STrEPH8 was found in the supernatant. However, considerably more 
soluble material could be produced with the new truncated and VLR hybrid constructs 
compared to the preceding experiments with the full length ECD or rtC-fusions. Though, 
initial efforts that were made to capture intracellular accumulated soluble material in the 
late phase of this work have not been successful. 
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3.6 Engineered BEVS host cell lines 
In addition to the multi-host donor and expression vector pFlpBtM-II, a BEVS host cell 
line was generated for stable expression of complex partners or auxiliary proteins 
enhancing protein folding and stability. For stable integration of target genes into the 
BEVS host cell the RMCE system was chosen, as it facilitates fast and robust genomic 
integration and furthermore would enable a compatible system to the existing CHO 
Lec3.2.8.1 master cell line. Thereby, an integrated expression platform for fast and 
versatile protein production in optimised cell lines should be provided. Likewise, 
fluorescence-activated cell sorting should be used for the isolation of clonal cell lines. 
3.6.1 Design and construction of the tagging vector 
The tagging vector design was based on pEF-FS-EGFP-dneo, which was previously used 
for the generation of CHO-RMCE master cell lines in our group (Wilke et al., 2011). It 
contains the heterospecific sites FRT3 and FRTwt and is thus compatible with the 
pFlpBtM donor vectors. Additionally, pEF-FS-EGFP-dneo contains an ATG-deficient 
aminoglycoside phosphotransferase gene (∆neo) downstream of the FRT cassette used as 
selection-trap to screen for positive RMCE events. The ∆neoR gene is complemented and 
activated upon correct cassette exchange and confers resistance to Geneticin (G418).  
Initial transient expression screenings revealed, that the EF1-α promoter used for stable 
expression of the protein in the CHO tagging vector is less active in Sf21 (data not shown). 
Therefore, it was exchanged by the promoter region of pIEX/Bac5, which contains a 
baculoviral immediate early promoter 1 and the hr5 enhancer as well as a downstream 
very late p10 promoter. The fragment was generated by PCR-primers flanked by BglII and 
HindIII and integrated in the pEF-FS-EGFP-dneo backbone where the corresponding 
region was deleted. A schematic map of the resulting vector termed pIE10-eGFP-dneo is 
shown in Figure 3-42. A second tagging plasmid was additionally constructed by 
exchanging the eGFP reporter gene against tdTomato. Its higher quantum yield compared 
to eGFP should help to identify stable producer cell lines.  
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Figure 3-42: Tagging vector for the generation of stable insect cell lines 
The promoter region consists of the baculoviral AcMNPV immediate early promoter ie1 and its enhancer hr5 as well as 
the very late p10 promoter, which is only active under the presence of baculoviral transcription factors and mRNA 
polymerase. The marker gene eGFP is flanked by heterospecific FRT sites (FRT3 & FRTwt). A downstream non-
functional aminoglycoside phosphotransferase gene (∆neoR) confers resistance only upon the integration of a 
promoter and an ATG codon via cassette exchange. The vector backbone contains a bacterial origin of replication (pUC 
ori) and a beta-lactamase gene for selection on Ampicillin (Amp). 
 
3.6.2  Integration of a RMCE-locus into Sf21 
While transfection of CHO cell lines is usually performed using the Nucleofector™ 
(amaxa), this method has not been established for lepidopteran cell lines. Although the 
manufacturer offers resuspension medium and pre-programmed electroporation settings 
for Sf21, the cells did not survive the transfection procedure in the amaxa device. Thus, 
small scale chemical transfections of suspension cultures in 6-well plates had to be tested 
and optimised in this work. In addition to the tests of different promoters, fluorescene 
rates were also compared between linearised and circular expression plasmids. The 
integration of linearised exogenic DNA is more likely compared to condensed plasmids, 
whereas the cytoplasmatic half-life and thus the expression rate in the early days post 
transfection is significantly higher when transferring intact plasmids. An exemplary 
fluorescence kinetic of these extensive evaluations is shown in Figure 3-43. Typically, 4 
times higher fluorescence rates were observed upon transfection with circular plasmids. 
However, continuous passaging resulted in a loss of fluorescence rates and an 
approximation between the cultures transfected with linear or circular tagging plasmids. 
The transfection of the host cell line with the tagging plasmids created an inhomogeneous 
population of transient expression and randomly tagged cells. Accordingly, the first 
sorting was performed 7 days post transfection to ensure a favourable ratio of the 
probability for stable integration and a high absolute amount of fluorescent cells.  
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Figure 3-43: Fluorescence profile of S21 transfected with circular and linearised tagging plasmids 
Suspension cultures of Sf21 were chemically transfected with linearised and circular pie10-eGFP-dneo or pie10-
tdTomato-dneo respectively. Fluorescence was daily assessed at the Guava EasyCyte Mini flow cytometer at green and 
yellow detection channel. 
 
3.6.3 Isolation of a clonal Sf21 cell line 
The enrichment of cells that integrated the RMCE-cassette into favourable chromosomal 
loci was performed by at least two rounds of preparative FACS followed by a clonal 
isolation of cell lines from the resulting cell pool. This strategy as shown in Figure 3-44 has 
also been used for the generation of the CHO Lec3.2.8.1 master cell lines for RMCE in our 
group. By avoiding antibiotic selection a more homogenous and stable expression of the 
transgenes in the resulting expression cell line is achieved (Kaufman et al., 2008). 
 
 
Figure 3-44: Strategy for the generation of clonal RMCE master cell lines by FACS 
Random integration of the tagging vector generates an inhomogeneous pool of cells which are sorted 7 days post 
transfection. After expanding the cells to suspension, a second (and potentially third) sorting is performed to isolate 
cells out of the enriched population. Those cells are further isolated and propagated to obtain clonal master cell lines. 
(Modified work, original source: Wilke, 2011) 
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However, preparative sorting of insect cell cultures is a rare technique and not well 
described in the literature. In this work, FACS of insect cells transfected with the tagging 
vector recurrently caused a drastic decrease of the viability from 80 - 90 % before sorting 
to 2 - 15 % in the enriched cell pool. Although the heavily stressed cells were seeded and 
incubated as adherent cultures, their low viability impeded a recovery of the sorted 
population. As a result, it was not possible to isolate a master cell line in the initial 
attempts. 
To reduce the shear stress during the sorting process and to enhance the viability of the 
sorted cell pool, supplementation with FCS and an increase in cell density up to 
1 × 108 c/mL of sorted cells were tested. This represents the limit at which a proper 
distribution of single cells into droplets is possible. Additionally, an alternative sorter was 
used and a pH- and osmolarity-optimised sheath fluid was developed and evaluated 
(data not shown). The most promising variations to increase the viability of sorted cells 
were the supplementation of FCS and the use of the MoFlo high-speed cell sorter 
(Beckman Coulter). A viability of up to 50 % could be retrieved when cells supplemented 
with 10 % FCS were sorted in this device (Figure 3-45) 
 
 
Figure 3-45: Effect of the sorting device and the supplementation with FCS on the viability of sorted cells 
Sf21 were sorted 7 days post transfection with the pie10-eGFP-dneo in the BD FACS AriaII (blue) and the Beckman 
MoFlo sorter (red). Cultures without FCS supplements and those adapted to 5 and 10 % FCS prior to the transfection 
were compared. The viability measured in the re-analysis upon sorting was normalised to its value prior sorting. 
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Using the optimised conditions, GFP-expressing cells could be enriched from 8 % on day 
7 post transfection to 94 %. The population was propagated as adherent culture for 14 
days and transferred into suspension on day 21 post transfection. Strikingly, flow 
cytometric measurements revealed, that only ~ 20 % of the cells of this culture fluoresced 
(data not shown). Obviously, the integration in a significant share of the cells was either 
not stable or the fluorescence was still mediated by residues of transient expression. To 
obtain stable clonal cell lines the population was sorted again after 10 days in suspension 
using an automated cell deposition unit for sorting into 96-well plates. Thereby, 9 plates 
with single cells per well and an additional plate with 10 cells per well were inoculated. 
Besides the isolation of these 960 cell clones, the rest of the culture was again sorted as a 
population and plated in 6-well plates.  
None of the cell clones in the 96-well plates recovered and formed colonies, so that the 
pool of sorted cells seeded at 6-well plates was consequently transferred to suspension. 
Again, despite the enrichment of fluorescent cells, the culture exhibited a fluorescence of 
only ~ 50 %. During the following 9 passages in suspension, eGFP-expression cells further 
decreased to ~ 30 % until they were sorted a third time 67 days post transfection. Notably, 
the viability of the sorted cells dramatically dropped to ~ 3 % (Figure 3-46), so that the 
cells had to be seeded with a very low initial density as adherent culture following the 
sorting. As a result, instead of growing to a confluent monolayer, small colonies were 
formed as shown in Figure 3-47. 11 days after the sorting, 24 of these colonies were 
isolated and further propagated in single wells of a 24-well plate for 18 days and 
subsequently transferred to suspension on day 96 post transfection of the parental Sf21 
cell line. However, only one out of 20 transferred single cell clones survived the first 5 
passages. Moreover, it remarkably exhibited an average fluorescence of only 30 % despite 
its clonal origin. Thus, further analyses of this cell line were performed as presented in 
chapter 3.6.5. 
Subsequent to the isolation of a Sf21-derived RMCE master cell line, the generation of 
corresponding tagged Hi5 cell lines was additionally carried out under the author’s 
direction as part of the Bachelor thesis of Gundula Sprick (chapter 3.6.4). In total, more 
than 10 iterative transfections with subsequent sorting- and isolation procedures were 
thus performed within this work between May 2010 and May 2011. 
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Figure 3-46: Isolation of Sf21 stably producing the eGFP reporter gene 67 days post transfection 
3
rd
 sorting of Sf21-pie10-eGFP-dneo 67 days post transfection at the MoFlo high-speed cell sorter (Beckman Coulter) in 
the department of Experimental immunology by Lothar Gröbe. Appropriate gates were adjusted according to negative 
control measurements. The pool of captured eGFP-positive cells was analysed directly after the sorting process 
(SS = sideward scatter, FS = forward scatter) 
 
 
 
Figure 3-47: Single cell colonies of Sf21-pie10-eGFP-dneo 11 after the third sorting 
Due to the low viability of cells enriched in the 3
rd
 sorting 67 days post transfection, seeding as adherent culture in low 
density caused the development of colonies instead of a confluent monolayer. 20 large colonies were separated and 
seeded in single wells of a 24-well plate for further proliferation. Only 1 survived the first 5 passages subsequent to the 
transfer in suspension. 
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3.6.4 Generation of clonal Hi5 cell lines 
For the generation of Hi5 RMCE master cell lines a second tagging vector named pie10-
tdTomato-dneo harbouring tdTomato as reporter gene was used besides pie10-eGFP-
dneo. The alternative reporter was used to achieve a higher fluorescence also in those 
cells, were the integration occurred in a transcriptionally less active locus and thereby 
increasing the number of fluorescent positive cells to be sorted. Figure 3-48 shows a 
representative enrichment of transfected Hi5 in the sorting 7 days post transfection. The 
resulting populations exhibited a fluorescence of more than 90 % with viabilities of ~ 25 -
 30 % directly upon sorting before seeding to 6-well plates. 
 
 
Figure 3-48: Enrichment of Hi5 cells transfected with eGFP- and tdTomato-tagging plasmids 
Hi5 transfected with pie10-eGFP-dneo (upper row) and pie10-tdTomato-dneo (lower row) were sorted 7 days post 
transfection at the MoFlo high-speed cell sorter (Beckman Coulter) in the department of Experimental Immunology by 
Lothar Gröbe. Appropriate gates were adjusted according to negative control measurements. The pools of captured 
eGFP- and tdTomato-positive cells were analysed directly after the sorting process. Fluorescence of the culture of the 
culture before sorting is shown as filled areas or as surrounded light areas in the re-analysis of the sorted cultures. (SS = 
sideward scatter, FS = forward scatter, pink numbers indicate the percentage of the gated populations).  
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Following the adherent propagation for 5 days the population was transferred to 
suspension. Fluorescence rates of more than 50 % for cells tagged with pie10-eGFP-dneo 
and more than 70 % upon integration of pie10-tdTomato-dneo could be confirmed by 
flow cytometry. To assess the stability of the reporter gene expression in the 
heterogeneous cell pools, the fluorescence was analysed during continuous cultivation 
over 18 (Hi5-pie10-tdTomato-dneo) and 28 passages (Hi5-pie10-eGFP-dneo), respectively. 
Thereby, fluorescence rates of ~ 60 % could be observed 70 days post transfection in Hi5-
pie10-tdToamato-dneo and 35 % 100 days post transfection in Hi5-pie10-eGFP-dneo. 
However, the values fluctuated between different passages (data not shown). 
Since repeated preparative FACS proved to be a disadvantage, the clonal isolation of Hi5 
RMCE cell lines was performed by conventional manual separation upon seeding of a 
dilution of the enriched population on 60 mm dishes. Colonies were picked and 
sequentially expanded as adherent cultures from 96-well plates up to 2 × 60 mm dishes 
until the cell clones could be transferred to suspension. Two tdTomato-expressing master 
cell lines and one with eGFP as a reporter could be generated by this means. As with the 
Sf21 master cell line, no homogeneous fluorescence could be detected in the Hi5 cells, 
although they are derived from single cell clones. Average fluorescence rate within 2 
weeks of continuous cultivation in suspension were ~ 50 %for Hi5-pie10-eGFP-dneo and 
58 % and 68 % for the two Hi5-pie10-tdTomato-dneo clones (data not shown). 
3.6.5 Evaluation of genomic expression 
Since the reporter genes within the RMCE cassettes did not have tags for purification their 
genomic expression in the isolated cell lines had to be analysed by fluorimetric 
measurements. Therefore, eGFP-RMCE master cells were infected by a virus containing 
mCherry to analyse the influence of the baculoviral infection on the genomic expression 
of eGFP within the RMCE cassette. As outlined in Figure 3-42 on page 101, the genomic 
expression of the reporter gene is driven by a promoter cassette comprising the 
baculoviral ie1 promoter and additionally by the very late p10 promoter. Upon infection 
of the cells with a baculovirus the latter should be activated due to viral transcription 
factors and the baculoviral mRNA polymerase. The progress of the fluorescence in Sf21-
pie10-eGFP-dneo infected with a Bac-sumostar-mCherry virus is shown in Figure 3-49.  
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Figure 3-49: Fluorescence of Sf21-pie10-eGFP-dneo upon infection with Bac-sumo-mCherry 
Sf21-pie10-eGFP-dneo was infected by a recombinant baculovirus harbouring a sumo-mCherry protein as a 
transfection control. Fluorescence was analysed at a Guava EasyCyte Mini flow cytometer. The fluorescence of 
mCherry does not affect the detection of green fluorescence since its emission wavelength is not covered by the green 
detector channel. 
 
Accumulation of viral encoded mCherry is observed not before 48 h post infection which 
corresponds to the time window necessary for the viral DNA to enter the nucleus and 
start the expression genes controlled by the very late promoters. In contrast, the amount 
of cells which exhibit green fluorescence increases immediately upon infection and 
reaches a maximum of > 95 % 72 hpi. This effect is mediated by the activation of the ie1 
promoter and its enhancer by immediate early viral transcription factors in the first 48 h 
post infection and the further increase of the transcription rate upon activation of the p10 
promoter in the later phases. The fact that eGFP is expressed throughout the whole 
culture strikingly demonstrates that the RMCE cassette is homogenously integrated in the 
cells despite the low fluorescence rate observed in the cell lines in the absence of infection. 
A quantification of the eGFP production was performed by analysing cell lysates at a 
Tecan NanoQuant InfiniteM200 plate reader using an eGFP-standard for correlation. The 
accumulation of eGFP by constitutive genomic expression in the stable master cell lines 
was compared with baculoviral eGFP-expression in the non-tagged parental cell line and 
the enhanced expression in the master cell lines upon infection with the control virus 
(Figure 3-50). 
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Figure 3-50: eGFP concentrations achieved by stable, viral and enhanced genomic expression 
The constitutive expression of eGFP in RMCE master cells lines (green) was compared with the enhanced expression in 
the same cell lines upon baculoviral infection and subsequent activation of the very late p10 promoter (red) and 
entirely baculoviral expression in non-tagged cells (blue). The concentrations within cell lysates were determined using 
a Tecan NanoQuant InfiniteM200 plate reader and correlated with an eGFP-standard (instrument parameters used for 
the measurements are listed in chapter 2.7.2.). 
 
The quantification revealed rather low constitutive expression yielding in 0.21 mg/L in 
Sf21-pie10-eGFP-dneo and 0.15 mg/L in Hi5-pie10-eGFP-dneo, respectively. However, 
upon infection with a baculovirus and the resulting transcriptional gain 2 mg/L and 
25 mg/L could be obtained in Hi5-pie10-eGFP-dneo and Sf21-pie10-eGFP-dneo which 
corresponds to a 13 - 125 fold increase. In contrast, via direct baculoviral-derived 
expression of eGFP yields of 177 mg/L in Hi5 and 196 mg/L in Sf21 were achieved. 
However, taken into account, that the stable expression is driven by only a single (or few) 
genomic integrations of the eGFP gene, whereas up to several hundred copies of the 
recombinant viral genome are present in the cell in the late phase of the infection, the 
yields achieved with the tagged cell lines are remarkable. In fact, the baculovirus induced 
increase in stable genomic expression of eGFP yields comparable amounts of protein as 
obtained upon direct baculoviral expression and purification of the closely related 
mCherry (cf. chapter 3.5.1.). Consequently, the Sf21 and Hi5 master cell lines for RMCE 
generated in this work are well suited for stable expression of heterologous proteins. 
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4 Discussion 
Minimizing the time required for cloning and screening of target constructs is a 
worthwhile goal for the optimisation of expression pipelines. Moreover, the use of 
engineered dedicated production cell lines facilitates the expression of challenging target 
proteins and leads to improved product yields. The aim of this work was thus the 
construction and evaluation of a novel expression vector which enables the flexible and 
fast screening for expressible target protein variants and the identification of the optimal 
expression system for any given target protein. By the incorporation of genetic elements 
for transient and viral expression as well as recombinase based targeted integration of 
transgenes into dedicated producer cell lines, the vectors should combine all expression 
systems available at the Recombinant Protein Expression group at the Helmholtz-Centre 
for Infection Research. Likewise, optimised lepidopteran cell lines that implement the 
RMCE system for inducible genomic expression of transgenes in addition to the BEVS 
were developed, thereby creating an integrated protein expression platform for the PSPF. 
 
4.1 Evaluation of pFlpBtM-I 
The first version of the vector comprised all elements required for the use as a donor 
vector for RMCE in the CHO Lec3.2.8.1 master cell line and in Tn7-based generation of 
recombinant bacmids of the Bac-to-Bac or MultiBac systems. Additionally, it was 
designed to be used for transient expression in insect cells, which is driven by the 
baculoviral immediate-early 1 promoter in combination with the homologous region 5 
transactivator. This combination utilises the endogenous insect-cell transcriptional 
machinery and was originally used for early expression of recombinant proteins in 
baculoviral vectors (Jarvis et al., 1996). The promoter region taken from the commercial 
pIEx plasmid provided by Novagen is complemented by an additional p10 promoter, that 
directs expression in the late/very late phases of baculoviral expression upon the 
generation of recombinant bacmids (Loomis et al., 2007). The proof of concept studies 
revealed, that the vector is suitable for RMCE based generation of stable cell lines without 
any constrains. The CHOLec3.2.8.1 producer cell line isolated upon cassette exchange 
with pFlpBtM-I as a donor vector homogenously expressed the reporter protein and was 
used for comparative expression studies that will be discussed below in chapter 4.2.1.  
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Transient plasmid based expression of the fluorescent model proteins in insect cells could 
also be detected. However, only very faint signals were observed. This was especially the 
case for mCherry, which has an intrinsically lower brightness compared to eGFP. 
Although transient expression of heat shock proteins, kinases and phosholipases using 
the parental pIEx vector have been reported with yields between 3 µg/mL (kinases) and 
48 µg/mL (HSP) (Loomis et al., 2005), the weak fluorescence and the absence of prominent 
Western blot signals of the model proteins used in this work indicated that this promoter 
combination provides only low expression in the pFlpBtM backbone. Moreover, the 
unfavourable cost-benefit-relation of lipofection reagents limits this application to small 
scale. Transfection of Sf21 using the cost-efficient chemical polyethylenimine was 
evaluated in preceding experiments (data not shown). Although fluorescence could be 
detected, the transfection rates were significantly lower compared to commercial 
lipofection reagents for insect cells which corresponds to even lower protein yields. 
Therefore, transient expression with pFlpBtM-I based on the AcMNPV ie1 promoter has 
to be considered as insufficient for preparative expression of target proteins. 
Consequently, new stronger endogenous promoters have to be identified and evaluated 
for this purpose. As this would be beyond the scope of this thesis, no further evaluations 
of this method were pursued.  
In contrary to the plasmid based expression in insect cells a remarkably brighter 
fluorescence was observed when eGFP and mCherry were expressed in the BEVS upon 
the generation of recombinant viruses using pFlpBtM-I as a donor vector. Likewise, the 
overexpression of the fluorescent model proteins was clearly proven in SDS-PAGE and 
Western blots. Traces of mCherry detected in the insoluble fraction probably result from 
protein misfolding. The very high expression rate mediated by the late p10 promoter may 
exceed the processing capacity of the host cells. In contrary, the occurrence of mCherry in 
the culture supernatant is a result of virus mediated cell lysis in the late phase of the 
infection. The viral expression of the challenging ECDmTLR2 could also be detected by 
Western blots. A notable amount of the protein accumulated intracellularly upon 
overexpression. However, this characteristic was also observed to the same extend when 
the ECDmTLR2 construct had been expressed using a conventional BEVS donor vector. 
This has been performed in the PSPF before and was reproduced for this work in a 
comparative expression study with pFastBac-ECDmTLR2 and pFlpBtM-I-ECDmTLR2 
(data not shown). Expression of TLR domains usually is problematic and yields in 
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improper folding so that soluble expression is only achieved as fusion proteins (Jin & Lee, 
2008). Besides unfavourable construct design, an impaired secretory pathway in the late 
phase of baculoviral infection further contributes to this effect. The shut down of the host 
cell protein synthesis following baculovirus infection may lead to a limitation in the 
supply of secretory assistance factors (Jarvis & Garcia, 1994). Likewise, insufficient levels 
of ER chaperones are a limiting factor in producing functional heterologous secreted 
proteins in the baculovirus system (Hsu & Betenbaugh, 1997; Ailor & Betenbaugh, 1999). 
Both, infection kinetics and expression profiles of the performed experiments indicate, 
that the vector architecture of pFlpBtM-I has no negative effect on the virus replication 
and expression. Likewise its applicability to serve as a donor for RMCE, it is thus very 
well suited to be used as a BEVS donor plasmid. However, since efficient capability for 
fast transient construct screening was one important requirement for the novel vector 
besides its use in stable and baculoviral expression, a remodelling leading to the 
generation of pFlpBtM-II was necessary. 
 
4.2 Evaluation of pFlpBtM-II 
HEK293 EBNA cells have been successfully utilised as expression hosts for protein 
production for crystallography (Nettleship et al., 2010). Since they are available at the 
Helmholtz PSPF, the improved version of pFlpBtM consequently should implement this 
expression system for transient expression. To utilise the EBV oriP mediated episomal 
replication techniques in HEK293-6E, which allow for significantly higher protein yields 
in transient expression, a new vector backbone comprising this replication origin had to 
be integrated. Likewise, the incorporation of a CMV promoter was essential to drive 
protein expression in mammalian cells. This was achieved via an exchange of the 
promoter region by a triple promoter construct derived from the vector pTriEx. It 
comprises a CMV promoter/enhancer combination, the same AcMNPV p10 promoter as 
in the previous version of pFlpBtM and an additional T7 promoter controlled by a lac 
operator. 
Proof of concept studies with the revised version in the BEVS, RMCE in CHO Lec3.2.8.1 
and HEK293-6E were successful. High transfection rates of HEK293-6E and strong 
overexpression of the fluorescent model proteins demonstrate that the transient 
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expression in HEK293-6E is far superior compared to ie1/hr5 mediated expression in 
lepidopteran cells. Fluorescence intensities and protein signals in SDS-PAGE reached 
similar levels as in baculoviral expression. In stable or baculoviral expression no 
differences could be observed compared to pFlpBtM-I. This fact demonstrates that the 
modifications in the backbone neither impair the RMCE in the CHO master cell line nor 
influence the Tn7 transposition in the generation of recombinant bacmids in E. coli. 
While the promoter region of pFlpBtM-I consists of only baculoviral sequences, the triple 
promoter integrated in pFlpBtM-II also contains the immediate early 1 promoter from the 
mammalian CMV and the bacteriophage T7 promoter. This has no effect on the genomic 
expression in stable master cell lines upon RMCE, since the FRT site is downstream of the 
promoter region which is thus not integrated into the host cell genome. Likewise, the 
tripartite promoter has no positive or negative impact on the expression in the BEVS as 
the CMV ie1 promoter is not active in lepidopteran cells (Pfeifer et al., 1997; He et al., 2008) 
and with a length of only 17 bp the bacteriophage T7 promoter is too small to act as a 
transcriptional element in eukaryotes. The baculoviral ie1 promoter, which contributes to 
the expression in pFlpBtM-I derived bacmids in the early stage of the infection, is absent 
in pFlpBtM-II. However, since its activity is negligible compared to the very late P10 its 
absence has no detectable influence on the protein yield. The performance of the triple 
promoter fragment was also tested at the Oxford Protein Production Facility (OPPF). 
Although no published data is available on comparative expression characteristics, no 
indication was found that the combination of the different promoters has any influence on 
their transcriptional activity compared to the use of each promoter in an isolated context 
(Nettleship, personal communication). 
4.2.1 Expression and purification of model proteins 
Subsequent to the generation and the successful proof of concept of pFlpBtM-II, its 
performance as a standard eukaryotic expression vector for the PSPF was demonstrated 
by the production of different model protein classes using pFlpBtM-II as a donor or 
expression vector. The fluorescent reporter mCherry, a secretory scFv-hFc fusion 
construct and the challenging target protein ECDmTLR2 were expressed in HEK293-6E, 
CHO Lec3.2.8.1 and the BEVS which enabled the identification of an optimal production 
strategy for each model by quantitative analyses of the yield and quality of purified 
proteins.  
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Intracellular accumulated mCherry was successfully purified by Ni-NTA IMAC upon 
chemical cell lysis. Average yields of 52 mg/L in transient expression and 42 mg/L in the 
BEVS show, that both systems are equally eligible for the production of this model 
protein. Due to the slightly higher yields and the significantly lower practical effort, the 
plasmid based transient expression in HEK293-6E is of advantage compared to the 
laborious BEVS in this case. However, if repeated experiments or scalability is desired, the 
BEVS has to be considered as superior, since viral stocks can be generated for repeated 
experiments with low batch-to-batch variability. Furthermore upscaling is possible 
without the requirement of large amounts of plasmid DNA. The single-copy integration 
of the transgene in stable genomic production in CHO Lec3.2.8.1 yielded lower amounts 
of only about 8 mg/L compared to expression with higher copy number in viral and 
plasmid-based expression. This corresponds to approximately 20 - 25 % of the yields 
achieved in the viral and transient strategies. This significant difference renders the stable 
expression as not favourable for the expression of “easy-to-express” target proteins with 
similar expression characteristics since time and labor expenses for the generation of 
producer cell lines would be unreasonably high. 
To evaluate the expression of the scFv-hIgG1Fc construct, it was produced in the BEVS 
and in HEK293-6E in this work. Immunoglobulins have been produced in insect cells 
since the early 1990 when recombinant antibodies were usually expressed in stable 
myeloma cell lines. It was only by the end of that decade that transient plasmid based 
expression of IgGs in mammalian cells driven by viral promoters such as CMV was 
developed. However, only very low yields of 0.4 mg/L in COS7 were reported 
(Norderhaug et al., 1997). In contrast, the first fully assembled IgG produced in the BEVS 
was captured at a level of 5 mg/L from supernatants of Sf9 monolayer cells (Hasemann & 
Capra, 1990). Various IgG antibodies have been produced with yields up to 18 mg/L in 
the following years (Verma et al., 1998; Liang et al., 2001). For alternative formats like scFv 
even higher titers were achieved and the development of optimised bioreactor processes 
allowed yields of up to 32 mg/L of secreted monomeric anti-phOx scFv (Kretzschmar et 
al., 1996). Today, industry-scale production of antibodies is usually performed in stable 
CHO cell lines with yields of several g/L (Durocher & Butler, 2009). However, the advent 
of highly effective transient expression in HEK293 by the development of genetically 
engineered producer cell lines and cheap transfection methods using PEI lead to a 1000-
fold increase in the productivity achieved by plasmid based transient expression in 
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mammalian cell lines (Backliwal et al., 2008a), which has consequently regained more 
significance. Accordingly, major differences were observed in the expression profile 
between these systems as opposed to mCherry. Not more than 5 mg/L could be captured 
from insect cell supernatants by protein A chromatography upon viral expression in Sf21 
and Hi5. Although the value is rather low, it still is perfectly in line with the reported 
titers usually achieved in the BEVS. In contrary, a significantly higher yield of 90 mg/L 
purified protein was obtained by transient expression in HEK293-6E, using pFlpBtM-
II(beta). Parallel expression of the model protein was performed to benchmark the 
expression capability of pFlpBtM-II compared to the conventional pCMV vector and pTT5 
which is the dedicated expression plasmid for this cell line. Due to its multiple genetic 
elements pFlpBtM-II(beta)-scFv-hIgG1Fc is 40 % larger than pTT5-scFv-hIgG1Fc and 30 % 
larger compared to pCMV-scFv-hIgG1Fc. Despite the resulting noteworthy decrease of 
the gene dose, still 85 % of the yield achieved with pTT5 is reached. Moreover, the 
concentration of captured antibody was 30% higher compared to pCMV, which is lacking 
the EBV-oriP. These findings impressively demonstrate that pFlpBtM-II is fully 
competitive to alternative expression plasmids for the use as expression plasmid in 
HEK293-6E. Its slightly lower expression capability compared to smaller, optimised 
expression plasmids for this system is negligible and certainly offset by its versatility. The 
fact that transient expression in HEK293-6E enables the production of at least 35 - 50 times 
more protein than the BEVS with less practical effort in a shorter time also underlines why 
the baculoviral expression has lost its former significance for fast and flexible production 
of immunoglobulins.  
Major differences in the expression profiles between BEVS and HEK were also observed 
for ECDmTLR2. Viral production resulted in significant intracellular accumulation of the 
protein in the soluble and insoluble fractions. However, secreted protein was successfully 
captured by affinity chromatography. In contrary, production of ECDmTLR2 was less 
successful in HEK293-6E. Expression could only be detected in Western blots and the 
protein remained almost completely in the insoluble fraction. Traces of recombinant 
protein secreted to the supernatant could be enriched by Ni-NTA, but were again only 
detected by immunostaining. Thus, the yield was insufficient to perform further polishing 
steps. These findings indicate, that plasmid based expression is too weak to produce 
sufficient amounts of this protein species, although expression is mediated by the strong 
CMV promoter. Stable genomic expression proved to be superior to transient or viral 
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expression strategies for ECDmTLR2. Purification of the model protein from concentrated 
culture supernatants of the CHO producer cell line yielded notable amounts of the protein 
between 1 – 5 mg/L. Moreover, the SDS-PAGE gels of the eluate fractions indicate, that 
capturing of stably expressed and secreted ECDmTLR2 from cell culture supernatants 
provided a higher purity with less contamination compared to the expression in BEVS, 
where a significant contamination by host cell proteins due to cell lysis is observed. 
Regarding yield and quality, the lower expression rate in stable genomic expression is 
obviously compensated by proper folding and secretion in this system. Additionally, the 
high yields and the significantly higher quality can reproducibly be achieved and easily 
scaled up in bioreactor productions. The multiparallel expression screening enabled by 
pFlpBtM-II thereby allowed the generation of the most suitable expression strategy for the 
challenging protein ECDmTLR2. Consequently, the stable CHO Lec3.2.8.1 producer cell 
line generated with the multi-host expression vector is by now the best expression system 
for ECDmTLR2 available as it provides 4 – 20-fold higher protein yields compared to 
previously reported expression methods (Kang et al., 2009).  
4.2.2 Applicability of pFlpBtM-II in alternative expression hosts 
It has not escaped the author’s notice, that the revised promoter cassette also provides the 
incorporation of the CMV promoter into the bacmids via Tn7 transposition. This renders 
the resulting recombinant baculoviruses suitable for mediating protein expression in 
mammalian cells (Hofmann et al., 1995). Although baculoviruses are capable of entering a 
broad range of mammalian cells they do not replicate in these hosts (Kost & Condreay, 
2002). Therefore, baculoviruses harbouring mammalian promoters have been used for 
many years for the transduction of mammalian cells especially in drug discovery and 
assay development (Kost et al., 2010) but also for large bioreactor scale production of 
recombinant proteins in HEK293 (Jardin et al., 2008). However, high MOIs of 10 – 10,000 
are required for efficient transduction so that a reconcentration of baculoviral stocks is 
essential (Andersson et al., 2007). As this procedure is time consuming and laborious and 
baculovirus infected mammalian cells are not used for the production of crystallization 
targets in the PSPF, the evaluation of pFlpBtM-II-derived viruses in mammalian cells was 
omitted.  
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Although pFlpBtM-II is intended to be employed as a eukaryotic expression vector, the 
inducible T7/lac promoter included in the promoter fragment should also confer the 
applicability of pFlpBtM-II in E. coli. However, the decision whether a protein might be 
expressible in prokaryotic system or may require the eukaryotic PTM machinery is 
usually made prior to the cloning process. Moreover, many expression vectors for protein 
expression in E. coli which feature different promoter regulation principles are available 
and have been constantly optimised over the last decades (e.g. pET system by Novagen or 
pGEX by GE Healthcare). A 6.8 kb eukaryotic expression plasmid consequently is not the 
vector of choice for recombinant production of a prokaryotic target protein. That is why 
the test expressions of the fluorescent marker in E. coli using pFlpBtM-II were not 
presented in detail in this work. However, such evaluations have been performed with 
striking results. No overexpression of the reporters was achieved neither in Rosetta2 DE3 
where T7 mRNA polymerase is controlled by an IPTG inducible lac promoter nor in 
BL21 AI, in which the production of T7 mRNA is driven by an arabinose promoter. Weak, 
basal expression was detected on Western blots instead. Since no pLys strains have been 
used in which T7 mRNA polymerase activity is suppressed and pFlpBtM does not contain 
the lacI repressor, the expression must be inhibited by a different mechanism. Control 
experiments using conventional pET vectors and the pTriEx performed in our group by 
Claudia Wylegalla proved both, the expressibility of the mCherry and eGFP genes in E. 
coli and the functionality of the triple promoter fragment.  
A probable explanation for the inhibited protein synthesis in E. coli is the formation of 
mRNA secondary structures in the 5’ untranslated region (UTR). In the parental pTriEx 
vector from which the promoter fragment was obtained the Shine-Dalgarno sequence is 
directly downstream of the promoter section whereas additional 78 bp comprising 
restriction sites and the Flp recombinase target site are present in pFlpBtM-II. As shown in 
Figure 1-6 on page 18 the FRT site consists of 3 inverted repeats and is thus highly 
amenable for intramolecular pairing. To assess the effect of this sequence an mRNA 
secondary structure prediction was performed. It confirmed the formation of a compact 
fold with two distinctive hairpins as shown in Figure 4-1. 
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Figure 4-1: Minimal free energy mRNA secondary structure prediction of the 5’UTR of pFlpBtM-II 
The minimal free energy structure of the 5’UTR of pFlpBtM-II was predicted using the RNAfold web server provided by 
the Institute for Theoretical Chemistry at the University of Vienna. The color code represents the base pairing 
probability from 0 % (purple) to 100 % (red). 
 
The formation of this thermodynamic favourable condensed structure is driven by a 
notable calculated minimal free energy of ΔG = - 31.49 kcal/mol. While the eukaryotic 
translational machinery evidently is capable of initiating the ribosomal assembly, this 
strong mRNA secondary structure probably inhibits the protein production in E. coli 
effectively. In this prokaryotic host a drastic decrease of the translation initiation 
efficiency to 30% or less of the full expression is already observed when mRNA secondary 
structures are formed in the flanking region with a ΔG of ≤ - 5 kcal/mol (Kubo et al., 
1990). The calculated value of the predicted structure of the UTR containing the FRT site is 
6 times higher, what clearly inhibits efficient expression of the target gene. 
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4.2.3 Screening of expressible ECDhTLR5 variants 
TLR5 activates an innate immunity response upon binding of monomeric bacterial 
flagellin. However, the analysis of the structural basis of that recognition is impeded by 
the problematic expression of the receptor protein. The efforts to produce the extracellular 
domain of human TLR5 in the BEVS and by transient expression demonstrated that 
neither the full length domain nor a fusion construct containing the carboxy-terminus of 
soluble rainbow-trout TLR5 can be expressed in soluble form in sufficient amounts. 
Therefore, the new expression vector was utilised for the fast screening of different VLR 
hybrid proteins and truncated variants of the target protein. The hybrid constructs were 
generated according to the LRR hybrid technology as reported for the production of the 
ECD of murine TLR2 (Kim et al., 2007; Jin & Lee, 2008). In total, 8 novel constructs, 
comprising 6 VLR hybrids and 2 truncated variants based on functional data and 
structure prediction were generated and evaluated for their expressibility in transient 
expression in HEK293-6E. 
However, none of these constructs yielded significant amounts of soluble material either. 
The results of parallel expression tests of ECDmTLR2 demonstrated that plasmid based 
transient expression in HEK293-6E might be of disadvantage for this protein class. 
Accordingly, recombinant bacmids were generated with the most promising constructs to 
evaluate their expressibility in the BEVS as well. The parallel generation was facilitated by 
the applicability of pFlpBtM-II for both expression methods so that no recloning was 
necessary. The amount of soluble material obtained from the baculoviral expression of the 
VLR hybrids was however not enhanced compared to the initial constructs. Initial efforts 
to recover intracellular accumulated protein by affinity chromatography upon cell lysis 
remained without success (data not shown). Altogether, 12 different constructs, 
comprising full length ECD variants with different secretion signals, rainbow-trout- and 
VLR-hybrids as well as C-terminally and N-terminally truncated constructs were tested 
for soluble expression in this work. Due to limitations in time and workload available for 
this side project, the generation of further protein variants had to be omitted. Likewise, no 
stable CHO Lec3.2.8.1 producer cell lines were generated via RMCE as no worthwhile 
candidates could be identified among the tested constructs. 
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A very recently published paper, available only a few weeks before this thesis was 
submitted, reported the expression of a truncated VLR-hybrid variant of a TLR5 ortholog 
from the zebrafish (Yoon et al., 2012). The authors strikingly emphasise that the “key 
roadblock against TLR5-FliC interaction studies has been the formidable technical challenge in the 
expression of the mammalian TLR5 ectodomain.” They failed in the expression of ECDTLR5 
from human, mouse, frog, and trout in the BEVS and also in HEK293 which they utilised 
for expression tests of human and mouse ECDTLR5. Moreover, the yield of the full length 
zebrafish TLR5 ectodomain in baculoviral expression was insufficient for structural 
studies. To improve protein yield and crystallizability, the group at the Scripps Research 
Institute also applied the VLR hybrid method. However, sufficient expression was still 
only achieved with the three shortest chimeras, including TLR5 residues 22-181, 22-342 
and 22-390. Notably, the largest of these fragments covers only 18 LRRs and is thus 
missing more than 35 % of the LRRs present in the full length ectodomain. Thereby, it is 
even shorter by 20 % compared to the smallest variant expressed in this work (Figure 4-2). 
 
 
Figure 4-2: Schematic comparison of full TLR5 constructs  
The full length ECD of TLR5 consists of 22 LRR motifs (blue boxes) flanked by N- and C-terminal regions (top). The 
shortest VLR hybrid construct of human TLR5 expressed in this work ranged to aa 480 and comprised 18 LRRs 
(middle). The succesfully expressed and crystallised TLR5 from the zebrafish (Danio rerio, drTLR5) was significantly 
shorter and contained only 14 LRRs (bottom). The C-terminal VLR B.61 capping region is shown as white boxes. The 
red frame represents the boundaries of the models built in the crystal structures. Residue numbers at N/C-terminal 
ends of the fragments are indicated above the module boxes (modified work based on Yoon, et al. 2012). 
 
The fact that only a few constructs could be purified and crystallised is characteristic for 
the challenge in recombinant expression of eukaryotic proteins. Although multiple 
constructs of each target protein are routinely designed based on bioinformatic prediction 
(Graslund et al., 2008) or random truncation libraries generated by automated PCR as 
performed at the ESPRIT platform at the EMBL in Gernoble (Yumerefendi et al., 2010), 
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obtaining soluble material remains a major bottleneck in structural biology. Only 2/3 of 
all target proteins for structural investigation were found to be expressible, and only less 
than 20 % could be obtained with serious effort in soluble form (Figure 4-3). Accordingly, 
the structural genomics consortium (SGC) officially aims at a structure determination 
success rate of 15 - 20 % for their target proteins (Savitsky et al., 2010). 
 
 
Figure 4-3: Structural target proteins statistics 
The values were obtained from the Protein Structure Initiative (PSI) TargetDB as of March, 1st 2012 and include data 
from structural genomics centers worldwide listed in the PSI. The value for solved structures only contains crystal 
structures. (Source: http://targetdb.sbkb.org/statistics/TargetStatistics.html) 
 
The production of challenging target proteins therefore requires a multiple step strategy, 
including combinatorial methods to design a set of several different constructs comprising 
mutants, orthologs, truncations and chimeric proteins as well as a profound screening in 
different expression systems. The tremendous workload using such elaborate techniques 
and tools underlines the need for optimised expression systems such as pFlpBtM-II and 
the usefulness of automated high-throughput pipelines. Likewise, dedicated host cell 
lines, which facilitate the expression of binding partners or auxiliary proteins, represent a 
valuable tool to further increase the success rate.  
The coexpression of chaperones might specifically aid the recombinant overexpression of 
Toll like receptors. Several reports characterise the glucose-regulated protein 94 (grp94) as 
an essential molecular chaperone for Toll-like receptors and integrins (Randow & Seed, 
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2001). It is a paralogue of the cytosolic HSP90 in the lumen of the endoplasmatic reticulum 
and is also known as HSP90b1, ErP99, gp96, endoplasmin, and TRA-1 (Wu et al., 2012). 
Functional studies revealed, that cells without grp94 or with catalytically inactive grp94 
lack functional TLRs which are retained intracellularly in the absence of this chaperone 
(Bloor et al., 2010). Moreover, a drosophila ortholog has been found, which is able to 
chaperone multiple murine grp94 clients including integrins alpha(4), alpha(L), and 
beta(2) as well as TLR2 and TLR9 in grp94 deficient murine cells (Morales et al., 2009). 
Besides the use of the VLR-hybrid technology, the coexpression of this modulator should 
therefore significantly enhance both protein yield and solubility of recombinantely 
produced TLRs in insect cells. To address this, insect master cell lines which enable the 
stable genomic expression of such auxiliary proteins have also been developed in this 
work.  
 
4.3 Generation of lepidopteran RMCE master cell lines 
Protein production in insect cells is usually performed by infecting the host cell line with 
recombinant baculoviruses. However, in many cases, stable genomic expression has been 
found to be a good alternative to the lytic baculoviral expression (Pfeifer, 1998; Kempf et 
al., 2002; Jardin et al., 2007). Moreover, BEVS host cell lines that stably express auxiliary 
proteins such as chaperones, kinases or binding partners can be used for a combinatorial 
approach for the production of demanding target protein. This principle has been applied 
for instance to provide BEVS host cell lines expressing human glycosyltransferases to 
produce glycoproteins with optimised glycan side chains (Hollister et al., 2002; Hill et al., 
2006). However, the beneficial influence of chaperone assisted protein production in 
insect cells has only been demonstrated for baculoviral coexpressed chaperones yet (Ailor 
& Betenbaugh, 1998; Martinez-Alonso et al., 2009). 
In this work, engineered insect cell lines for stable genomic expression were generated by 
the implementation of the RMCE system to enable a fast and flexible integration of 
auxiliary proteins. Thereby, BEVS host cell lines that specifically improve the expression 
of a particular target protein can be provided by the variable genomic coexpression of 
appropriate modulators. Moreover, the RMCE system confers compatibility to the 
existing system in CHO Lec3.2.8.1 used at the Helmholtz PSPF (Wilke et al., 2011). 
  DISCUSSION 
 123  
However, the application of a FACS-based strategy for the isolation of stably tagged 
master cell lines proved to be difficult. In contrast to mammalian cells for which this 
technique has been used and optimised for many years (Nehlsen et al., 2009; Zuberbuhler 
et al., 2009), insect cells lines are obviously much more susceptible to shear stress. As a 
result, a severe decrease in the viability upon sorting was observed. Moreover, the 
tendency of isolated cells to stop proliferating compromised the propagation of single cell 
clones upon sorting, serial dilution and even when methylcellulose based semi-solid 
media were used for the isolation of colonies (data not shown). Despite this bottleneck, 
three RMCE master cell lines Sf21-pie10eGFP-dneo, Hi5-pie10eGFP-dneo and Hi5-
pie10tdTomato-dneo were generated which stably express the corresponding marker 
genes. Since the screening of cell clones expressing the target gene subsequent to the 
cassette exchange relies solely on the G418 selection trap, the sensitivity of the 
lepidopteran cells for preparative sorting will not impede this technique. 
Strikingly, only between 40 - 70 % of the cells of each isolated master cell line 
constitutively produced the markers in detectable amounts. The expression was however 
stable over several months. These findings suggested that in all master cell lines 
subpopulations exist, in which the RMCE cassette might have been deleted after the 
clonal isolation. However, infection assays of the master cell lines expressing eGFP as a 
marker revealed, that all cells of the population carry the genomic integration of the 
RMCE cassette. The activation of the late p10 promoter via baculoviral infection caused a 
significant boost in translational activity resulting in both an increased eGFP expression 
throughout the culture of more than 90 % and a higher fluorescence intensity. Apparently, 
the inhomogeneous expression might therefore result from gene silencing in a certain 
quota within genetically homogenous populations. The silencing of transgenes is a well-
known effect, which often is mediated by cell cycle dependent histone acylation (Pikaart 
et al., 1998; Krebs et al., 1999). The integration of the RMCE cassette in different 
chromosomal loci with varying activity might be another explanation for the 
inhomogeneous expression profile of non-infected cells. This however implies that the cell 
lines are still non-clonal populations. In both cases, the impact of the baculoviral infection 
of the cell and the resulting transcriptional activation of the p10 promoter outweighs the 
epigenetic down- regulation of the weak constitutive expression mediated by the 
baculoviral ie1 promoter. 
DISCUSSION 
 
 124  
Due to the lower gene dose and the weak intrinsic promoter strength of the AcMNPV ie1 
promoter, the expression level of the stably integrated marker protein is 1000-fold lower 
than baculoviral mediated expression as determined by fluorescence quantification. 
However, activation of the p10 promoter mediates a 100-fold increase in the genomic 
expression of the integrated gene. Even though the product concentration is still 10 times 
lower compared the levels reached by baculoviral expression, this inducible expression 
profile is particularly beneficial for the production of auxiliary proteins like chaperones, 
kinases or phosphatases. While low levels of these proteins are provided by the 
constitutive ie1 activity prior to the infection, the expression level is increased when the 
demand for these proteins rises due to the baculoviral production of the main target. This 
two-step optimised expression profile is superior to conventional unbalanced 
coexpression, which may trigger unfavourable side effects (Martinez-Alonso et al., 2010) 
and complicate succeeding downstream processing steps due to excessive amounts of the 
modulating proteins. 
The inducible p10 promoter activity observed in the characterization of the stable cell 
lines might also be utilised for the transient screening of protein variants in unmodified 
insect cells. The subsequent infection of insect cells, which have been transiently 
transfected with either pFlpBtM-I or pFlpBtM-II provides the necessary elements to 
initiate p10 promoter mediated transcriptional activity of target genes encoded on the 
plasmid. Consequently, a boost in the expression level of these proteins is triggered. This 
combination of plasmid based expression driven by a strong very late baculoviral 
promoter should allow the production of sufficient amounts of the encoded target 
proteins for a construct screening without the need for the preceding generation of 
recombinant viruses. This technique will also allow for coexpression of different proteins 
by cotransfecting the host cells with several donor plasmids. By modulating the gene dose 
of each target in the transfection mixture, any desired stoichiometry of the target proteins 
can be achieved. Moreover, whenever a construct proved to be expressible in insect cells 
with this technique, a subsequent integration of the target gene into bacmids for 
reproducible production in larger scale is possible with the same pFlpBtM vector without 
requiring additional recloning steps. 
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5 Conclusions and outlook 
The applicability of the novel expression and transfer vector pFlpBtM-II has been 
demonstrated for different production methods, including transient, viral and stable 
expression. A fast screening for expressible protein variants is possible in the optimised 
mammalian cell line HEK293-6E, but also in Sf21 and Hi5 aided by the p10 promoter 
activation via baculoviral superinfection. Furthermore, the plasmid can be utilised as a 
donor vector in all Tn7-based systems for the generation of recombinant baculoviruses for 
protein production in the BEVS. In combination with the CHO Lec3.2.8.1 master cell line 
developed at our institute and the lepidopteran master cell lines generated in this work, 
the plasmid also acts as a donor vector for fast and flexible RMCE based generation of cell 
lines. This technique can be utilised for both the production of target proteins and the 
deployment of auxiliary proteins for subsequent baculoviral expression. 
Since the performance of the vector was demonstrated with different model protein 
classes it is now used as the new standard eukaryotic expression vector of the Helmholtz 
PSPF. The unique combination of a variety of optimised expression hosts and different 
production methods provides an exceptional infrastructure for protein production. This 
integrated platform which was termed multi-host expression system (mHost-XS) 
therefore is a powerful tool and will significantly fasten the timeline of expression projects 
at the Helmholtz PSPF. The different elements of mHost-XS and the versatile applications 
of pFlpBtM-II are summarised in Figure 5-1. 
Several projects to provide large amounts of high quality protein for structural analyses 
using mHost-XS are currently in the PSPF pipeline, including further Toll like receptor 
variants and viral proteases. Moreover, pFlpBtM-II is in use in the labs of cooperation 
partners throughout Europe, e. g. the Division of Structural Biology at the University of 
Oxford, the Department of Biochemistry of the University of Prague, the Heinrich Pette 
Institute in Hamburg as well as in the structural biology research groups at the 
Universities of Bielefeld, Würzburg and Kiel. 
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Figure 5-1: Overview of the multi-host expression system mHost-XS 
Genes of interest (GOI) integrated into pFlpBtM can be produced by transient expression in HEK293-6E in which the 
EBV oriP provides higher product yields due to episomal replication and enhanced nuclear localization. Plasmid based 
transient expression is also possible in insect cell lines upon infection with a wild-type virus to initiate p10 promoter 
activity. The vector can also be used as a donor vector for Tn7-transposition dependent generation of recombinant 
bacmids for the BEVS. For stable genomic production of proteins in dedicated master cell lines the vector is capable to 
act as a RMCE donor vector in both CHO Lec3.2.8.1 and the novel Sf21 and Hi5 derived master cell lines. Thereby, 
insect cells providing genomic expression of auxiliary proteins (AUX) can be used as optimised host cells for baculoviral 
expression. 
 
Projects to demonstrate the chaperone assisted expression of target proteins upon RMCE 
in the insect cell lines are in progress. Likewise, the technique of baculoviral enhanced 
transient expression upon infection of precedingly transfected cells as well as the use of 
recombinant baculoviruses to transduce mammalian cells will be tested at the PSPF. 
The pioneering work presented here also paves the way for further optimisations of the 
system. The integration of multiple RMCE cassettes into host cell lines for stable 
coexpression of proteins is currently performed in our group. This multiplexing will 
require pFlpBtM variants with alternative FRT sites compatible to the new cassette. By the 
integration of a synthetic remodelled RMCE section into pFlpBtM-II the vector was 
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already prepared for such modifications by the integration of restriction sites flanking all 
RMCE elements like the FRT sites and promoters for their flexible exchange. It is also 
planned to expand mHost-XS to Pichia pastoris by the integration of a corresponding 
RMCE locus into the host cell genome. Additionally, it is worthwhile to evaluate a 
modification in the 5’ UTR of the vector to displace the T7 promoter downstream of the 
FRT site. While the short sequence is expected not to influence expression in the stable cell 
lines upon RMCE, the closer distance between promoter and Shine-Dalgarno sequence 
should enable the use of pFlpBtM for protein production in E. coli as well. By expanding 
the scope of applications of mHost-XS, the value of this tool to widen the bottleneck of 
producing proteins for biochemical and structural analyses will increase even further.  
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Appendix: Oligonucleotides 
Vector construction and mutagenesis 
Name Sequence 5’ → 3’ 
hr5-ie1-p10_BbsI for AGGAGGAAGACTACGGCTGATCATGGAGATAATTAAAATG 
hr5-ie1-p10-NsiI rev AGGAGATGCATTGTGGATCCGCGCCCGATGG 
pFBie10-mut_Bbs-Aat   for GCTTCAGGAGATCGGACGTCCTGATCTGATCATGG 
pFBie10-mut_Bbs-Aat   rev CCATGATCAGATCAGGACGTCCGATCTCCTGAAGC 
Frt-sighis-PGK_BamHI for AGGAGGGATCCGGATCGGGAGATCAGC 
Frt-sighis-PGK_AvrII rev AGGAGCCTAGGCGAGAAGTTCCTATACTTTCTAG 
Triex_Cass_SmaI for AGGACCCGGGTCGACTATTAATAGTAATCAATTACGGGGTC 
Triex_Cass_BamHI rev AGGAGGATCCTGATTGTAAATAAAATGTAATTTACAG 
pTT_Nco_mut   for GGTGGGCTAATGTTGCCTTGGGTAGCATATACTACCC 
pTT_Nco_mut   rev GGGTAGTATATGCTACCCAAGGCAACATTAGCCCACC 
pTT_Bbs_mut   for AGGAGAAGACGACCTTTCCTGTTCAAGAATTAATTCTCATGTTTGACAGC 
pTT_Xma   rev GGGTAGCATATGCTTCCCGGGTAGTAG 
pTT5-backbone_EcoRV for AGGAGATATCAGCGCTGTAGGTGGGCGGGCCAAGATAGG 
pTT5-backbone_SapI rev AGGAGCTCTTCCGCTATGTGAGCAAAAGGCCAGCAAAAGG 
FRT-Cass_Bcl for AGAGATGATCAGAAGTTCCTATTCCGAAGTTCCTATTCTTC 
FRT-Cass_Not rev AGAGAGCGGCCGCGAAGTTCCTATACTTTCTAGAGAATAGGAAC 
   
Sequencing primers 
Name Sequence 5’ → 3’ 
pFlpBtM Seq for CGGATCGGGAGATCAGCTTGAAG 
pFlpBtM Seq rev CAGCCATACCACATTTGTAGAGG 
pFastbac Seq   for TCCGGATTATTCATACCGTCCC 
pFastbac Seq   rev CCTCTACAAATGTGGTATGGCTG 
PCR pFast F for CCCAGTCACGACGTTGTAAAACG 
PCR pFast R rev AGCGGATAACAATTTCACACAGG 
pFastbac PromSeq   for CGAACGAGCGCAAGGTTTC 
pFS_Seq for GGAGATCAGCTTGAAGTTCCTATTCCGAAG 
pTT5_Seq for GGCCATACACTTGAGTGACAATGAC 
pTT5_Seq (pYD5-AS) rev TGTCCTTCCGAGTGAGAGACACAA 
pTT-mut_seq rev AGGGGTTCCGCGCACATTTCC 
Seq_Amp rev GGGGCGAAAACTCTCAAGG 
Frt_Seq_1 for GAACAACCAAGTGACTCCGGG 
Frt_Seq_2 for CAGGTTCAGGGGGAGGTGT 
Frt_Seq_3 rev AACTGGGTGTAGCGTCGTAAGC 
IE1 Promotor   for TGGATATTGTTTCAGTTGCAAG 
IE1 Terminator   rev CAACAACGGCCCCTCGATA 
Seq rtTLR5-c-Term for CCTTACAGCGAACCTCATCCA 
Seq rtTLR5-c-Term rev TCGAACTGCGGGTGGCTC 
TLR5_Seq_internal for GCCTCGCAGCTAATAGCTTG 
eGFP_Prom rev CTTGTGGCCGTTTACGTCG 
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Insert cloning 
Name Sequence 5’ → 3’ 
tomato_BstBI for GGAACTTCGAATTTCCGGTCGCCACCATGGTGAGCAAGGGCGAGGAGG 
tomato_BsaBI rev GGCTGATTATGATCAGTTATCTACTTGTACAGCTCGTCCATGCCGTAC 
BsmBI_mCherry for AGGACGTCTCACATGGTGAGCAAGGGCGAGGAGGAT 
BsmBI_mCherry rev TCCTCGTCTCAGATGCTTGTACAGCTCGTCCATGCCGCC 
His_MluI rev AAATACGCGTTCAGTGGTGGTG 
His_Not rev AGGAGCGGCCGCTCAGTGGTGGTGATGATGATG 
BsmBI_GFP for AGGACGTCTCACATGAGCAAAGGAGAAGAACTTTTCACTGG 
BsmBI_GFP rev TCCTCGTCTCAGATGTTTGTAGAGCTCATCCATGCCATG 
Nco_eGFP for CCGGTCGCCACCATGGTGAGC 
BsmBI_eGFP_stop rev TCCTCGTCTCAGATGCTAGATCCGGTGGATCTGAGTCC 
BsmBI_eGFP_His rev TCCTCGTCTCAGATGGATCCGGTGGATCTGAGTCCGG 
mCherry_Kpn for CCCCGGTACCTTATGGTGAGCAAGGGCGAGGAGG 
mCherry_Not rev CCCCGCGGCCGCCTACTTGTACAGCTCGTCCATGCCG 
GFP_Kpn for CCCCGGTACCGGCCCATCACAAGTTTGTACAAAAAAGCAGGC 
GFP_Not rev CCCCGCGGCCGCTCATTTGTAGAGCTCATCCATGCC 
GFP_CciI for GGTCTATCATGAGCAGCAGCCATCATC 
GFP_Not rev CCCCGCGGCCGCTCATTTGTAGAGCTCATCCATGCC 
mCherry_CciI for CGCCATCATGAGGAGCAAGGGCGAGGAG 
mCherry_Not rev CCCCGCGGCCGCCTACTTGTACAGCTCGTCCATGCCG 
hTLR5 for CCCAGGTCCTCAACACCACTGA 
hTLR5 rev GGTCTTCGTGGCTCACGTCCA 
Nco_TLR for AGGACCATGGGAGACCACCTGGACC 
BsmBI_TLR-wt rev TCCTCGTCTCAGATGCTTTAGGGACTTTAAGACTTCCTCTTC 
BsmBI_TLR-rtC rev TCCTCGTCTCAGATGTATTTTTGTCAAAGATGGTTTTGGGTACTTTTCCG 
TLR5rtC_pFlpBtM-I_Nco for TACGTCGCCATGGGAGACCACCTGGACCT 
TLR5rtC_pFlpBtM-I_BsmBI for AGCGTCTCACTCCATTCCTTCCTGCTCCTTTGATGGCCG 
TLR5rtC_pFlpBtM-I_BsmBI rev TCCTCGTCTCAGATGTATTTTTGTCAAAGATGGTTTTGGGTACTTTTCCG 
hTLR5rtC_pFastBac_SalI for AGGAGGTCGACATGGGAGACCACCTGGACCTTCTCC 
hTLR5rtC_pFastBac_NotI rev GCTCTGCGGCCGCTCAATGGTG 
ssTLR5_pTT_ApaI for AGGAGGGCCCATGGGAGACCACCTGGACCTTC 
ssTLR5_pTT_Not rev GAGCTCTGCGGCCGCTCAATG 
ssTLR5_pTT_Not rev CTCTGCGGCCGCTCAATGGTGATG 
TLR-wt_QC_BsbBI rev TCCTCGTCTCAGATGCTTTAGGGACTTTAAGACTTCCTCTTCATCAC 
ssTLR_BamNco for AGGAGGATCCAACCATGGGAGATCATCTTCACCTTCTCCTAGGAGTGGTG 
TLR-576-Nhe rev AGGAGCTAGCTATATCCAAGACACTAAGTGATACAAATACATCAGG 
TLR-555-Nhe rev AGGAGCTAGCTATGTCCAGGATCTCTAAATTAGCAGG 
TLR-533-Nhe rev AGGAGCTAGCGAGGCTTAGTCCCCTTAATGCAG 
TLR-509-Nhe rev AGGAGCTAGCCAAATACAGAACTTGAAGATGAGAAAGTCCC 
TLR-480-Nhe rev AGGAGCTAGCAAGGAAAAGCTGTTCTAAGCTGGG 
TLR-198-Nhe rev AGGAGCTAGCCCCTTGTAGGGGCTCGAGCTCATG 
ssTLR_BamNco_265_f for AGGAGGATCCAACCATGGGTGCCGGGTTTGGCTTCCATAAC 
TLR_Nhe_591 rev AGGAGCTAGCGATAAAAGTGCTAAGTTCACATTCACAAATGAAC 
mTLR2H8_pFlpBtM-I_BsaI for AGGAGGTCTCACATGCTACGAGCTCTTTGGCTC 
mTLR2H8_pFlpBtM-I_BsaI rev AGGAGGTCTCTGATGGTGCTGGTGACATTCC 
mTLR2H8_pFlpBtM-II_XhoI rev AGGACTCGAGCTGGTGACATTCCAAGACG 
mTLR2H8 in pTT_XbaI for AGGATCTAGACCAATGCTACGAGCTCTTTGGCTC 
mTLR2H8 in pTT_NotI rev CGAAAGCGGCCGCGTTATCAATGG 
scFv-hIgG1Fc_EcoRI for AGGAGAATTCCACCATGGGATGGAGC 
scFv-hIgG1Fc_BamHI rev CTAGAGGATCCTTATTTACCCGGGGAC 
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